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Abstract
Metallothionein complexes are of a complex nature and have 
yet to be fully characterised. The work in this thesis 
concentrates on the complexation of oligopeptide fractions 
similar to those in thionein with cadmium(II) so as to 
simulate the complexation sites in the protein and to help 
clarify the most likely points of attachment of the metal. 
Complexes of related ligands have also been investigated. 
In Chapters 2-5 the preparation of various types of 
ligands, their complexes with cadmium(II) and the solution 
behaviour of these complexes are described.
Cadmium(II) forms octahedral and pseudoctahedral
complexes of the type CdL2X2 or CdLX2 (X = halide) with 
non-thiol ligands such as pyridine, diaminodithiaoctane,
l,3-bis-(2-aminoethyl)-l,3-propanediamine, the Schiff's 
base 2-hydroxyacetophenoneethylenediimine, and
dioxocyclam. In these complexes the ligand complexation 
sites are N or/and 0 atoms with the halides acting as 
bridging ligands.
Ligands which contain thioether donor sites only, e.g. 
tetrathiadioxatricyclohexacosane, do not form complexes 
with cadmium(II), but if another coordinating group is 
present in the same ligand, e.g. NH2 or COOH, complexes 
are readily formed with likely involvement of the 
thioether group in coordination. Hence the complexes 
CdL2 and CdLCl were obtained with S-benzyl-L-cysteine and 
S-benzyl-L-cysteine ethyl ester respectively.
Monocarboxylate monothiol ligands, e.g. cysteine and 2- 
thiolethanoic acid, form the complexes [Cd(HL)X]n in 
ethanol and [CdL]n in water in which X = halide, thiolate 
groups or carboxylate groups act as bridging ligands. In 
case of dithiolate ligands such as 1,2-ethanedithiol, 1 ,3- 
propanedithiol, trans-1 ,2-dithiolcyclohexane and 1 ,4,8,1 1- 
tetrathiaunedecane polynuclear complexes form in which 
all the S atoms complex to one metal and some are also
involved in bridging. Biological thiol ligands such as 
L~cysteine and D-penicillamine also form polymeric type 
complexes with cadmium(II) of formulae [Cd(HL)X]n and 
[Cd(L)]n. A number of peptide complexes of cadmium(II) 
have been isolated. These include [Cd(H2L)Cl]n and 
[Cd3L2]n where H3L is glutathione; Cd2 (HL)Cl3 and Cd2LCl2 
where H2L is gly-cys; Cd2 (HL)Cl2 and Cd(L)Cl where H3L is 
cys-cys; and CdL.xH20 where H2L is gly-cys-gly, gly-cys- 
ala, gly-cys-val, leu-cys-leu and val-cys-val-val.
Dissociation and complex formation equilibria involving a 
number of cysteine-containing tri- and tetra-peptide 
ligands were investigated by potentiometric methods and 
the data analysed using the "MINIQUAD" computer program. 
The ligands investigated were gly-cys-AA (AA = gly, ala, 
val), val-cys-val, thr-cys-val, asp-cys-val, leu-cys-leu, 
val-val-cys-val and val-cys-val-val (their synthesis is 
described in Chapter 4). At ligand to metal ratios of 
1:1 the main complex species in solution are LMH (111), 
LM (110) and LMOH (11-1) the last of these being formed as 
a result of deprotonation of an aquo ligand.
Peptide ligands containing a thiolate and two carboxyl 
groups such as asp-cys-val form higher stability constants 
than those with no thiolate or carboxyl group such as gly- 
gly-gly or those with a thiolate group but with out a side 
chain carboxylate such as val-cys-val. This indicates that 
stronger complexes between Cd(II) and cysteinyl peptides 
will be formed when a coordinating group such as C02 is 
present in the ligand side chain. The major coordinating 
sites are therefore most probably the thiolate, carboxyl 
and terminal amino (when available) groups. Likely 
structures for the complexes formed in solution are 
proposed.
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THE CHEMISTRY AND BIOCHEMISTRY OF 
CADMIUM AND MET AT .1 .OTHTDNETN
1-0 The Chemistry and Biochemistry of Cadmium, and Metallothionein
1.1 Cadmium
1.1.1 Physical and chemical characteristics
Cadmium is a rare, toxic metal which is found at the end 
of the second transition series in group IIB, between zinc 
and mercury. It differs significantly from both although 
it resembles zinc more. Cadmium has the 5s2 4d10
■ • 9 iconfiguration and the 5s electrons can be easily removed 
■ 9 +to give the Cd^ cation. As the ionization energy of 
Cd(II) is very large, Cd(III) compounds are not known. 
The s-p energy separation is smaller for cadmium than for 
either zinc or mercury. The cadmium therefore is more 
easily excited to the valence state and forms a collinear 
covalent bond easier, than for its neighbouring
1 aelements.
Cadmium(II) has a similar ionic radius (0.92A) to that of 
calcium(II), but cadmium(II) is more polarizable, due to 
the larger number of electrons, and more polarizing, due 
to the poor nuclear screening of the 4d10 shell.la This 
implies that compounds of cadmium(II), especially with 
polarisable ligands, will have covalent character. 
Cadmium(II) cations are "softer acids” than zinc(II) 
cations, but "harder acids" than mercury(II) cations.
Both cadmium and zinc have negative reduction potentials,
1
protective agents against corrosion.
Cadmium(II) compounds are by far the most common 
compounds of the metal although a few Cd(I) compounds are 
also known and they resemble those of Hg(I). Compounds 
containing [Cd-CdJ2+ metal to metal bonds exist. There is 
also evidence that Cd(I) exists briefly in solution, when 
Cd(II) is reduced to Cd°.
Cadmium(II) has variable coordination number in its 
complexes. The most common coordination numbers of
cadmium(II) are four and six, yielding tetrahedral and
octahedral arrangements. ^  The arrangement adopted depends 
greatly on the ligand coordinating to the metal. The
homoleptic species, such as [CdL4]2“ and [CdL6]2+, are 
regular tetrahedral and octahedral complexes because of 
the absence of Jahn-Teller distortion and any appreciable 
d-s mixing effects."Soft" donor ligands, e.g. S-donors, 
favour four-coordination, while "hard" donor ligands, 0- 
or N-donors, favour the six-coordination. Some seven and 
eight-coordinate complexes have been isolated with "hard" 
chelating ligands such as nitrates and acetates.
Cadmium(II) on complexation has a tendency to form bridged 
species in both the solid state and in solution. All
halide complexes for example CdCl2 and CdCl2.2(urea) were 
found to be bridged. Sulphur donor ligands have also been 
found to give bridged complexes with cadmium(II), such as
Z n ( I I ) ( - 0 . 7 6 3 V )  <  C d ( I I )  ( - 0 . 4 0 3 V )  a n d  c a n  b e  u s e d  a s
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A point to consider when forming cadmium(II) complexes is 
the metals tendency to coordinate with hydroxy ligands. 
Although the equilibrium constant for the reaction,
Cd1 1 a^g^  + H20 ---- > Cd(OH)+ + H+,
is only 0.07 times that of Zn(II), various basic salts, 
such as Cd(0H)Cl are well known. The possibility of 
[Cd(0H)n (H20)6„n](2“n)+ and derived polynuclear complexes 
in solutions of moderate pH, must not be overlooked.
Comparing zinc, cadmium and mercury it is evident that the 
ionic character of the halides decreases as the molecular 
weight increases, Zn > Cd »  Hg (F »  Cl > Br > I).
Cadmium oxide has the rock salt structure, while zinc and 
mercury oxides have a wurtzite-like structure. The ionic 
character of group IIB compounds decreases in the order, 
Cd > Zn > Hg.
While Cd(II) and Zn(II) complexes are relatively similar 
in strength (i.e have similar formation constants), 
mercury complexes seem to show greater variation. Zn(II), 
Cd(II) and Hg(II) form weak complexes with fluoride but 
much stronger ones with iodide. The very soft ligand 
s2°32” forms strong complexes with the soft metal Hg much 
weaker with Cd and weaker with Zn. Zn is said to be a 
"hard" acid while mercury is said to be a "soft" acid. 
Inevitably, as cadmium lies between them it has "soft" and 
"hard" acid properties. Cadmium(II) forms stronger
C d 1 0 [ ( S C H 2 C H 2 O H ) 1 6 3 4 + . l b
3
« • — 9 —complexes with "soft" ligands, snch as X and S20 3 , and
weaker complexes with "hard" ligands, N03“, Cl", compared 
to zinc(II). All the IIB cations form strong complexes 
with CN", but interactions with CO, NO, alkenes and 
alkynes have been found to be very weak. Some anomalies 
have been found to occur where a "hard" ligand forms a 
stronger complex with cadmium(II) than zinc(II).
Ligands containing deprotonated thiol groups form strong 
complexes and cadmium(II) is held more tightly than 
zinc(II). S-alkylation of the ligand causes the basicity 
to fall and the order of complexation reverses so that the 
zinc ion is now held more strongly.
1.1.2 Uses and environmental considerations
Coating of ferrous metals has been the major use of 
cadmium. A thin film (5-25pm) is applied normally by 
electrolysis using an alkaline cyanide electrolyte. Some 
dipping or spraying techniques have also been occasionally 
used. Cadmium sulphide is used as a pigment in paints and 
enamels as its colour widely ranges from yellow to maroon.
Cadmium salts are used in the inhibition of pvc 
degradation by radiation and or oxidation. Other uses 
of cadmium are in the production of nickel-cadmium 
batteries, low melting solder alloys, semiconductor and 
photovoltaic devices, and control rods in nuclear 
reactors, as cadmium has a good neutron absorbing
4
capacity.
The use of cadmium is being reduced as it is toxic at very 
low levels. The body has poor means of defence and 
excretion and therefore ingested metal concentrates within 
various organs. Its residence time in organisms, 
especially mammals, can be measured in years.2~^ Strict 
limits of the amounts of cadmium permitted in air and 
water have been laid down by many countries,*-4 especially 
in the EC.**
1.2 Metallothionein
Although cadmium is found in small concentrations in the 
earth's crust, its salts accumulate through food-chains in 
animals and especially mammals. The cation is poorly 
absorbed through the mammalian intestine, but once 
absorbed it is stored in the liver and the kidneys6 ' 7 as 
metallothionein, which is a cadmium complex of the low
• , . . R * . «molecular weight protein thionem, which is sulphur rich 
due to the many cysteinyl residues it contains.
Kagi and Vallee9 found that metallothionein from horse 
kidney contained 5.9% Cd2+, 2.2% Zn2+ and 8.5% sulphur,
of which 95% was from cysteinyl amino acid residues. Human 
kidney metallothionein similarly contains 4.2% Cd2+, 2.6%
Zn2+, 0.3% Cu2+ and traces of Hg2+ which are very strongly 
bound to the sulphydryl groups.*-6
B y  r e p e t i t i v e  a d m i n i s t r a t i o n  o f  e x c e s s  c a d m i u m  l a r g e
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quantities of metallothionein were produced in the livers 
of rabbits. It is therefore believed that thionein 
synthesis is induced to provide a defence against the 
toxic heavy metal cation.
Other metals also induce thionein synthesis. Zinc as
well as cadmium metallothioneins have been discovered in
the liver and kidneys of rabbits, 1 0 ' 12 rats, 13 mice, 14
sheep15 and humans. 16 Copper metallothionein has been
1 7  1 8isolated from the intestinal track of chick,x/ rat,x and
bovine. 19 Intestinal metallothionein is known to be
• 90 21 .induced by oral administration of cadmium. ' Cadmium-
metallothionein has been found m  the pancreas,
testes, 2 3 ' 24 blood, 12 brain, heart, lung and spleen. 25
Mercury, 26 gold, 26 silver, 27 and platinum27 metallo­
thioneins have been isolated from various animal organs.
There is no general procedure for the isolation of a
« 7  8metallothionein from animal tissues. Piotrowski et al. ° 
developed a method specifically for rat liver and kidney, 
which is believed to be applicable to other tissues. In 
modern methods of analysis the metallothionein is first 
filtered through a Sephadex G-75 column. Amperometric 
titration with Ag+ provides a rapid and convenient method 
for the determination of the sulphydryl groups of
O Q 4- .(cadmium, zinc)-metallothionein.0f* The Ag displaces 
both Zn2+ and Cd2+ removing all bound cations, except 
Hg2 + . 16
6
Mammalian thioneins are proteins composed of 61 to 62
• , OOamino acid residues of which 18 to 20 are cysteine. They 
do not have any aromatic or histidine amino acid 
residues. 2 9 ' 30 In vivo the cysteinyl residues do not 
exist as such but are either dimerised or bonded to metal 
ions such as Cd2+, Cu2+, Zn2+ or Hg+. Mammalian
metallothioneins also consist of two iso-proteins, I and 
II, although 3 to 4 different ones have been isolated 
within various animal species. 29' 3 1 ' 32 As well as ion- 
exchange separation of iso-proteins, HPLC separation, 
which has a superior resolving power, has been used. 33 
Human metallothionein fraction II has been found to be 
homogeneous, whereas fraction I can be a mixture of at 
least two different proteins where heterogeneity occurs at 
six different amino acid positions. 34
Rat liver metallothionein has been resolved into two
polymorphic forms each of which is homogeneous and retains
9 +  •almost the same amount of Cd*6 cation. The fractions 
were termed I and II and found to retain 33% and 37% of 
cation respectively by polyacrylamide gel electrophoresis. 
The primary structure of form I contains more glutamate, 
valine and leucine but less cysteine, (26% as opposed to 
28%) than form II, accounting for its smaller Cd2+ 
binding.
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1.2.1, Amino acid composition, structure, and properties of thionien
Several amino acid sequences have been found in 
metallothioneins from various animal species such as horse 
kidney (1.1) , 3 5  mouse, 36 rat, 37 rabbit29 and human. 38 All 
sequences show a high cysteine(25-35%), serine(7-17.5%) 
and lysine(10-15%) amino acid residue composition. 
Aromatic amino acids are not found within most thioneins.
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The amino acid sequence of horse kidney metallothionein-IB 
(1.1) is a typical sequence of such proteins. The 
methionine amino acid residue is often found to be the 
terminus of the protein. 35 Horse kidney metallothionein-IB 
is composed mainly of cysteinyl(2 0), serinyl(8), 
alanyl(7), lysyl(7) and glycyl(5) amino acid residues. The 
cysteinyl residues seem to be concentrated towards the 
centre of the thionein and help to maintain rigidity of 
the chain on complexation with the cations. Fourteen out
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of the twenty cysteinyl residues appear as tripeptide 
sequences cys-X-cys, where X is a variable amino acid 
residue. 31 As seven groups of cys-X-cys and seven cadmium 
cations are complexed to the protein, it was strongly 
believed that each cys-X-cys group attaches itself to one 
cation. 37 The other six remaining cysteinyl residues are 
found in two sequences, a cys-cys-X-cys-cys (position 33- 
37) and cys-cys-X-cys (position 57-60).
Thioneins are also noted for their high content in lysinyl 
(6-8) and serinyl (7-10) residues. 38 These residues are 
believed to stabilise the charge at the metal-thiolate 
centres. 00 Most of the other metallothioneins
characterised seem to have very similar amino acid residue 
sequences with some minor differences from that of horse
i • *DQkidney thionein- 1B *
1.2.2 Structure and properties of metallothionein
Cadmium(II) binds three thousand times more strongly to 
thionein than zinc(II) does. Cadmium(II) will displace 
zinc(II), when the zinc(II) complex is dialysed in a 0.5mM 
Cd2+ solution at pH 7.I. 9 ' 10 At pH 4.6 90% of the
zinc(II) is displaced by H+ whereas at pH 3.5 only 50% of
0 4 .  ,  ,  J ,  ,  ,Cd is displaced by H ions, showing the superior 
strength of Cd2+ in complexation with the protein. Both 
Cd2+ and Zn2+ are totally displaced by H+ ions at pH 1.4, 
thus the metal-free thionein-apoprotein can be obtained by 
acidolysis of the metallothionein at pH < 1.4. 8 ' 13 The
9
metal can also be removed by treatment with 0.2M 
mercaptoethanol in 8M urea at pH 8.5 followed by gel-
• A  9filtration in 0.01M hydrochloric acid, or by gel 
filtration on a column of Sephadex G-25 equilibrated with 
lOmM EDTA at pH 3.5.13 The metal-free protein must be 
stored under an inert atmosphere as exposure to air can 
induce formation of intra- and/or inter-molecular 
disulphide linkages.40
The order of affinity for thionein by cations is:
Cu2+ < Zn2+ < Cd2+ < Ag+ < Hg2+.
A spectrophotometric study4 of the competition of H+ ions 
against the cation for (cadmium, zinc)-thionein showed no 
changes between pH 11 and 4.5. As the pH was lowered 
further the UV spectrum began to change and at pH 2 became 
identical to that of thionein.
Thionein has been found to complex to seven Cd2+ or Zn2+
ions41 where the complexation is mainly composed of seven
[M2+(Hcys” )3]“ groups. As coordination of Cd2+ or Zn2+
to three ligand groups is unusual, tetrahedral
coordination at each cation may be completed by an
additional donor group provided by an amino acid residue
other than cysteine such as lysine and/or serine. The
structures of individual metal coordination sites have
been obtained from -L-LOCd-NMR studies of the isotopically
labelled metallothionein I and II, isolated from various 
» 4  9animals. A Seven cadmium atoms were found to be arranged
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clusters, one cluster containing three cations and the 
other four (1.2a and 1.2b). The three cation cluster is 
a "cyclohexane-like" Cd3S3 six-membered ring where nine 
cysteine thiolate ligands complex to the three cations. 
The four-metal cluster forms a bicyclo [3:1:3] structure 
in complexation with eleven cysteine thiolate ligands. In 
total, in the two clusters, five metal ions are linked to 
two bridging and two non-bridging cysteines, while the 
other two are linked to three bridging and one non­
bridging cysteine.
From the crystal structure of (cadmium,zinc)-metallo- 
thionein-II43 it appears that the molecule folds into two 
domains of equal size. 44 The three-metal cluster was 
observed to adopt a hexane "chair" conformation, while the 
four metal cluster forms distorted tetrahedra described as 
a "butterfly" ([3.1.3]).
Metallothionein has structural variability and flexibility 
in the metal-sulphur coordination bonds. The structure can 
undergo various temporary and reforming stages and facile 
exchanges between molecules. 45 Thus the protein exists in 
various conformational and/or configurational states.
1.3 Aim of work
The aim of the work reported in this thesis was to
improve our understanding of cadmium(II)-metallothionein 
interactions by synthesising and studying smaller peptide
complexes in which the ligands mimic the complexing
residues of the protein. As thionein is rich in cysteinyl 
residues the work was concentrated on thiol-type ligands.
To achieve the aim prior to studying peptide-cadmium(II) 
interactions, complexes with simple non-thiol ligands such 
as pyridine, thioethers, amines, amides were to be 
investigated. Complexes of thiols were next prepared.
Finally a series of complexes of cadmium(II) with 
tripeptides and tetrapeptides which contain cysteinyl 
residues were studied. The peptides were synthesised by a
12
solid phase method, and their ionization constants 
determined by potentiometric titrations; the data were 
analysed using the computer program "MINIQUAD". Stability 
constants and species distribution curves for the peptide 
complexes with cadmium(II) were also determined and 
structures inferred on the basis of the results.
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CADMTUM(TT) COMPLEXATTON WITH NON-THIOL
LIGANDS
2.0 Cadmium(II) Complexation with Non-Thiol Ligands
2.1 Introduction
In order to understand the coordination chemistry of 
cadmium(II) in greater depth it was thought best to 
prepare new complexes with a variety of simple non-thiol 
ligands first before proceeding to complexes of peptides. 
The ligands chosen were (i) pyridine (py), (ii) 1,8- 
diamino- 3,6-dithiaoctane (ddo) (2 .1 ), (iii) 1/9-diamino-
3,7-diazanonane (ddn) (2.2), (iv) 2-hydroxyacetophenone- 
ethylenediimine (HapenH2) (2.3), (v) dioxocyclam (H2dxm)
(2.4), (vi) S-benzyl-L-cysteine (2.5), (vii) S-benzyl-L- 
cysteine ethyl ester (2 .6), (viii) 1,4,8,11- 
tetrathiacyclotetradecane (2.7), (ix) 2,8,15,21-tetrathia- 
5,18-dioxotricyclo(20.4.0.0.9.14)hexacosane (2 .8 ), and (x) 
cyclohexene trithiacarbonate (2.9). Attempts to prepare 
complexes of the last three ligands with cadmium(II) were 
unsuccesful, however.
Pyridine complexes of cadmium(II) have previously been
studied, 4 6 ' 47 and stability constants have been 
■ 4 Rdetermined. The crystal structure of the complexes, 
Cd(II)(py)4X2 .2py where X = Cl“, Br“, I” (Section 2.4) 
have been determined. 49 To preserve the crystals they were 
sealed in the presence of excess pyridine in order to 
avoid loss of pyridine ligands and the formation of a 
different cadmium(II)-pyridine complex, possible
structures of which are given in Section 2.4.
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Both 1,8-diamino-3,6~dithioctane (ddo) and 1,9-diamino-
3,7-diazanonane (ddn) were complexed with cadmium(II) in 
the hope that crystal structure determinations would 
reveal the coordination sites and in particular to 
establish whether or not the thioether atoms in ddo and 
the secondary amino groups in ddn, were powerful enough 
donors to form pseudo-octahedral complexes, CdLX2 (where X 
= halide and L = ddn or ddo). The addition of excess 
ligand could produce the complexes CdL2X2. ddo acts as a 
model for peptides and proteins with thioether complexing 
sites from methionine residues. Both ddo and tau are 
believed to be quadridentate in complexes with metal ions 
other than cadmium(II) . 50 Due to the ligands' multiple 
stereochemistry, donor atom arrangement and varied 
solvation sphere characteristics, they are ideally suited 
for mechanistic investigations. This versatility is also 
shown by related ligands such as 1 ,9-diamino-3,7- 
dithianonane (ddtn) (2.1 0), 1 ,10-diamino-4,7-dithiadecane
(ddd) (2.11), 1,3,6,8-tetrazaoctane (2.12), 1,4,7,10-
tetrazadecane (2.13). These ligands can form either a-cis
(2.14), B-cis (2.15) or trans complexes (2.16). The 
cobalt(III) complexes, [Co(L)X2]n+ (where L = ddo, ddn, 
ddd and X = Br-, N3-, NCS”, N02~, oxalate, 2,2'- 
bipyridyl), have the a-cis configuration. 50-52 The
hydrolytic lability of the complexes has been thoroughly 
investigated by Worrell et al. 5 3 - 5 5 The
[Co(ddo)Br2 ][C104] complex has been used for the oxidation
17
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of iron(II).56
o-Hydroxyacetophenoneethylenediimine (HapenH2) is a 
Schiff’s base which acts as a tetradentate ligand since 
the phenolato-oxygen and the imino nitrogen atoms are the 
coordinating sites. Other similar Schiff base ligands 
include the dithiol, N,N'-ethylenebis(dithiolbenzoyl- 
acetoneimine) (2 . 17 ) . 57 Complexes containing ligands of 
this type are very important especially in the 
determination of central atom exchange reaction 
kinetics. 57
2 .17
r s Phenyl
Cyclic macrocycles act as polydentate ligands enclosing 
the metal within the structure and forming a very stable 
complex. Cyclam-type ligands (2.18) have recently been 
used in complexation with various metal ions such as 
Pt(II), Pb(II), Hg(II) and Cd(II) . 5 8 ' 59 As these metals 
are toxic a ligand with selective properties is required 
for therapeutic purposes. Cyclams can undergo large 
conformational changes thus enabling large metal ions such 
as Cd(II) and Pt(II) to fit within its cyclic aperture.
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Octahedral, trigonal bipyramidal, or square planar 
complexes are found with such ligands depending on the 
size of the counter ion. When the counter ion is Cl” the 
complex is usually octahedral while in case of N03- the 
complex is trigonal bipyramidal. 50 As expected the metal 
ion also influences the geometry; Pt(II) and Ni(II) afford 
square planar complexes while Cd(II) gives an octahedral 
one through coordination of the counter ions.
Dioxocyclam (2.19) was found to extract Pt(II) 
selectively from aqueous metal ion mixtures. 59 
Simultaneous deprotonation of the two amide groups occurs. 
The same phenomenon is also evident in many metal peptide 
complexes, to yield square planar species. Complexation 
of cadmium(II) with dioxocylam was investigated so as to 
establish whether the ligand combines with this metal ion 
and hence might have applications in the treatment of 
cadmium poisoning.
2 1
° V ^ x y 0
Tetrathiacyclotetradecane (ttct) and tetrathiadioxa- 
tricyclohexacosane (ttdh) are polyether sulphide type 
ligands. Cyclic ligands such as these form cationic 
complexes with ease. Silver(I) and gold(I) complexes of 
the hexacosane have been isolated, 00 while tetragonal 
complexes of Ni(II) have been isolated with ttct. 01 These 
ligands allow the coordinating capability of thioether 
groups to be assessed and comparisons made.
Complexes of L-cysteine-protected ligands with cadmium(II) 
were also investigated. The ligands chosen were (i) S- 
benzyl-L-cysteine and (ii) S-benzyl-L-cysteine ethyl 
ester. A comparison of cysteine with that of its 
protected derivatives was aimed for.
2.2 Ligand Synthesis
All starting materials were purchased from Aldrich and 
were not purified further unless specified. Infrared 
spectra were recorded on Perkin Elmer 1750 FT-IR or
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Perkin Elmer 577 spectrophotometers. Analyses for C, H and 
N were carried out on a Carlo Erba 1106 microanalysis 
apparatus while cadmium(II) was determined on an 
Instrument Laboratory 357 Atomic Absorption
Spectrophotometer as in Section 3.2.
2.2.1 Synthesis of 1.8-diamino-3,6-dithiaoctane62
1.8-Diphthalimido-3,6-dithiaoctane (ll.Og, 0.026mol) 
obtained as in 2.2 .l(i) was suspended in hot ethanol 
(40cm3). A 50% aqueous hydrazine hydrate (5.0g , 0.08mol) 
solution was added whereupon a solid formed which then 
dissolved and another separated out rapidly. The mixture 
was refluxed for two hours, then concentrated hydrochloric 
acid was added with caution, and the reflux was continued 
for another forty five minutes. The ethanol was distilled 
off and water (30cm3) added. The phthalahydrazine which 
precipitated was filtered off and washed with a small 
portion of water. The filtrate was concentrated to half 
bulk, cooled, and made strongly alkaline with dilute 
sodium hydroxide solution. The oil which separated was 
extracted with dichloromethane (3x100cm ). The 
dichloromethane was evaporated off and the solid which 
remained was purified by vacuum distillation under 
nitrogen (b.p. 126-128°C / 0.1mm Hg). The final product,
1.8-diamino-3,6-dithiaoctane, was stored in ethanol 
saturated with nitrogen. Yield, 3.23g, 73%; m.p. 43-45°C, 
lit.43°C. 62 Infrared bands: 3330(w, sp), v(-NH2) ; 3240(w,
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br), v (-NH2); 3100(w, br), v(-NH2); 1600(s, br), 5(-NH2). 
2.2.l(i) Synthesis of 1.8-diphthalimido-3,6-dithiaoctane 
Ethane-1,2-dithiol (3.7g, 0.04mol) was added to a solution
oof sodium ethoxide made from 1.85g of sodium in 30cm of 
absolute ethanol. Without delay, a solution of N-2-bromo- 
ethylphthalimide (20g, 0.08mol) in hot absolute ethanol
was added slowly. The mixture was refluxed for two hours 
until the reaction was complete. The ethanol was removed 
and the residual solid filtered off, washed with water and 
a small amount of ethanol, and recrystallised from glacial 
acetic acid. Yield, 8.20g, 47%; m.p. 152-154°C, lit.
154°C.02 Infrared bands: 1760(s, sp), v(-C=0); 1700(s,
br), v(-C=0).
2.2.2 Synthesis of_____ 1,8-diamino-3.6-dithiaoctane
dihvdrochloride
1,8-Diamino-3,6-dithiaoctane (2g, lmmol) was dissolved in 
ethanol (25cm3). Calcium chloride dried hydrogen
chloride was bubbled through the ethanolic solution and a 
white crystalline precipitate formed which was filtered 
off, washed with ethanol and dried under vacuum. Yield, 
2.64g, 94%; m.p. 179-181°C. Infrared bands: 3100(m,
SP)r v (-NH3+); 3040(m, sp), v(~NH3+ ); 3000(m, sp), (-
NH3+ ); 1580(s, br), 6 (-NH3+ ).
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2.2.3 Synthesis of l,4,8,ll-tetrazocvclotetradecane-5,7- 
dione (DioxocvclanO
Diethyl malonate was purified by distillation at water 
pump pressure before use.
Diethyl malonate (15g, O.Olmol) and 1,3-bis(2-aminoethyl)-
1,3-propane diamine (15g, O.Olmol) were dissolved in 
absolute ethanol (1000cm3) and refluxed for five days. The 
yellow solution which resulted was concentrated (to 50cm ) 
and left in the fridge for five days. White crystals of 
dioxocyclam were formed which were filtered off and washed 
with a little ethanol. Yield, 5.50g, 26%; m.p., 174-176°C, 
lit, 174-175°C. Found: C, 52.88%; H, 8.93%; N, 24.32%.
Calc. for C10H20N402: C, 52.63%; H, 8.77%; N, 24.56%.
Infrared bands: 3320(s, sp), v(-NH); 3220(s, sp), v(-NH);
3050(w, sp), v(-NH); 1650(s, br), v(-C=0); 1550(s, br),
5(-NH); 1100(s, sp), 6(2° -NH).
2.2.3(1) Synthesis of 1,9-diamino-3,7-diazanonane
1,2-Diaminoethane (89g, 1.48mol) was placed in a 3-necked
round bottom flask equipped with a mechanical stirrer, 
addition funnel and thermometer. The diamine was cooled 
to ice temperature, 1,3-dibromopropane (18.8g, 0.09mol)
was added dropwise, and the mixture stirred vigorously 
over one hour. Once addition was completed the mixture was 
concentrated to one third of its original volume. The 
concentrate was returned to its original vessel and 
potassium hydroxide (15.0g, 0.09mol) added. The new
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new mixture was heated on a water bath for a further two 
hours with efficient stirring after which time the 
solution was cooled to room temperature. The solid which 
separated was filtered off washed with several portions of 
diethyl ether, and disgarded. The ether washings and 
filtrate were combined and evaporated to yield an oil 
which was vacuumed distilled on a 20cm Vigneux column; 
B.p. 108-110°C / 0.1mm Hg, Yield, 9.0g, 61%. Infrared
bands: 3370(m, sp), v(-NH); 3250(m, sp), v(-NH); 1600(w,
br), 6 (-NH). Molecular ion calc., 160; found, 160.
2.2.4 Synthesis of______2,8.15.21-tetrathia-’5,18-
dioxatricvclo (20.4.0.0.9.14) hexacosane
A mixture of trans-l,2-dithiolcyclohexane (see 2.2.4(i)) 
(lOg, 0.067mol) in 1-butanol (87cm3) and sodium hydroxide 
(2.54g, 0.064mol) in water (34cm3) at 60°C was added
dropwise to bis(2-chloroethyl)ether (4.55g, 0.032mol)
diluted with 1-butanol (12cm ) over one hour. The solid 
formed was filtered off and the filtrate concentrated to 
an oil. The residue was dissolved in dichloromethane 
(35cm3), washed with 5% sodium hydroxide (when an emulsion 
formed) and the dichloromethane evaporated. The brown 
oil that remained was transferred to an alumina column 
(1.75" x 6") and eluted with benzene. The first 300cm3 of 
the eluent contained all the desired product. Yield, 
1.54g, 8.2%. Infrared bands: 1130(w, br), v(-C-O-C-).
2 6
Cyclohexene trithiocarbonate (see 2.2.4(H)) (28g,
o0.147mol) dissolved m  tetrahydrofnran (250cm°), was added 
dropwise over a period of two hours to a stirred slurry of 
lithium aluminium tetrahydride (9.1g, 0.24mol) in sodium-
O fdried diethyl ether (175cm°). The heat of reaction 
caused a little refluxing. The mixture was cooled to 0°C,
• *3 • i  .treated very cautiously with water (175cm°), acidified 
with 6M hydrochloric acid and immediately extracted with
■ Qdiethyl ether (3 x 150cm°). The ether extracts were 
combined and washed with sodium bicarbonate and dried over 
anhydrous magnesium sulphate. The solvent was then 
evaporated leaving behind trans-1,2-cyclohexanedithiol as 
a volatile liquid, which was distilled at water pump 
pressure. B.p. 98-100°C / 8-20mm Hg, Yield, 19.Og, 90%. 
Infrared bands: 2550(w, br), v(-SH). Molecular ion calc.,
148; found, 148.
2.2.4(ii) Synthesis of cyclohexene trithiacarbonate
A solution of potassium hydroxide (28.75g, 0.20mol) in
methanol (122cm3) containing carbon disulphide (46.53g, 
0.61mol) was treated with cyclohexene oxide (2 0.Og, 
0.20mol) and the mixture was left overnight at room 
temperature. Water (800cm ) was added and the product was 
heated on a steam bath until the excess carbon disulphide 
was removed. The yellow cyclohexene trithiacarbonate 
obtained was filtered off and washed with water. Yield,
2.2.4(i) Synthesis of trans-1,2-cvclohexanedithiol
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2.2.5 Synthesis of S-benzvl-L-cvsteine ethvl ester64
S-Benzyl-L-cysteine ethyl ester hydrochloride was 
synthesised as in Section 4.8.1.4.
S-Benzyl-L-cysteine ethyl ester hydrochloride (1.5g,
. . .  30.006mol) was dissolved in distilled water (10cm ). To
the solution sodium hydroxide (0.25g, 0.006mol) was added.
The mixture was heated on a water bath for ten minutes and
the water evaporated off. The solid was extracted with
diethyl ether (3 x 100cm3). On standing at room
temperature the ether evaporated off leaving a white
solid. Yield, 1.08g, 85%. Infrared bands: 3270(w, br),
v(-NH2); 3050(w , sp), v(-CH benzene); 1730(s, sp), v(-
C=0); 1585(w, br), 6 (-NH); 1190(m, br), v(-OCH2CH3).
2.2.6 Synthesis of 1,4.8,11-tetrathiacvclotetradecane61
Sodium metal (4.7g, 0.204mol) was dissolved in absolute
ethanol (700cm3) under nitrogen. 1,4,8,11-
Tetrathiaunedecane (TTU) (see 2.2.6(1)) (23.4g, 0.104mol)
was added slowly to this solution which was then refluxed 
gently. To the resulting mixture 1,3-dibromopropane 
(21.Og, 0.0104mol) was added dropwise with stirring. The 
mixture was filtered hot and the ethanol evaporated off. 
The solid which remained was soxhlet-extracted for twenty 
four hours using anhydrous diethyl ether. The ether was 
then evaporated and the white precipitate which remained
2 8 . 6 g ,  8 0 % ;  m . p .  1 6 6 - 1 6 8 ° C .
2 8
was sublimed at 0.1mm Hg at 130°C. The solid was purified 
by recrystallisation from ethanol. Yield, 1.80g, 6.5%;
m.p. 120-121°C, lit.119-120°C.61 %Found: C, 44.51; H,
7*48; %Calc. for 0]_o^2O^4' 44.72; H, 7.52.
2.2.6(i) Synthesis of 1.4.8,11-tetrathiaundecane
1 , ll-Dioxa-4,8-dithiaundecane (see 2.2.6(H)) (10g,
0.038mol), thiourea (7.82g, 0.077mol) and concentrated
hydrochloric acid (30cm3) were refluxed for twelve hours. 
The resulting mixture was cooled and potassium hydroxide 
(17.18g, 0.31mol) in water (105cm3) was added cautiously
and the solution refluxed for a further three hours with 
stirring. The two-layer mixture which resulted was cooled 
and separated. The upper aqueous layer was acidified with 
dilute hydrochloric acid and extracted with diethyl ether 
(2 x 100cm3). The ether extracts were combined with the 
oily, second layer, dried by anhydrous magnesium sulphate, 
filtered, and concentrated to an oily residue. The oil was 
twice purified by vacuum distillation; first boiling 
range, 148-154°C / 0.1mm Hg, second boiling range, 148- 
150° / 0.1mm Hg, Yield, 6.65g (58.2%). Infrared bands: 
2535(m, br), v(-SH).
2.2.6(11) Synthesis of 1,ll-dioxa-4,8-dithiundecane
Sodium metal (4.6g, 0.2mol) was dissolved in absolute
ethanol (200cm3) under nitrogen. The ethanolic solution 
was warmed gently and propane-1,3-dithiol (lOg, O.lmol)
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was added dropwise with stirring. To the resulting 
solution 2-chloroethanol (16.1g, 0.2mol) was added
cautiously and the mixture refluxed for three hours. The 
reaction vessel was cooled and the ethanol evaporated off. 
The oil which remained was distilled at reduced pressure. 
B.p., 160-162°C / 0.1mm Hg. Yield, 15.97g (88%). Infrared 
bands: 3350(s, br), v(-OH), 1005(s, sp), v(-C-O-).
2.2.7 Synthesis^ of 2-hvdroxvacetophenoneethvlenediimine 
(HapenHgl
2-Hydroxyacetophenoneethylenediimine was synthesised as in 
reference 65.
2.3 Preparation of Complexes
2.3.1 Pyridine, p v . complexes
Pyridine was freshly distilled before use and an excess 
was used in all experiments.
2.3.1.1 Diiodobis(pyridine)cadmium(III„ Cd(pv)oI2
Cadmium iodide (0.2g, 0.55mmol) was dissolved in a minimum 
of absolute ethanol. The solution was brought to the 
boil and mixed with hot pyridine (10cm3). After stirring 
for ten minutes on a hotplate the mixture was cooled in an 
ice-bath and crystals formed. The crystals were filtered 
off, washed with a little ethanol and diethyl ether, and 
then dried.
This caused the crystals (thought to be Cd(py)4I2.2py, see
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Section 2.4.1) to collapse a powder which was further 
dried under vacuum at room temperature. Yield, 0.24g 
(84%); m.p. > 300°C(decomp). %Found: C, 22.89; H, 1.91; 
N, 5.34; %Calc• for C10H10N2CdI2: C, 22.89; H, 1.91; N, 
5.34. Infrared bands: 1600(m, sp), v(-C-N).
2.3.1.2 Dichlorobis(Pvridine)cadmium(II) . Cdfpv^CJ^
The preparation of Cd(py)2Cl2 was carried out as above. 
Yield, 0.20g (73%); m.p. > 300°C(decomp). %Found: C, 
34.91; H, 3.25; N, 8.10; Cd, 32.64; %Calc. for 
C10H10N2CdC12: C' 35-15? H/ 2.93; N, 8.20; Cd, 32.93.
Infrared bands: 1600(m, sp), v(-C-N).
2.3.2 l.S-Diamino-S.e-dithiaoctane. ddo. complexes
2 .3.2.1 Diiodo-1.8-diamino-3,6-dithiaoctanecadmium(II)r 
Cd(ddo)Io
The diaminodithiaoctane (0.21g, O.OOlmol) was dissolved in 
ethanol (20cm3). Cadmium iodide (0.23g, O.OOlmol) was 
also dissolved in ethanol (20cm3). The solutions were 
heated, mixed slowly with stirring and left for three 
minutes while warming. A  white precipitate formed which
.  *3 ,was filtered off, washed with ethanol (30cm ) and diethyl 
ether (30cm3) and dried under vacuum. Yield, 0.48g (95%); 
m.p. 209-210°C (decomp). %Found: C, 13.04; H, 2.93; N,
4.75; Cd, 19.75; %Calc. for C6H16N2S2CdI2: C, 13.18; H, 
2.93; N, 4.75; Cd, 19.76. Infrared bands: 3330(s, sp), v(- 
NH2); 3250(s, sp), v(-NH2); 1580(s, sp), 5(-NH2).
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Attempts to recrystallise the complex from various 
solvents were unsuccesful. Recrystallisation from
pyridine caused decomposition of Cd(ddo)I2 to crystals of
Cd(py)4I2 -2py, which further collapsed on drying as 
described in Section 2.3.1.
2.3.2.2 1,8-Diammonium-3,6-dithiaoctane tetrachloro-
cadmium(II), f(ddoHo)1fCdCl l^
1,8-Diamino-3,6-dithiaoctane dihydrochloride (0.lg, 
0.4mmol) was dissolved in methanol (10cm3). Cadmium 
chloride (0.09, 0.4mmol) was also dissolved in methanol
(10cm3). The solutions were mixed and brought to the
Oboil. Diethyl ether (40cm ) was added and the white 
precipitate which formed was filtered off, washed with 
ethanol (10cm ) and diethyl ether (40cm ), and dried under 
vacuum at room temperature. Yield, 0.15g (87%); m.p. 
268-271°C (decomp). %Found: C, 16.03; H, 3.99; N, 6.32;
Cd, 25.44; %Calc. for C6H18N2S2CdCl4: C, 16.49; H, 4.12; 
N, 6.42; Cd, 25.76. Infrared bands: 3150(s, br), v(-NH3); 
1585(s, br), v(-NH3).
2.3.3 1,3-Bis-( 2-aminoethvl)-1,3-propanediamine.
Baepd, complexes
2.3.3.1 Diiodo-1.3-Bis-( 2-aminoethvl)-1,3-propane- 
diaminecadmiumdl) r Cd (Baepd) I2
1,3-Bis-(2-aminoethyl)-1,3-propanediamine (O.lg, 0*62mmol) 
was dissolved m  hot absolute ethanol (10cm ). Cadmium(II) 
iodide was also dissolved in hot absolute ethanol (20cm3).
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The two solutions were mixed and brought to the boil while 
stirring. The white precipitate which formed on cooling 
the mixture in an ice bath was filtered off, washed with 
ethanol (5cm3), diethyl ether (40cm3) and dried under 
vacuum at 50°C. Yield, 0.28g (85%); m.p. > 300°C
(decomp). %Found: C, 15.84; H, 3.85; N, 10.46; %Calc. for 
C7H20N4CdI2: C, 15.96; H, 3.80; N, 10.64. Infrared bands:
3290(s, sp), v(-NH); 3240(s, sp), v(-NH); 3220(s, sp), v(- 
NH); 3140(w, sp), v(-NH); 1590(s, br), 6 (-NH).
2 .3.3.2 Dichloro-1,3-bis-( 2 -aminoethvl)-1.3-propane-
diaminecadmiumdl) , Cd(Baepd)Cl2
This complex, Cd(Baepd)C12 was isolated according to the 
method described in Section 2.3.3.1.
Yield, 0.16g, (75%); m.p. > 300°C (decomp). %Found: C,
24.08; H, 5.52; N, 16.31; %Calc. for C7H20N4CdCl2: C, 
24.46; H, 5.82; N, 16.31.
2.3.4 Complexes of 2-hvdroxvacetophenoneethvlenedi- 
imine, HapenlU
Only one complex was isolated with this ligand, HapenH2, 
as it was found to be insoluble in solvents such as 
ethanol and methanol. This limited the experimental 
procedure to using tetrahydrofuran (THF) in which most 
cadmium(II) salts are insoluble. The most soluble salt 
in THF is cadmium(II) iodide.
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2.3.4.1 Diiodo-2-hvdroxvacetophenoneethvlenediimine
cadmium(IIT, Cd(Hapeni^TI3
HapenH2 (O.lg, 0.34mmol) was dissolved in hot 
tetrahydrofuran (THF) (10cm3). Cadmium(II) iodide
(0.12g, 0.34mmol) was also dissolved in hot THF(20cm3).
The two solutions were mixed hot, whereupon a yellow
precipitate formed. The mixture was cooled in an ice-
• « 3bath, the solid filtered off, washed with ethanol (20cmJ)
and diethyl ether (40cm3), and dried under vacuum at room
temperature. Yield, 0.19g, 85%. %Found: C, 32.92; H,
3.00; N, 4.05; Cd, 17.42; %Calc. for C1 0H2QN2O2CdI2: C,
32.62; H, 3.02; N, 4.22; Cd, 16.97. Infrared bands:
3200(w, br), v(-OH); 1610(s, br), v(-C=N).
2.3.5 Dioxocvclam, Hodxm, complexes
2.3.5.1 DiiododioxocvclamcadmiunUIIT. Cd(HodxmTIo and 
Cd(HodxmTI2.EtOH “ “
Cadmium(II) iodide (0.32g, 0.9mmol) was dissolved in
O ,ethanol (20cm ), as was dioxocyclam (0.2g, 0.9mmol) 
(20cm3). The solutions were brought to the boil, and the 
ligand solution added dropwise to the metal solution. The 
mixture was heated for a further five minutes and cooled
in an ice-bath whereupon a white precipitate formed. The
• . • 3solid was filtered off, washed with cold ethanol (5cm ),
diethyl ether (30cm3) and dried under vacuum at room
temperature. Yield, 0.35g, 72%; m.p. 136-138°C. %Found: C,
19.00; H, 3.16; N, 8.95; Cd, 19.22; I, 40.80; %Calc. for
34
c10H20N4°2CdI2: C' 20-19? 3.37; N, 9.42; Cd, 18.92; I,
42.71. Infrared bands: 3300(s, br), v(-NH) amide; 3060(w, 
br), v(-NH) amine; 1660(s, br), v(-C=0); 1540(s, br), 6 (- 
NH) .
The above procedure was repeated with two equivalents of 
the non-complexing base triethylamine added to the ligand 
solution to encourage deprotonation of the amide nitrogen 
to produce Cd(L) (where L=Cioh18n4°2)* Tbe Product 
isolated was not the required one but instead 
Cd(H2L)I2.EtOH was obtained. m.p. 136-138°C (decomp). 
%Found: C, 22.13; H, 3.82; N, 9.69; I, 39.88. %Calc. for
C10H18N4°2Cd: C' 35-46; H, 5.32; N, 16.55; %Calc. for
C10H20N4°2CdI2*EtOH: C' 22*53? H' 4.12; N,8.80%; I, 39.76. 
Infrared bands: 3290(s, br), v(-NH) amide; 3080(w, br),
v(-NH) amine; 1650(s, br), v(-C=0); 1540(s, br), 6 (-NH). 
The complex is thought to be the triethylamine- 
contaminated Cd(H2dxm)I2.
2 .3.5.2 Dioxocvclammonium tetraiodocadmium(II) dihvdrate 
(H3dxm)oTCdl^l.2H^O
Dioxocyclam (0.2g, 0.9mmol) was dissolved in ethanol and 
two equivalents of glacial acetic acid (O.llg, 1 .8mmol) 
were added. Cadmium(II) iodide (0.20g, 0.45mmol) was
also dissolved in ethanol (20cm3). On mixing the two 
solutions hot a white precipitate formed which was 
isolated and collected in the usual manner. Yield, 0.41g, 
90%; m.p. 201-203°C (decomp). %Found: C, 22.77; H, 3.90;
35
N, 10.31; Cd, 10.00; I, 46.84; %Calc. for C2QH42Ng04CdI4: 
C, 22.26; H, 3.90; N, 10.39; Cd, 10.43; I, 47.09.
2.3.5.3 Dichlorodioxocvclamcadmium(II), Cd(HodxmlClo
Cadmium(II) chloride (0.5g, 2mmol) and the ligand (0.5g,
. « 32mmol) were dissolved separately m  methanol (20cm ). The
two solutions were mixed while boiling. A white
precipitate formed and was filtered off after the mixture
, qhad cooled. The complex was washed with methanol (10cm ) 
and diethyl ether (4 0cm3), and dried under vacuum at room 
temperature. Yield, 0.44g, 80%; m.p. 195-215°C. %Found: 
C, 28.25; H, 4.49; N, 12.79; Cd, 26.25; %Calc for 
C10H20N4°2CdC12: C' 29.17; H, 4.86; N, 13.61; Cd, 27.32.
Infrared bands: 3390(w, sp), v(-NH) amide; 3250(s, sp),
v(-NH) amine; 3070(w, br), v(-NH) amine; 1675(s, br), v(- 
C=0); 1550(s, br), 6 (-NH).
The dioxocyclamcadmium(II) nitrate was also prepared as 
above. %Found: C, 26.44; H, 4.52; N, 17.90; Cd, 25.32;
%Calc• for C10H20N608Cd: C, 25.84; H, 4.31; N, 18.09; Cd,
24.20.
2.3.6 S-Benzvl-L~cvsteine, HL, complexes
2.3.6.1 Bis(S-benzyl-L-cysteine)cadmium(II), CdLo
S-Benzyl-L-cysteine (0.22g, l.Ommol) was suspended in 
water (10cm ) and dissolved by the addition of sodium 
hydroxide (0.04g, lmmol). Cadmium(II) chloride (0.12g,
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0.5mmol) was dissolved in water (10cm3). The aqueous 
solutions were mixed while hot and stirred for five 
minutes. The complex which precipitated was filtered off 
and washed with water, ethanol and diethyl ether, and 
dried under vacuum at 50°C. Yield, 0.24g, 95%; m.p. 218- 
226°C (decomp). Anal.: %Found: C, 45.06; H, 4.65; N,
4.99; Cd, 21.02; %Calc for C20H24N2O4S2Cd: C, 45.08; H, 
4.51; N, 5.26; Cd, 21.11. Infrared bands: 3310(s, sp), v(- 
NH2), 3240(s, br), v(-NH2); 3060(w, sp), v(-CH) phenyl;
3020(w, sp), v(-CH) phenyl; 1640(m, sp), v(-C=0); 1595(s, 
br), v(-C=0); 1570(s, br), 6 (-NH2).
The above preparation was repeated with cadmium(II) 
iodide and an identical complex, CdL2, where HL is the 
neutral ligand was was obtained. M.p. 218-226°C 
(decomp). %Found: C, 45.08; H, 4.48; N, 5.11; Calc, for
C20H24N2°4S2Cd: C' 45-08? H/ 4.51; N, 5.26.
2.3.7 S-Benzvl-L-cvsteinvl ethvl ester, L, complex
2.3,7.1 Chloro-S-’benzvl-L-cvsteinvlethvlestercadmiumfIIT . 
CdfLTCl
S-Benzyl-L-cysteine ethyl ester (O.lg, 0.4mmol) was
■ 3 •dissolved m  absolute ethanol (10cm ) as was cadmium(II)
chloride (0.12g, 0.4mmol). The solutions were mixed
while hot and further heated with stirring for ten
minutes. On cooling in an ice-bath a white precipitate
formed which was filtered off, washed with a little cold
ethanol and sodium-dried diethyl ether and dried. Yield,
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0.16g, 90%; m.p. > 300°C (decomp). %Found: C, 34.01; H, 
4.02; N, 3.18; Cd, 26.13; %Calc. for
34.09; H, 4.02; N, 3.31; Cd, 26.61. Infrared bands:
3310(m, br), v(-NH); 3260(m, br), v(-NH); 3040(m, br), v(-
CH) phenyl; 3020(w, sp), v(-CH) phenyl; 1735(s, sp), v(-
C=*0) ester; 1600(m, sp), 5(-NH); 1045(s, br), v(-C-O)
ester.
2.4 Discussion
2.4.1 Pyridine complexes
Single crystal structure investigations have shown that 
the most favoured structure for cadmium(II) complexes is 
octahedral. 66 Four- and five-coordinate arrangements are 
limited to cases where they are imposed by bulkiness of 
the ligand (steric requirements of the ligand).
As pyridine is a monodentate ligand and cadmium favours 
octahedral complexation the most likely complex in excess 
pyridine, steric factors permitting, is Cd(py)4X2 (X=C1~, 
l“ ) . 22 To confirm this, the crystal structure of 
Cd(py)4I2 .2py (Section 2.3.1.1) was determined. On drying 
the crystals collapse and to overcome this they were 
mounted in a pyridine-rich environment to maintain 
crystallinity. Single crystal analysis showed the complex 
to be octahedrally coordinated to four pyridine nitrogens 
and two iodides in trans position. The crystal structure 
consists of perpendicular layers, built up of trans-
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Cdl2 (py)4 (2.20) units linked together by Van der Waals 
interactions between the ligating pyridine molecules. 
There are also two pyridine molecules of crystallisation 
held in cavities between the layers (2.21). Similar 
clathrate compounds have been found with other complexes 
of formula M(py)4X2*2py ( M = divalent metal, X = 
halogen) . 4 9 ' 72 Bond lengths and bond angles are given in 
Tables 2.1 and 2.2 respectively. Two of the Cd-N bonds 
are shorter than the other two. Weak coordination is 
thought to exist between the cadmium(II) and the longer 
bonded pyridine nitrogens. On washing the crystals, with 
ethanol and diethyl ether, the two lattice pyridine 
molecules and two of the coordinated pyridine molecules 
were removed and the complex Cd(py)2X2 (X = Cl", I") 
formed as shown by elemental analysis. The residual 
complex Cd(py)2X2 is now thought to be either tetrahedral
(2.22), or pseudoctahedral (2.23). Pseudoctahedral 
complexes of cadmium(II) with pyridine ligands and with
• 7 3chloride bridges have previously been reported. J
CC24)
2.20
Atom(1) Atom(2) Bond Length(&)
Cd N 11 2.463(15)
Cd N 21 2.368(15)
N 11 C 12 1.33(2)
N 21 C 12 1.36(2)
C 12 C 13 1.42(2)
C 13 C 14 1.36(2)
C 22 C 23 1.35(2)
C 23 C 24 1.38(2)
Cd I 2.986(15)
Table 2.1. Bond lengths of Cd(py)4I2 complex in
angstroms. Numbers in parenthesis are
estimated standard deviations in theleast significant digits.
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Atom(1) Atom(2) Atom(3) Bond Angle
N 11 Cd N 21 90
C 12 N 11 C 12 117(2)
C 22 N 21 C 22 117(2)
N 11 C 12 C 13 124(2)
C 12 C 13 C 14 117(2)
C 13 C 14 C 13 1 2 1(2 )
N 21 C 22 C 23 123(1)
C 22 C 23 C 24 1 2 1(1 )
C 23 C 24 C 23 117(2)
Table 2.2. Bond angles of Cd(py)4I2 complex in degrees.
Numbers in parenthesis are estimated 
standard deviations in the least significant 
digits.
Complexation of cadmium(II) to pyridine seems to be weak 
as only a small shift is observed in the C-N stretching 
band in the infrared spectrum on complexation (Table 2.3).
C O M P O U N D /C O M P L E X v (O N )
Pyridine (py)
C d(py >2C12 
Cd(py h h
1600 1585
1600 1580 
1600 1580
Tabic 2.3 . Infrared bands o f pyridine and pyrid ine complexes
Four complexes were isolated with pyridine, 
Cd(py)4Cl2 .2(py), Cd(py)4I2 .2(py), Cd(py)2Cl2 and
Cd(py)2I2, the first two are octahedral while the last two 
are pseudoctahedral.
2.4.2 Complexes of 1,8-Diamino-3,6-dithiaoctane and its 
dihvdrochloride
1,8-Diamino-3,6-dithiaoctane, ddo, has four possible 
coordinating sites, the amino groups (~NH2) and the 
thioether groups (-C-S-C-) which are thought to have only 
a small, if any, influence on coordination with 
cadmium(II). The complex isolated from ddo and Cdl2 in a 
1:1 mole ratio in ethanol has the formula Cd(ddo)I2 and is 
thought to be either pseudoctahedral with bridging halide 
ligands (2.24) or more likely octahedral containing a 
tetradentate ligand (2.25). Attempts to prepare the
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complex, [Cd(ddo)2 ]^+ by the addition of two ligands to 
one metal failed. The important infrared bands of the 
complex and the ligand are given in Table 2.4. As the 
amino infrared stretch bands of the complex show a shift 
to lower wavenumber, compared to the free ligand, it can 
be concluded that the amino groups are strongly 
coordinated to the cadmium(II). The thioether (-C-S-C-) 
stretching band shows little or no shift and it can 
therefore be concluded that interaction between the 
thioether sulphur and the cadmium(II) is weak.
r\
\  \ /  .car
.NH,
'NH,
2.24
VJ
2.25
/NH2
COMPOUND/COMPLEX v(-NH2) v(-NH2)-lcm
v(NH2) S(NH2) v(-CS)
ddo 3340 3240 3160 1590 650
Cd(ddo)I2 3310 3250 3130 1580 650
ddo.HCl 3310 3040 3000 1580 650
[CdCLd2' [ddoH2]2+ 3100 3120 3040 1580 720
Table 2.4. Infrared bands of ddo and its complexes.
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In diaminodithiaoctane dihydrochloride only the sulphur 
atoms are available for coordination as the amino groups 
are protonated. Infrared stretching bands, such as those
show a shift to a higher wavenumber. As complexation 
shifts are usually to lower wavenumbers it is thought that
thioether group is not coordinated to the metal. Attempts 
to recrystallise the complex from pyridine yielded only 
the cadmium-pyridine complex, [Cd(py)4C12].
2.4.3 1,3-Bis(2-aminoethvl)-1,3-propanediamine
complexes
The addition of Baepd to CdCl2 or Cdl2 in ethanol afforded 
the complexes Cd(Baepd)X2, X = Cl“, I~. These complexes 
are likely to have the octahedral structures shown in 
2.27. From the infrared stretching bands (Table 2.5) both 
the primary and secondary -NH vibrations show shifts to 
lower wavenumbers indicating coordination to the cation. 
The ligand appears threfore to be tetradentate. Similar
of the -NH and -CS groups in the final complex formed,
the complex [ddoH2]2+[CdCl4]2'" is formed (2.26) and the
2+
2-
2.26
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ligands with both primary and secondary amino groups such 
as bis-(2-aminoethyl)amine, bis-(3-aminoethyl)amine and 2- 
aminoethyl-(3-aminopropyl) amine, also form octahedral 
complexes with cadmium(II) . 7 4 ' 75 Simple primary amine 
ligands such as 1,3-diaminopropane were found to form 
pseudoctahedral complexes, with chloride bridges. 76 Both 
complexes formed needle-like crystals by the slow 
evaporation of the solvent from methanol solution. 
Unfortunately, these did not diffract well enough in X-ray 
diffraction studies for a crystal structure determination 
and no further work was carried out. Pyridine was found to 
have no effect on the complex.
L IG A N D /C O M P L E X v(N H 2) v (N H 2) v (N H  ) 8(-N H )
1.3-B is(2-am inoethyl)-
1.3-propane diam ine 
(Baepd)
Cd(Baepd)Cl2
Cd(Baepd)I2
cm" 1
3370 3300 3250 1600
3350 3280 3240 1590 
3290 3240 3220 1590
Table 2.5. Infrared bands cm" 1 of Baepd and its
complexes.
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2.4.4 2-Hvdroxvacetophenoneethvlenediimine complexes
Non-thiol Schiff *s bases coordinate very weakly to 
cadmium(II). HapenH2 forms the complex Cd(HapenH2 )I2 but 
is thought to be weakly complexed as only small infrared 
shifts were observed on complexation (Table 2.6). 
Suprisingly the phenolic groups are not ionised in the 
complex and remain either uncoordinated or are weakly 
coordinated since there is a small or no change in the 
position of the OH stretching bands as a result of 
coordination. A possible structure of the complex is shown 
in 2.28. Instead the positions of the coordinated phenolic 
groups in the complex may be occupied by bridging iodide 
ligands.
C O M P O U N D /C O M P LE X v (-O H ) v (O N )
HapenH2
Cd(HapenH2) I2-
cm*-1 
3200 1625
3200 1620
Table 2.6 . Infrared bands o f HapenH2 and its complexes.
I
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Only the one complex was isolated as the ligand is soluble 
only in THF and only one cadmium(II) salt (Cdl2) was 
soluble in this solvent.
Pyridine was found to displace the ligand easily, as 
Cd(py)4I2 .2py crystals formed with cold pyridine.
2.4.5 Dioxocvclam complexes
Dioxocyclam (H2dxm) was found to have weak affinity for 
cadmium(II) since no complex could be isolated from 
aqueous solution . However, complexes were isolated from 
non-aqueous solvents, such as ethanol and methanol. 
Attempts were made to deprotonate the amide groups by the 
addition of triethylamine, but these failed. An attempt 
was also made using butyl lithium but the results obtained 
were not satisfactory and are not reported. It is known 
that cyclams have a large enough aperture to accommodate 
cadmium(II) , 58 The complexes isolated with dioxocyclam
are believed to be octahedral, where the cadmium(II) is 
attached to the four nitrogen-donor groups with the 
halides being the counter ions. Infrared stretch bands 
(Table 2.7) show greater shifts for the amino bands than 
those for the carbonyl bands. The infrared stretching 
bands of the complex were found to be much broader than 
those of the ligand.
Four complexes of Cd(II) with dioxocyclam were isolated, 
Cd(H2dxm)Cl2 (2.29), Cd(H2dxm)I2 (2.29), Cd(H2dxm)(N03 ) 2
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COMPOUND/COMPLEX v(-NH) v(-NH) v(-NH) v(-C=0)
i
5(-NH) 5(2°-NH)
Dioxocyclam (H2dxm) 3320 3220
cm
3050 1650 1550 1125
Cd(H2dxm)Cl2 3310 (br)-- > 3060 1660 1540
Cd(H2dxm)I2 3300 (br)-- > 3050 1650 1540 --
Cd(H2dxm)(N03 ) 2 3280 (br)---- -  > 1670 1550
Cd(H3dxm)2I4 3390 3280 3070 1695 1540
Tab le 2 .7 . Infrared bands o f Dioxocyclam  and its complexes
2
2 .29
w +
2 -
[Cd I4]
2 .3 0
4 8
(2.29), Cd(H3dxm)2I4 (2.30). The first three are thought 
to be octahedrally arranged with the halide and nitrate in 
the trans positions. Although amide nitrogen atoms are 
very weakly basic and so are poor coordinating sites in 
this case they may be forced by the chelate effect to 
coordinate to the metal. The last complex, Cd(H3dxm)2I4, 
is more likely to be [Cdl4 ]2”[H3dxm]2+ as is suggested 
from the infrared stretching bands. Several attempts to 
obtain crystals of these complexes failed.
Hot pyridine was found to have no effect on the first 
three complexes but reacted with the fourth complex 
as anticipated on the basis of structure 2.30.
2.4.6 S-Protected L-cvsteinvl complexes
The two S-protected cysteinyl ligands used for 
complexation were S-benzyl-L-cysteine and S-benzyl-L- 
cysteine ethyl ester.
S-Benzyl-L-cysteine was found to be insoluble in most 
common solvents and a mole equivalent of sodium hydroxide 
was added to dissolve it in water. The predominant 
complex formed between this ligand and cadmium(II)
chloride or iodide was CdL2 where HL = S-benzyl-L-
cysteine. The amino group stretching bands of the complex 
are found at a lower wavenumber than for the ligand (Table
2 .8) and it can be concluded that this group is involved
in coordination. It is possible that the complex in this
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case is tetrahedral (2.31) and not octahedral unless 
bridging occurs. An alternative mode of bridging for the 
ligand involves the amino and thioether coordination 
sites. In the tetrahedral arrangement (2.31) two five 
membered rings are formed.
The addition of S-benzyl-L-cysteine ethyl ester to CdCl2 
in ethanol produced on heating a precipitate of the 
complex CdLCl2. In this complex S-Benzyl-L-cysteine 
ethyl ester seems to act as a bidentate N, S ligand (Table
2.8). The ester carbonyl group is not involved in 
coordination as is confirmed by the fact that there is no 
shift in the C=0 stretching frequency on coordination. A 
strong shift to lower wavenumber is observed for the NH 
stretching band as well as band sharpening. Tetrahedral 
coordination or pseudoctahedral coordination with chloride 
bridging (2.32) are the most favourable structures of the 
complex.
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COMPOUND/COMPLEX v(-*OH) v(-NH2) v(-NH2) v(-NH2) 
-1
v(~C=0) v(-C=0)
S-Benzyl-L-cysteine 3140 3050 (br) -
cm
— -------------------------------------- > 1655 1615
Cd(S-benz-L-Cys)2 3320 3310 3240 1640 1595
S-Benz-L-Cys eihyl ester — 3380 3300 1735 ---------
Cd(Benz-Cys ethyl est)Cl2 — 3310 3260 1735 ---------
Tabic 2.8. Infrared bands o f S-Benzyl-L-cysteine (and ethyl ester) and its complexes
O jc h 2-s -c h 2-c h -c ,L v °V 2 /\  '  2.31
Cd
/ \
n h 2
° \  I
C -C H -C H 2-S -C H 2
/
C H 2 v  y  c h 2- c h -c o 2c 2h 5
V a
\ /  ^ n h 5
C l Cd-/ I
2.32
Cl
Cd Cl \
Cd'
5 1
2.5 Conclusions
No complexation occurred when the ligands 2,8,15,21- 
tetrathia-5,10-dioxatricyclo(20.4.0.0.9.14)hexacosane, 
1,4,8,1 1-tetrathiacycloundecane, cyclohexenetrithia
carbonate, and several thioether ligands were mixed with 
cadmium(II) salts.
Three main points emerge from the work described in this 
chapter: (1) For complexes of non-thiol ligands with
cadmium(II) an octahedral preference is shown when the
number of coordination sites and steric factors permit. 
If insufficient coordination sites are available then 
bridging will occur provided a good bridging group is 
present, to yield a pseudooctahedral complex, (2) 
Cadmium(II) has a very low affinity for ether (-C-0-C-)
and thioether (-C-S-C-) donor groups. It can be
concluded that thioether ligands will not complex to
cadmium(II) unless a more influential coordinating group, 
e.g. -NH2/ is present. Thioether type amino acids will 
only coordinate via the amino group and the thioether 
group will have very little, if any, influence on the 
final conformation of the complex, (3) By attempting to 
dissolve the final complexes in hot pyridine a qualitative 
order of stability was established which is Cd(HapenH2 )I2 
~ Cd(ddo)I2 < Cd(py)I2 < Cd(H2dxc)I2 « Cd(Baepd)I2. As the 
Baepd ligand is held stronger by cadmium(II) than ddo, as 
shown from the above order, it can be concluded that
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secondary amino groups have a stronger affinity for 
cadmium(II) than thioether groups do.
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COMPT.F.XATTON OF MONO- AND DI-THIOL 
I.IGANDS WITH CADMTUM(II) IN AQUEOUS AND 
NDN-AQIIEOIJS MEDIA
3 »0 Complexation of Mono- and Di-Thiol Ligands with 
Cadmium(IIT in Agueous and Non-Agueous Media
3.1 Introduction
Although some work on cadmium (II)-cysteine and 
cadmium(II)-glutathione complexes has been referred to 
previously the major part of this is reviewed in this 
chapter. It was considered necessary to extend previous 
work in this area and to investigate other cadmium(II) 
thiol systems. The complexes discussed here are those 
isolated as solids, while those formed in solution are 
described in Chapter 5.
Two types of thiol ligands were used in complexation with 
cadmium(II): biological ligands and their derivatives
such as cysteine (3.1), glutathione (3.2), N,N'-ethylene- 
bis-(L-cysteine) (3.3), glycyl-L-cysteine (3.4), L- 
cysteinyl-L-cysteine (3.5), and mono- and di-thiol ligands 
such as thiolethane (3.6), ethanedithiol (3.7), 
propanedithiol (3.8), 1,4,8,11-tetrathiaundecane (3.9),
and trans-1,2-dithiolcyclohexane (3.10). Complexes of 
these ligands were prepared in agueous and non-aqueous 
(ethanol or methanol) media.
3.1.1 Biological thiol ligand complexes
Interactions of cadmium(II) with biologically important 
ligands, such as amino acids and oligopeptides, are of 
great interest and a better understanding of such
54
HS-CHr CH-COOH
I
NH2
3.1
O
HOOC-CH-CH2-CHr C-NH-CJH-C-NH-CH2-COOH
NH2 O CH2-SH
HS-CH2-CH-NH-CH2-CH2-NH-CH-CH2-SH 3.3
I I
COOH COOH
H2N-CH2-(j-NH-CjH-COOH 3 4
O CH2-SH
O
n
h 2n -c h -c -n h -c h -c o o h  •> <
2 1 I 3 5
c h 2 p 2
SH SH
h s -c h 2- c h 3 3 -6
5 5
H S -C H r CH r SH 3.7
HSCH2CH2CH2SH 3.8
n\S S . 3.9
SH HS
•SH
3.10 
SH
5 6
chemistry can provide an answer as to how metallothionein 
is synthesised within the body on ingestion of cadmium or 
zinc ions. As there is no means of excreting cadmium(II) 
from the body, ligands such as penicillamine, which are
used as antidotes for heavy metal poisoning, may have a
• « • 77vital role m  this area.
3.1.1.1 L-Cysteine and its complexes
Cysteine residues are important constituents of 
metallothionein and so cysteine is the simplest molecule 
which can be used as a model for Cd(II)-metallothionein 
interactions. Its complexation with several metal ions, 
such as zinc(II), mercury(II), lead(II), cobalt(II) , 78- 88 
and (III) , 80 has been extensively studied. The ligand has 
three possible coordination sites, the carboxyl, 
sulphydryl and amino groups. It can therefore act as a 
tridentate ligand and form polymeric complexes in the 
solid and solution states. Several complexes have been 
reported to form in solution with cadmium(II); they are 
discussed in Chapter 5 . 89,90
Many complexes have been isolated but no crystal 
structures have been reported. The main complex which 
forms at physiological pH has the empirical formula 
[Cd(SCH2CH(NH3+)COO) ] n . 7 8 , 9 1 , 9 2 The complex is difficult 
to identify as it is insoluble in most common solvents but 
is thought to be polymeric. Brown and coworkers proposed 
that the complex is trinuclear and of the form
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{Cd[Cd(HL)2 ] )2)'3 [CciCl4 ] 2 (3.11), since the infrared 
stretching bands of [CdCl4]2" have been found at 252cm"
1 QO _A.  ^ In the presence of Br an analogous complex is 
thought to form although there is no absorption band due 
to [CdBr4]2" in this region. The [ZnCl4]2" stretching band 
has been accounted for at 281 cm- 1 in the case of the 
analogous zinc complex. The presence of an -NH3+ group 
was characterised by two bands arising from the symmetric 
and asymmetric bending modes, at around 1510cm"1 and 
1600cm"1 respectively. 94
fa
c -c h -c h 2 ^
/ . \  
cr '  ' ck
\  ** 
c -c h -c h 2
I +
. NFL
^ C H 2- o j c  
•s % . , 0 '  ’ O
M .
:s
c h 2-c h -c
I +
n h 3
2+
[M X J
2-
3.11
The position of the carboxyl stretch in the infrared 
spectrum was used as an indication of the bond strength 
between some metal ions and the carboxylate coordinating 
group. The order was found to be:
Zn2+ > Cd2+ > Hg2+ > Pb2 + . 78 
On the other hand, overall formation constants between 
the ligand and the metal ions above follow the order: 95
Pb2+ > Hg2+ > Cd2+ > Zn2+,
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which reflects the predominant influence of binding to 
sulphur.
Q •Zegzhda et al., have reported the preparation of the
complexes, {Cd[SCH2CH(NH3+)C00]2.2H20} (3.12) and
{Cd[SCH2CH(NH3+ )COO]2}- from cysteine hydrochloride.
HoO
?
H 3N -C H -C -0  s . I 
I k c d : 
c h 2-s  —
+
o -c -c h -n h 3
I
~ - s - c h 2
3.12
H ,0
Reaction of two moles of cysteine with one mole equivalent 
of a cadmium(II) salt in the presence of a base (NaOH) 
yielded the bis-ligand anionic complex
Na2 [Cd[SCH2CH(NH2 )C02]2] (3.13), in which amino group 
complexation is proposed because of the lowering of N-H 
stretching vibrations is evident from the infrared 
spectrum. A nitrogen-15 nmr investigation gave no evidence 
for amino group coordination to zinc(II) at high pH (pH >
10) for complexes of the type [Zn(SCH2CH(NH3 )COO)2]2- 97
c h 2- s  .. _
X  /tt* \  1
J ; c -n r 2 s -c h 2
00c
/
N H 2-C H
coo'
2Na 3. 13
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3.1.1.2 Complexes of derivatives of L-cysteine, D-
penicillamine_______and______2-mercaptoethvlamine
(cvsteamine)
2,2-Dimethyl-L-cysteine, (H2pen), has a very similar
structure to L-cysteine and is believed to exhibit very
similar complexation properties. Simple complexes of
formulae Cd(pen) 9 1 ' 92 and the protonated [Cd(penH)]” 98
have been succesfully isolated similarly to the L-
cysteine complexes. A 3:1 complex is also believed to form
in solution, but has not been isolated. 99 The main
advantage of the complex, Cd(pen), is that on slow
evaporation of the solution a crystalline material is
obtained and two crystal structure determinations of the
complex have been reported. Hexagonal prisms of D-
penicillaminecadmium(II) hydrate, [Cd{NH2CH(C02 )C(CH3 )2S}]
H20, were obtained by the slow evaporation of an aqueous
solution containing stochiometric quantities of
cadmium(II) chloride and D-penicillamine at pH 6.100 The
complex crystallises as a one-dimensional polymer in which
each penicillamine molecule is bonded to four cadmium ions
(3.14). Each cadmium lies in a distorted octahedral ligand
field composed of two sulphur atoms, three carboxylate
oxygens and one amino nitrogen, involving a total of four
ligands. The metal-ligand bond lengths correspond to weak
interactions in contrast to the strong interactions found
• 101in lead(II)-penicillamine. The water molecules were
found to be hydrogen bonded to one amino group, one 
carboxylate atom and two other water molecules.
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The second structure, {CdBr[SC(CH3 )2CH(NH3 )C0 0]H20}.2H20, 
published was of a crystalline material obtained from an 
aqueous ethanol mixture and involves bromide anions acting 
as bridging ligands to yield an octahedral coordination 
arrangement. 97 Infinite chains of alternating cadmium(II) 
ions and bridging tridentate penicillamine molecules are 
linked by asymmetric double bromide bridges. Each 
penicillamine utilises a deprotonated sulphydryl group to 
bind to one cadmium ion and two oxygen atoms of the 
carboxylate group to bond asymmetrically to a second 
cadmium atom (3.15). Overall it can be concluded that 
complexes formed between D-penicillamine and cadmium(II) 
have octahedrally arranged polymeric structures.
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Cysteinyl derivatives used in complexation with 
cadmium(II) include the sulphur protected compounds S- 
methyl-L-cysteine (3.16) and S-ethyl-L-cysteine (3.16). 
The complexes bis(S-methyl-L-cysteinato)-cadmium(II) and 
-zinc(II) have been isolated. 78 A slightly distorted 
octahedral geometry involving the amino and carboxylate 
groups was evident from the crystal structure 
determinations. The geometry is completed by
coordination of two carboxylate oxygen atoms of 
neighbouring ligands at longer distances (3.17). A 
polymeric structure in which there is no thioether 
coordination to the metal was found.
R -S -C H r C H -C O O H
I
n h 2 (R  = -C H 3, -C H 2-C H 3)
3.16
h 3c - s - c h 2
h 2H<p —  N
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O
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N — C H  
H 2
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Complexes of S-ethyl-L-cysteine with Cd(II) in solution 
have been investigated and stability constants determined 
for Cd(L), Cd(L)2, Cd(L)2 (OH), where HL = S-ethyl-L-
cysteine. 163 An order of stability of metal ion complexes 
with S-ethyl-L-cysteine was found to be:
Cu2+ > Hi2+ > Zn2+ > Co2+ > Cd2+ 103
Cysteamine (l-amino-2-thiolethane) (3.18) is a simple
bidentate ligand and its complexes with various metals in 
solution at various metal to ligand ratios have been 
extensively studied. 164 Several mononuclear and
polynuclear cadmium(II) complexes of this ligand have been
. • 2+ characterised m  solution such as, [Cd(HL)2] ,
[Cd(HL)3]2+, [Cd(HL)4]2+, [Cd(HL)2L]+, • CdL2,
[Cd3 (HL)2L2]4+, and [Cd3L4]2" where HL = HS(CH2 )2NH2 . 104
The formation of [Cd(L)]+ and [Cd(HL)]2+ in solution has
also been reported, 165 as well as the stepwise formation
of [Cd(L)]+ and Cd(L2 ) . 95 Polarographic studies of 2-
• • 1 Ofimercaptoethylamme complexes have been carried out.
H2N-CH2-CH2-SH 3.18
Jicha and Busch isolated the complex [Cd(CdL2 )2 ][CdCl4] 
which was proposed to have a structure (3.19) similar to
that of the cysteine complex Cd(HL)Cl. The formation 
and stability of chelates of 2-mereaptoethylamine with 
Ni(II), Pd(II), Pt(II), Zn(II), Cu(II), Co(II), Co(III), 
and Cd(II), have been investigated by G.Ponticelli et
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Thiomalic acid H3L, (3.20) is a thiolate ligand similar to 
cysteine. Complexes with various metal ions e.g, Zn(II), 
Cd(II), Hg(II), and Pb(II) have been studied. 108 The best 
characterised cadmium(II) complex is [Cd(HL)]n. Structure 
characterisation was based on infrared spectroscopy only 
as the complex was found to be insoluble in most common 
solvents. A polymeric structure with oxygen and sulphur 
bridges was proposed.
H O O C -C H -C H r CO O H
i
SH
3.20
3.1.1.3 Complexes of glutathione and other thiol- and 
non-thiol peptides
Complex formation between glutathione and metal ions has 
been widely studied, as the ligand can be synthesised with 
ease, unlike other cysteinyl-containing oligopeptides. 
Most of the work carried out has been on the solution 
chemistry using pH-metric methods. 109' 110 Two complexes 
form at neutral pH between cadmium(II) and glutathione.
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These are Cd(HL) and [Cd(HL)2]2- where H3L = glutathione
and in these the sulphydryl group is coordinated and the
amino group is protonated. Quantitative study of metal-
glutathione complexation presents difficulties due to the
111multiplicity of coordination sites. Carbon-13xx and 
cadmium-113112 nuclear magnetic resonance spectroscopy 
have been widely used to identify the coordination sites. 
It was found that coordination to the various sites 
depends on the pD of the solution. Hence at low pD values 
the sulphydryl group was found to be the only coordination 
site, while at higher pD values all three coordinating 
groups, i.e. the sulphydryl, the carboxylate and amino 
groups, were involved in coordination. Cadmium(II)- 
glutathione complexes show no NH peptide group 
coordination.
Despite the fact that a lot of work has been carried out 
on the solution chemistry very little has been reported on 
the isolation and structures of cadmium(II)-glutathione 
complexes.
Complexes of mercaptopropionylglycine (3.21), with 
cadmium(II) and other metal ions have been 
investigated. 1 1 3 ' 114 Although no complex has been 
isolated with cadmium(II) the mercury(II) complex 
Hg(MPGH)2, where MPGH2 = 2-mercaptopropionyl-glycine, has 
been characterised. In this complex the ligand is 
thought to act in a monodentate fashion and no involvement
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of the carboxyl group in coordination was inferred from 
the infrared spectrum.
Crystal structures of the non-thiol peptido-cadmium(II) 
complexes Cd(L-Met)2, bis-(L-asparaginato)cadmium(II), 
Cd(L-Glu), Cd2 (L-Glu)(H20 ).3H2 0, [Cd(Gly-L-Glu)H20].H20,
Cd(Gly-Gly)2C12 and Cd(Gly-Gly)(H20)C1 showed that (i) 
stable chelate rings of various sizes can form, (ii) the 
carboxyl group can act as a bridging ligand resulting in a 
long chain polymeric complex, (iii) the coordination 
arrangement around the metal is genarally slightly 
distorted octahedral, (iv) in some cases 7-coordination 
was evident, and (v) no coordination was evident between 
the thioether group and cadmium(II). Chloroglycyl- 
glycinato-(imidazole)cadmium(II) was found to have an 
approximately octahedral arrangement with the coordination 
sites as above, occupied by terminal amino, amide 
carbonyl, imidazole, bidentate carboxylato and Cl’", in 
dimeric units. 115 Other complexes isolated include Zn(S- 
cys)2 (His) 2 , 108 where tetrahedral coordination is evident, 
and various non-thiol amino acid-cadmium(II) species. 
Amongst these are the DL-threonine complex and the J5- 
alanine-N-sulphonamide complex where the thioether group 
is not involved in complexation. x
3 .21
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3.1.2.1 Simple polymeric thiol-complexes
Several thiol ligands with and without other coordinating 
groups have been used in complexation with cadmium(II), 
ranging from the simple aliphatic monothiols to the 
thiopropolonates. Aliphatic ligands such as ethanethiol, 
butanethiol, ethane-1 ,2-dithiol and propane-1,2-dithiol 
form various complexes with group IIB metals in solution, 
the stoichiometry of the complex depending on the pH and 
the metal-to-ligand ratio.
Simple complexes such as ML and sometimes ML2, are often 
insoluble in most common solvents. Complexes of higher 
ligand to metal ratios, such as ML4, are often soluble in 
water and in many cases have been studied by various 
spectroscopic techniques, especially cadmium-113, carbon- 
13 and proton nmr as well as UV and MCD.117/118 Monothiol- 
ligand complexes are usually studied at ligand- to-metal 
ratios of 4:1 while dithiol ligand complexes are studied 
at ligand to metal ratios of 2:1 .
Metal-sulphur stretching bands of ethanethiol and 
butanethiol with cadmium(II), zinc(II) and mercury(II) 
have been observed in the far infrared region between
—1 _ i i i q425cm and 100cm •L a X J - * These complexes were found to be 
M (SBut) 2 or M(SEt) 2 where M = Cd(II), Hg(II), Zn(II) by 
elemental analysis. A polymeric tetrahedral structure is
3.1.2 Complexes containing thiol ligands
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17 0the mercury complex.
But But But
I » i
formed (3.22), as confirmed by the crystal structure of
Ethane-1,2-dithiol (H2det) is a ligand which has been
extensively studied in its complexation reactions with
various metal ions, including Ti(II), V(II), Cr(II),
Mn(II), Fe(II), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II).
7 —Two crystalline complexes were isolated [Zn(det)2] and 
[Cd(det)2]2~ and their crystal structures determined. 
These complexes had previously been identified in 
solution by potentiometric studies, but had not been 
isolated. 1 1 7 ' 118 The isomorphous complexes
(Et4N)2 )[M(det)2] where M = Cd(II) or Zn(II), have also 
been isolated as colourless crystals. Both anionic 
complexes were found to be isostructurally tetrahedral
(3.23).
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with monothiol ligands (RSH) in acetonitrile was found to
.  . 191 «yield the M(SR) 2 complex m  high yields. ^  Far infrared
analysis of the complexes showed that polymeric species
were most likely to have formed as in 3.22.
Thiophenols, 122-127 ancj thiopyridines, 1 28- 1 3 0 have also 
been used in complexation with cadmium(II). Thiophenols 
usually yield cage structures and will be discussed in
section 3.1.2.2. Pentachlorothiophenol forms a simple
• * 1 9 9polymeric tetrahedral complex, Cd(SCgCl5 ) 2 as m  3.22. ^
A related complex isolated, bis(toluene-3,4-
dithiolato)cadmate(II) also has a distorted tetrahedral
structure similar to 3.23, where a mononuclear CdS4 kernel
is formed131. The complex is found to have properties
typical of a neutral cadmium-thiolate complex,
insolubility in all but donor solvents, and the CdS2
species formed is a Lewis acid and therefore prone to
polymerisation through sulphur bridging.
• ■ « 19 ft—130 « « ■Thiopyridines, and their non-aromatic thio-
piperidine analogues form simple polymeric complexes and
do not form cage structures. Monothiopyridine acts as a
bidentate N, S ligand, while dithiopyridine acts as a
« . 1 *30 • • ■tridentate ligand. The piperidine complex
[Cd(SC5H9NH(CH3 ))2][C104 32.2H20 has a tetrahedral geometry
around the metal and the nitrogen atoms of the piperidine,
• t a • 1 1unlike pyridine, are not involved m  complexation. '
Direct electrochemical oxidation of anodic cadmium or zinc
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Solution studies of the above system revealed several
polynuclear, polymeric complexes. 133 A complex of 1-
methyl-4,4-dimercaptopiperidine has been isolated where
only one sulphydryl group coordinates to cadmium(II) to
1 34yield a tetrahedral complex.
In conclusion complexes of cadmium(II) with thiol donor 
ligands only seem to favour the distorted polymeric 
tetrahedral arrangement.
3.1.2.2 Cage clusters containing thiol ligand complexes
Several cage complexes of cadmium(II) have been isolated. 
Their observed molecular structures range from
tCd8S12^3+ 135 to [cd10S16^4+ 136-140 in the case of 
2-thioethanol and from [CdS4]2- to [Cd^S^]2-, in the case 
of thiophenol. 1 23 - 1 2 7 Cage structures were first observed 
in complexes of 2-thioethanol with cadmium(II).
The complex [ICdg(SCH2CH2OH)^2]3+ ^as ^een studied by 
crystallography. 135 The eight cadmium cations were found 
to be on the corners of a distorted cube and the centre of 
the cube was occupied by the iodide. The twelve sulphur 
atoms bridge the twelve edges of the cube to form a 
distorted icosahedron and the cadmium is either five or 
seven coordinate.
Cadmium-113 nmr spectroscopy of the complex 
[Cd1 0(SCH2CH2OH)ig]4+ in solution predicted that more than 
one Cd-S framework existed within the entire structure.
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Crystal structures of both the sulphateXJ/ and 
pechlorate1 3 9 ' 140 salts revealed the three frameworks to 
be four distorted CdS303 adamantate like tetranuclear 
fragments, four distorted trigonal bipyramidal CdS40 sites 
and two distorted tetrahedral CdS4 sites. The counter 
ions, S042- and C104~, were found to be involved in 
hydrogen bonding with a water of crystallisation. As well 
as polynuclear cage complexes 2-thioethanol has yielded 
the simple [Cd(SCH2CH2OH)2] which is believed to be 
polymeric with tetrahedral coordination around the 
metal. There is no evidence that the hydroxyl group is
involved in coordination in [(CdS2 ) OQ3 and CC<^ 8S12^3+ 
unlike [Cd10S1g]4+.
Polynuclear metal-thiolates of thiophenols have been 
isolated with various metal ions, Mn(II) , 145 
Fe(II) , 1 4 1 ' 142 Co(II) , 143 Zn(II) , 144 and Cd(II). Various
complexes of cadmium(II) have been fully identified.
7— •[Cd4 (SCgH5) -^q ] contains an adamantate like Cd4 (p-S) 6 
cage composed of distorted Cd4 tetrahedra and highly 
irregular distorted octahedra. Each cadmium(II) has one 
terminal thiolate ligand bound in a distorted tetrahedral 
CdS4 unit. Cd-113 solution nmr of the anionic complex, 
[Cd4 (SPh)iq]2~ revealed Cd-111 to Cd-113 coupling 
indicating cadmium-cadmium interactions. 125 The complex, 
[(C2H5 )3NH]2 [Cd4 (SPh)10] was prepared by the
electrochemical oxidation of the metal in an 
acetonitrile/triethylamine/thiophenol solution mixture.
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The complex obtained was found to be crystalline and of 
the same structure as 3.24.144
S
Another important cluster compound of thiophenol which was 
isolated is [(Me3)4N]4 [S4M 10(SPh)16] (where M = Zn, 
Cd).125 This complex was prepared by the reaction of 
[M4 (SPh)x q ]2" sulphur. The structure of this complex
has been reported.
Ethyl-2-mercaptoacetate coordinates to cadmium to yield 
complexes with two coordination environments, the 
distorted tetrahedron CdS4 and the distorted dodecahedron 
CdS404 .146 The molecular formula was found to be [Cd(jj- 
SCH2COOCH2CH3)]n , indicating the polymeric nature of Cd-S 
complexes•
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Most of the complexes isolated were found to be insoluble 
in common solvents and therefore were difficult to 
characterise. Some crystalline complexes were isolated but 
a crystal structure determination was not possible as the 
crystals were either too small or twinned. Unfortunately, 
a cadmium-113 solid nmr probe was not available and 
characterisation of the complexes was carried out by 
infrared spectroscopy, elemental analysis for C, H, and N, 
and atomic absorption spectroscopy for Cd. Infrared 
spectra were recorded on a Perkin Elmer FTIR
spectrophotometer as described in 2.2.
The following procedure was used for the quantitative 
determination of cadmium(II) by atomic absorption 
spectroscopy. A known quantity of the cadmium(II)
. ■ . . .  3complex was dissolved m  concentrated nitric acid (lcm ) 
and further diluted to a concentration of between 0.5 and
1.5 mg/1. Standard solutions were prepared from a Cd(N03 )2 
solution (lg/1) (BDH). The standard solutions were used 
to establish a calibration curve and the unknown
concentrations were obtained from this curve. Each 
determination was carried out in triplicate.
All starting materials were purchased from Aldrich and 
were purified prior to use, either by recrystallisation 
from a suitable solvent, or distillation. All ligands
3 .2  E xperim enta l
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3.2.1 Cysteinvl ligand complexes
L-Cysteine, H2cys, and L-cysteine hydrochloride were used 
in complexation with cadmium(II). Both of the ligands 
were purified by crystallisation from a water/ethanol 
mixture. Cys, %Found: C, 29.56; H, 5.84; N, 11.56; %Calc. 
for C3H7N02S: C, 29.74; H, 5.94; N, 11.38. Cys.HCl,
%Found: C, 23.02; H, 4.88; N, 9.00; %Calc. for C3H8N02SC1: 
C, 22.86; H, 5.08; N, 8.89.
3.2.1.1 Preparation of chloro-L-cvsteinatocadmium(II), 
Cd(Hcvs)Cl
L-Cysteine (0.2g , 1.7mmol) was dissolved in a minimum
O , ,amount of hot water (lcnr). Cadmium(II) chloride (0.38g,
• * 31.7mmol) was dissolved m  excess absolute ethanol (50cm )
and the two solutions were mixed while hot. A white
precipitate formed. The complex was filtered off, washed
with ethanol, diethyl ether and dried under vacuum at
60°C. Attempts to recrystallise the complex failed as it
would not dissolve in any solvent. Yield, 0.23g (52%).
m.p. > 300°C (decomp.). Anal.: %Found; C, 12.27; H, 2.89;
N, 5.23 (air dried); C, 14.01; H, 2.52; N, 5.30; Cd,
40.12; (60° in vacuum); %Calo. for C3H6H02CdCl.l/8Bt0H; C,
14.26; H, 2.26; N, 5.11; Cd, 41.06; Infrared bands;
3420(w, br), v(-OH) EtOH; 3100(m,br), v(-NH3+ ); 1600(s,
br), v(-C=0).
e le m e n ta l a n a ly s is .
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3 . 2 . 1 . 2  P r e p a r a t i o n  o f  L - c v s t e i n a t o c a d m i u m ( I I ) , C c U C v s )
L-Cysteine (O.lg , 0.83mmol) was dissolved in water
(10cm3 ) together with one equivalent of sodium hydroxide 
(0.033g , 0.83mmol). Cadmium(II) chloride (0.19g ,
0.83mmol) was also dissolved in water (10cm3 ), and the two 
solutions were mixed while hot whereupon a white
precipitate formed. The complex was filtered off, washed
with water, ethanol and diethyl ether, and dried under 
vacuum at 60°C. The complex was found to be insoluble in 
most common solvents. Yield, 0.17g(89%). m.p.> 300°C
(decomp). %Found: C, 14.92; H, 2.78; N, 5.41 (air dried);. 
C, 15.30; H, 2.46; N, 5.28; Cd, 49.23 (60° in vacuum); 
%Calc. for C3H5N02SCd: C, 15.56; H, 2.16; N, 6.05; Cd,
48.58. Infrared bands: 3320(w, sp), v(-NH2 ); 3280(w, sp), 
v (-NH2 ); 1595(s, sp), v(-C=0); 1545(s, br) 6(-NH).
The above complexes (3.2.1.1 and 3.2.1.2) were also
isolated using L-cysteine hydrochloride as starting 
material.
3 . 2 . 2  N , N ' - E t h v l e n e b i s ( L - c v s t e i n e ) , H ^ L ,  c o m p l e x e s
N,N’-Ethylenebis(L-cysteine) was prepared as in sections
3.2.2i,ii and purified by repeated precipitation from its 
sodium salt by dilute hydrochloric acid. Analysis and 
infrared spectrum of the ligand are given in Section 
3.2.2i.
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Thiazolidine-4-carboxylic acid (16g, 0.12mol) was
« ■ i *3 ,suspended m  liquid ammonia (150cm ). Sodium metal was 
then added until a permanent blue colour appeared. The 
mixture was stirred for 30 minutes and then ammonium 
chloride was added until the blue colour changed to brown. 
The excess liquid ammonia was evaporated off and the 
residue was dissolved in water (150cm3 ); the solution was 
filtered and the filtrate acidified with concentrated 
hydrochloric acid to pH 2, whereupon a white precipitate 
formed. The white precipitate was purified by succesive 
precipitation of the acid by the addition of dilute HC1 to 
a solution of its sodium salt, and washed with water 
(400cm3). Yield, 8.3g (52%), m.p. 244°C (Lit.,147 251- 
253°C)• %Found; C, 35.92; H, 6.15; N, 10.42; %Calc. for 
C8H16N2°4S2 : C ' 35.82; H, 5.97; N, 10.45. Infrared
bands: 3100(s, br), v(-NH) andv(-OH); 2540(w, br), v(-
SH); 1600(s, br), v(-C=0); 1500(s, br), 6(-NH); 675(m, 
sp), v(-CS).
3.2.211 Synthesis of thiazolidine-4-carboxvlic acid148
L-Cysteine hydrochloride (50.Og , 0.32mol) was dissolved
in water (170cm3 ) and 40% analar formaldehyde (37cm3 ,
0.49mol) was added.On adding pyridine crystals were formed 
within two hours. The crystals were filtered off, washed 
with a little distilled water and dried under vacuum at 
room temperature. Yield, 23.3g (62%). m.p., 194-196°C
3 . 2 . 2 i  S y n th e s is  o f  N .N * -e th v le n e b is (L -c v s t e in e T 147
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3 . 2 . 2 . 1  N . N 1- E t h v l e n e b i s ( L - c v s t e i n a t o ) d i c a d m i u m ( I I )
m o n o h v d r a t e , C d o L . H o O j  G d 2 —
N,N'-Ethylenebis(L-cysteine) (0.2g , 0*7mmol) was
suspended in water (10cm3) and dissolved by the addition 
of sodium hydroxide (0.06g , 1.4mmol). Cadmium(II)
chloride (0.32g , 1.4mmol) was dissolved in water (lOcnrf). 
On mixing the two solutions while hot a white precipitate 
formed. This was filtered off, washed with hot and cold 
ethanol, and diethyl ether, and dried under vacuum at 
80°C. Yield, 0.28g(90%). m.p. > 300°C (decomp). %Found: C, 
18.42; H, 3.02; N, 5.54; Cd, 43.38 (air dried); %Calc. for 
C8H16N2°6S2Cd2 : C ' 18*29; H, 3.05; N, 5.34; Cd, 42.84;
%Found: C, 19.38; H, 2.56; N, 5.52; Cd, 44.13 (80° in
vacuum); %Calc. for C8H14^2°5S2Cd2 : C, 18.94; H, 2.79; N, 
5.34; Cd, 44.35. Infrared bands: 3500(s, br), v(-OH)
water; 3250(w, br), v(-NH); 1625(m, br), v(-C=0); 1600(s, 
br), 6 (-NH); 725(w, sp), v(-CS).
3 . 2 . 3  G l u t a t h i o n e ,  H 3 L ,  c o m p l e x e s
Glutathione oxidises very slowly in air to form the 
disulphide hexapeptide. Purification of the tripeptide, 
by recrystallisation from an ethanol/water mixture, was 
therefore found to be difficult. %Found:C, 38.96; H, 5.95; 
N, 13.18; %Calc. for C10H17N3O6S: C, 39.08; H, 5.54; N, 
13.18. Many of the complexes isolated were found to give
( l i t . , 148 19 6 -1 9 7 °C ) ;
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unexpected elemental analysis results but were identified 
as far as possible.
3.2.3.1 Chloroglutathionatocadmium(II) , CdfHgcrliQCl
Glutathione (0.2g , 0.7mmol) was dissolved in water
(0.5cm3 ). Cadmium(II) chloride (0.16g , 7mmol) was
dissolved in ethanol (50cm3) and the two solutions were 
mixed while hot whereupon a white precipitate formed. The 
complex was filtered off, washed with ethanol and diethyl 
ether and dried under vacuum at 40°C. Yield, 0.22g(88%). 
m.p. 210-212°C. %Found; C, 26.45; H, 3.72; N, 8.97; Cd, 
24.64; %Calc. for C10H16N3O6SCdCl: C, 26.43; H, 3.52; N, 
8.97; Cd, 24.76. Infrared bands: 3300(s, br), v(-NH) and 
v (-NH2 )? 3100(m, br), v(-OH) carboxylic acid type; 1720(m, 
br) , v(-C=0) amide; 1650(s, br), v(-C=!0) acid; 1555(s,
br), 6(-NH); 740(m, sp), v(-CS).
3.2.3.2 Bis(qlutathionato)tricadmium(II) dihvdrate.
Cd3 (qlu)2 .2HoO
To a solution of glutathione (O.lg , 0.33mmol), sodium
hydroxide (0.04g , lmmol) in water (5cm3 ) was added and 
stirred for a while. The glutathione/sodium hydroxide 
solution was warmed and a solution of cadmium(II) chloride 
(O.llg , 0.48mmol) in water (10cm3 ) was added whereupon a
white precipitate was formed. The complex was filtered 
off, washed with water, ethanol and diethyl ether, and 
dried under vacuum at 40°C. Yield, O.llg(73%). m.p. >
300°C. %Found: C, 24.85; H, 3.30; N, 8.11; Cd, 33.25;
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%Calc. for C2oIi32^6^14826'd3 ! 24.47; H, 3.26; N, 8.56;
Cd, 34.35. Infrared bands: 3400(s, br), v(-OH); 3300(s,
br), v (-NH2 and -NH); 1640(s, br), v(-C=0); 1570(s, br),
v (-C=0) and (-NH).
3 . 2 . 4  G l v c v l - L - c v s t e i n e  a n d  L - c v s t e i n v l - L - c v s t e i n e ,  
c a d m i u m d l T  c o m p l e x e s
Two dipeptides, glycyl-L-cysteine and L-cysteinyl-L- 
cyteine, were prepared by the traditional solution phase 
peptide synthesis of Zervas and complexed with 
cadmium(II). Both peptides oxidise rapidly in air and 
complexation was carried out under nitrogen. The infrared 
spectra of both complexes and ligands were found to be of 
poor quality due to the high hygroscopicity of the
materials. As both ligands were found to oxidise readily 
no pH-metric titrations were possible.
3 . 2 . 4 . 1  T r i c h l o r o - g l v c v l - L - c v s t e i n a t o d i c a d m i u m f I I T . 
C d 2 ( H q l y - C Y s ) c l 3
The yield of glycyl-L-cysteine H2gly-cys was assumed to be 
100% from the deprotection experiment (Section 4.8.2). 
Glycyl-L-cysteine (0.2g, 1.12mmol) in hot ethanol (100cm3 ) 
was filtered into a solution of cadmium(II) chloride
Q(0.51g, 2.24mmol) in ethanol (20cm ) and an adequate
supply of nitrogen was passed through to prevent oxidation
of the ligand. The precipitate was filtered off, washed 
with absolute ethanol and diethyl ether, and dried under 
vacuum at 60°C. Yield, 0.32g(56%). M.p. 219°C (decomp).
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%Found: C r 11.39; H, 2.08; N, 5.60; Cd, 44.07; %Calc. for
C5HllN2°4SCd2C13: C ' 11*40; H, 2.11; N, 5.32; Cd, 42.70.
Infrared bands: 3400(s, br), v(-OH); 1635(s, br), v(-C=0); 
1630(s, br), v (-C=0); 1570(s, br), 6(-NH); The infrared
stretching bands for the amino groups are very difficult 
to pin-point.
3 . 2 . 4 . 2  D i c h l o r o - q l v c v l - L - c v s t e i n a t o d i c a d m i u m ( I I ) ,
c& 2  < g 1  Y -g .y _ s )  £ ± 2
TrichIoro-glycyl-L-cysteinedicadmium(II) (see 3.2.4.1) 
(0.2g, 0.37mmol) was suspended in water and dissolved by
the addition of dilute ammonia solution. The solution 
was heated for a while whereupon a white precipitate 
formed which was washed with several portions of water (5 
x 20cm3), ethanol (2 x 10cm3 ), diethyl ether(2 x 10cm3 ) 
and dried under vacuum at 60°C. Yield, 0.15g (84%). m.p. 
> 300°C (decomp). %Found: C, 12.68; H, 2.10; N, 5.68; Cd, 
45.93; %Calc. for C5H8N203SCd2Cl2: C, 12.71; H, 1.70; N, 
5.93; Cd, 47.65; %Calc. for C5H10N2O4SCd2Cl2 : C, 12.25; H, 
2.06; N, 5.72; Cd, 45.88. Infrared bands: 1635(s, br), 
v(-C=0); 1625(s, br), v(-C=0); 1570(s, br), 6(-NH). The
NH2 stretches could not be assigned.
3 . 2 . 4 . 3  D i c h l o r o - L - c v s t e i n v l - L - c v s t e i n a t o d i c a d m i u m (  I I ) ,  
C d 2 ( H c y s - c y . s ) C l 2
The yield of L-cysteinyl-L-cysteine, H3cys-cys, was 
assumed to be 100% from the deprotection step (section 
4.8.1). L-Cysteinyl-L-cysteine (0.lg, 0.5mmol) in hot
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ethanol (100cm3 ) was filtered into a cadmium(II) chloride 
(0.22g, lmmol) ethanolic solution, under nitrogen to 
prevent oxidation of the ligand. A white precipitate was 
formed which was filtered off, washed with ethanol, 
diethyl ether and dried under vacuum at 60°C. Yield 0.08g 
(40%). m.p. > 300°C(decomp). %Found: C, 13.89? H, 2.44? 
N, 5.55? Cd, 42.60? %Calc. for C6H10N2O3S2Cd2Cl2 : C,
13.90? H, 1.95? N, 5.41; Cd, 43.42. Traces of water seem 
to be present in the complex. Infrared bands: 3420(s, br), 
v(-OH) water? 3330(m, sp), v(-NH); 3260(m, br), v(-NH); 
3060(m, br), v(-NH3)+ ; 1640(s, sp), v(-C=0); 1580(s, br); 
6(-NH).
3.2.4.4 Chloro-L-cvsteinvl-Ii-cvsteinatodicadmium(II) .
Cd2-C^s=cys)Cl
This complex was prepared as in section 3.2.4.2.
Yield, 0.07g(76%). m.p. > 300°C (decomp). %Found: C,
14.83; H, 2.06; N, 5.42? Cd, 47.85; %Calc. for
C6H9N203S2Cd2Cl; C, 14.96? H, 1.87; N, 5.82? Cd, 46.71.
Infrared bands: 3420(s, br), v(-OH); 1630(s, br), v(-C=0);
1620(s, br), v(-C=0); 1580(s, br), 6(-NH). The NH2
stretches were not assigned.
3.2.5 Thiol-organic complexes
Most of the ligands under this category used in 
complexation were of a simple nature. Some of the 
complexes have been previously isolated by other research 
teams, although different complexes were prepared by
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varying the metal/ligand ratio and/or the solvent.
3 . 2 . 5 . 1  I o d o f e t h a n e t h i o l a t o T c a d m i u m f l l T . C d L I
Cadmium(II) iodide (1.18g , 3.2mmol) was dissolved in 
absolute ethanol (10cm3 ). Ethanethiol (0.20g , 3.2mmol) 
was also dissolved in ethanol (10cm3). On mixing the two 
solutions, whilst hot, a fine white precipitate was formed 
which was filtered off, washed with ethanol and diethyl 
ether, and dried under vacuum at room temperature. Yield, 
0.32g (35%). m.p. > 300°C(decomp). %Found: C, 7.29; H,
1.67; Cd, 37.98; %Calc. for C2H5SCdI: C, 7.99; H, 1.67;
Cd, 37.43. Infrared bands: 720(w, br), v(-CS).
3 . 2 . 5 . 2  E t h a n e - 1 . 2 - d i t h i o l a t o c a d m i u m ( I I T . C d L
Ethane-1,2-dithiol (O.lg , 1.06mmol) was dissolved in hot
water (5cm3 ). Cadmium(II) chloride (0.24g, 1.06mmol) was
also suspended in hot water (5cm3) and the two solutions 
were mixed while hot. A white precipitate was formed 
which was filtered off, washed with water, ethanol, and 
diethyl ether, and dried under vacuum at 40°C. Yield, 
0.12g (55%). m.p. > 300°C(decomp). %Found: C, 11.87; H, 
2.10; Cd, 53.21; %Calc. for C2H4S2Cd: C, 11.74; H, 1.96;
Cd, 54.99. %Calc. for C2H4S2Cd.l/4H20: C, 11.49; H, 2.15;
Cd, 53.80. No thiol stretching band was evident in the 
infrared spectrum.
82
3.2.5.3 Propane-1.3-dithiolatocadmium(IIT, CdL
The complex was synthesised and isolated as in section
3.2.5.2. Yield, 0.14g (69%). m.p. > 300°C(decomp).
%Found: C, 15.82; H, 3.10; Cd, 48.96 (before drying); C,
16.40; H, 2.84; Cd, 50.28 (after drying); %Calc. for 
c3H6S2Cds C ' 18-48? H f 2.75; Cd, 51.47. %Calc. for 
C3H6S2Cd.l/4H20; C, 16.15; H, 2.94; Cd, 50.41.
3.2.5.4 1.4.8.ll-TetrathiaundecanecadmiumfII), CdL
1,4,8,11-Tetrathiaundecane (O.lg , 0.44mmol) was dissolved 
in a minimum amount of ethanol (2cm3 ). Cadmium (II) 
chloride (O.lg , 0.44mmol) was dissolved in an excess of
water (20cm3 ). The two solutions were mixed while hot 
whereupon a white precipitate formed. The resulting 
mixture was left to boil until all the ethanol evaporated 
off and the complex was filtered off, washed with water, 
ethanol, and diethyl ether, and dried under vacuum at 
60°C. Yield, 0.13g (93%). m.p. > 300°C(decomp). %Found: 
C, 24.57; H, 4.03; Cd, 32.93; %Calc, for C7H14S4Cd: C, 
24.82; H, 4.14; Cd, 33.21. No thiol stretching band was 
evident in the infrared spectrum.
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3 . 2 . 5 . 5  D i c h l o r o - 1 , 4 , 8 , 1 1 —t e t r a t h i a u n d e c a n e d i c a d m i u m f I I )  
C d o L C l n
Cadmium(II) chloride (0.2g , 0.9mmol) was dissolved in
q  ,absolute ethanol (20cm ). 1,4,8,11-tetrathiaunedecane
(TTU) (0.2g , 0.9mmol) was dissolved in absolute ethanol
q  • • • <(10cm ) and the two solutions mixed while hot. A white 
precipitate was formed which was left to stir, while 
heating, for five minutes. The complex was finally 
filtered off, washed with ethanol, and diethyl ether, and 
dried under vacuum at 40°C. Yield, 0.39g (86%). m.p. > 
300°C(decomp). %Found: C, 16.11; H, 2.68; Cd, 41.46; 
%Calc. for C7H14S4Cd2Cl2 : C, 16.10; H, 2.68; Cd, 43.08. No 
thiol stretching band was evident in the infrared 
spectrum. The ratio of ligand to metal was varied but the 
same complex was obtained.
3 . 2 . 5 . 6  C v c l o h e x a n e - l , 2 - d i t h i o l a t o c a d m i u m ( I I ) , C d L
The complex was synthesised and isolated as in section 
3.2.5.5. Yield, O.lg (57%). m.p. > 300°C(decomp).
%Found: C, 27.97; H, 3.72; Cd, 44.33; %Calc. for
C6H10S2Cdl C ' 27*86; H, 3.87; Cd, 43.50. No thiol 
stretching band was evident in the infrared spectrum.
3 . 2 . 5 . 7  D i c h l o r o - c v c l o h e x a n e - 1 . 2 - d i t h i o l a t o d i c a d m i u m ( I I ) ,  
C d 2 L C l 2 . l / 2 H 2 0
Cadmium(II) chloride (0.63g , 2.8iranol) was dissolved in 
absolute ethanol (20cm3 ). Trans-1,2-cyclohexanedithiol 
(0.2g , 1.4mmol) was also dissolved in absolute ethanol
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(10cm3 ). The two solutions were mixed while hot whereupon 
a gelatinous white precipitate was formed. Filtration 
was carried out by gravity as the complex was very fine 
and went through the filter barrier under suction. Finally 
the complex was washed with a little ethanol, diethyl 
ether and dried under vacuum at 40°C. Yield, 0.25g (32%). 
m.p. > 300°C? %Found: C, 16.20? H, 2.38? Cd, 49.63?
%Calc. for C6H10S2Cd2Cl2 : C, 16.30? H, 2.26? Cd, 50.88?
%Calc. for CgH^QS2Cd2Cl2.1/2H20: C, 15.97? H, 2.46? Cd,
49.86.
3 . 2 . 5 . 8  2 - T h i o l a t o e t h a n o a t o c a d m i u m ( I I ) ,  C d L
2-Thiolethanoic acid (O.lg , l.lmmol) was dissolved in 
water (10cm3 ) and heated to about 60°C. Cadmium(II) 
chloride (0.25g , l.lmmol) was dissolved in water (10cm3 ) 
and the two solutions mixed while hot, whereupon a white 
precipitate formed. The complex was filtered off, washed 
with water, ethanol, and diethyl ether, and dried under 
vacuum at 60°C. Yield, 0.12g (54%). m.p. > 300°C(decomp)? 
%Found: C, 11.45? H, 1.16? Cd, 55.55? %Calc. for
C2H202SCd: C, 11.86; H, 0.99; Cd, 55.54. Infrared bands:
1550(w, br), vf-C^O).
On addition of one and then two mole equivalents of sodium 
hydroxide to the ligand solution prior to the addition of 
the metal cation the following elemental analysis was 
obtained? %Found: C, 11.69; H, 1.16? Cd, 54.31 for one
mole equivalent which represents CdL with some water;
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%Calc. for CdL.l/4H20: C, 11.60; H, 1.21; Cd, 54.32.
%Found: C, 11.66; H, 1.23; Cd, 56.13 for two mole
equivalent which represents CdL.
3 . 2 . 5 . 9  C h l o r o ~ ( 2 - t h i o l a t o e t h a n o i c  a c i d T c a d m i u m ( I I ) , 
C d f H L T C l
The complex was synthesised in ethanol and isolated as in 
Section 3.2.5.7. Yield, 0.48g (47%). m.p.
300°C(decomp). %Found: C, 10.23; H, 1.49; Cd, 47.16;
%Calc. for C2H302SCdCl: C, 10.05; H, 1.26; Cd, 47.05.
Infrared bands: 3530(s, br), v(-OH); 1700(s, br), v(-C=0).
3 . 2 . 5 . 1 0  C h l o r o - m e t h v l - 2 ’- t h i o l a t o e t h a n o a t e c a d n r i . u m ( I I T . 
C d L C l
The complex was synthesised in ethanol and isolated as in 
Section 3.2.5.7. Yield, 0.70g(74%). m.p. 234°C(decomp). 
%Found: C, 13.34; H, 2.15; Cd, 44.93; %Calc. for
C3H5 0 2SCdCl: C, 14.12; H, 1.96; Cd, 44.09. Infrared
bands: 1680(s, sp), v(-C=0); 1175(m, sp), v(-OCH3 ).
3 . 2 . 5 . 1 1  C h l o r o - e t h v l - 2 - t h i o l a t o t h a n o a t e c a d m i u m f  I I T , 
C d L C l
The complex was synthesised and isolated as in Section 
3.2.5.7. Yield, 0.59g (6 6%). m.p. 248°C(decomp). %Found: 
C, 17.60; H, 2.39; Cd, 42.51; %Calc. for C4H702SCdCl: C, 
17.98; H, 2.62; Cd, 42.12. Infrared bands: 1705(s, sp), 
v (~C=0); 1225(s, sp), v(-0CH3 ).
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3 .3 D is cu s s io n
3 . 3 . 1  B i o l o g i c a l  l i g a n d s
3 . 3 . 1 . 1  C v s t e i n v l  c o m p l e x e s
Two complexes were isolated using either L-cysteine 
(H2cys) or L-cysteine hydrochloride (H3cys+ ) as starting 
materials, the product depending on whether or not sodium 
hydroxide was added to the reaction mixture. These have 
the formulae [Cd(Hcys)Cl]n and [Cd(cys)]n . Both complexes 
were found to be insoluble in all common solvents and no 
solution studies were possible. However, infrared bands 
(Table 3.1) give an indication of the coordination sites 
in both complexes isolated.
In the case of [Cd(Hcys)Cl]n the major coordinating group
is thought to be the sulphydryl, as the thiol stretching
.1  « ■ . ■band at 2540cm in cysteine is no longer present m  the
infrared spectrum after complexation. The infrared
spectrum (Spectrum 3.1), with the exception of the thiol
stretching band, is very similar to the specrum of L-
COMPOUND/COMPLEX v(-OH) v(-NH) v(-SH) v(-C=0) 5(-NH) v(-CS)
- 1cm
Cysteine 3160 3060 2540 1610 1580 660
Cysteine.HCl 3370 3020 2560 1740 1620 660
Cd(HCys)Cl <-- 3080 ~> — 1610 1590 ?
Cd(Cys) <-3320, 3270-> — 1590 1540 ?
Table 3.1. Infrared bands of cysteine and cysteine complexes
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cysteine and not L-cysteine hydrochloride. It is
therefore likely that neither the carboxylate group nor 
the amino group is involved in coordination and the amino 
acid ligand is present in the zwitterionic form. The
presence of the -NH3* group is confirmed by the doublet 
arising from the asymmetric and symmetric bending modes 
observed at *1600 and 1510cm”1 (Spectrum 3.I ) . 94 A
complex of the same stoichiometry has been isolated 
previously and this is thought to have a trinuclear 
structure (3.11) as [CdCl4 ]2” stretching bands were
identified at 218cm”1 in the infrared spectrum . 7 8 The 
carboxylate group is said to be coordinated in this
structure. However, because of the similarity between the 
infrared spectrum of the complex isolated in this work and
that of cysteine in the C=0 stretching region it is felt
that the carboxylate group is not coordinated to the 
metal. In the infrared region between 400cm”1 and 200cm” 1 
both the complex and CdCl2 show an absorption band of the 
same intensity (Spectrum 3.2). The complex formed is 
therefore thought to be of a polymeric nature with the
main coordination groups being the sulphydryl and the
chloride, both acting as bridging ligands and giving a 
distorted tetrahedral geometry around the metal (3.25).
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In the preparation of the [Cd(cys)]n complex base was used 
and it appears that in this case the carboxylate group is 
coordinated to the metal since the C=0 stretching band is 
shifted to 1590cm"1 and is much sharper than that in 
Cd(HL)Cl and L-cysteine and at a lower wavenumber. Amino 
group coordination is also possible although no firm 
evidence of this was obtained. The final complex isolated 
is again thought to be of a polymeric nature with both the 
sulphydryl and carboxylate groups involved in bridging. It 
can also have the trinuclear structure of the cation 
described in 3.11. If the amino group is involved in 
complexation then a pseudoctahedral geometry around the 
metal may be found. The [Cd(L)]n complex was also formed 
as an insoluble complex during the pH-metric titrations 
(Chapter 5) of cysteine and cadmium(II) trifluoroacetate 
with base. Elemental analysis results showed very good 
agreement between theoretical and found values and the 
infrared spectrum of the complex was identical to that 
prepared from cadmium(II) chloride and cysteine.
In summary the two complexes formed between L-cysteine 
and cadmium(II) are both thought to be of a polymeric 
nature with sulphur bridging groups. The spatial 
arrangements around the metal are probably that of 
distorted tetrahedra or pseudoctahedra.
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N,N'-Ethylenebis(L-cysteine) is insoluble in common 
solvents and was solubilised in water by formation of its 
conjugate base with NaOH. This was reacted with CdCl2 - 
As the final complex isolated was found to be insoluble in 
all common solvents identification of the coordination 
sites relied heavily on the infrared spectrum (Table 3.2). 
The infrared spectrum shows the absence of a thiol 
stretching band for the complex while the carbonyl (-C*0) 
stretching band is found to be lower than that of the 
ligand. The coordinating sites are therefore the 
carboxylate groups and the sulphydryl group and it is 
likely the amino groups are also coordinated. A possible 
structure for the complex is shown in 3.26. Two water 
molecules complete the distorted tetrahedral environment 
around each cadmium(II).
3 .3 .1 .2  N ,N * -E th v le n e b is (L -cv s te in e T  com p lexes
COMPOUND/COMPLEX v(-OH) v(-NH) v(-SH) v(-C=0) 8 (-NH) v(-CS)
N,N'ethylenebis- 
(L-cysteine) 
(H4L)
Cd2(L)
- 1cm A
3100 ? 2540 1600 1580 675
3500 3250 -—  1580 1570 ? 
H20
Table 3.2. Infrared bands of N,N'ethylenebis(L-cysteine) 
and its complexs.
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3 .3 .1 .3  G lu ta th io n e  com plexes
Two complexes were prepared with glutathione, H3glu, 
[Cd(H2glu)Cl]n and [Cd3 (glu)2]n , the product obtained 
again depending on whether or not sodium hydroxide was 
added to the reaction mixture. The main coordinating sites 
of the complexes were again found to be the sulphur atoms 
in both complexes, as well as the carboxylate group in the 
latter complex. Characterisation of the coordinating sites 
was achieved from the infrared spectrum (Spectrum 3.3) as 
both complexes were found to be insoluble in all common 
solvents.
Four main points can be extracted from the infrared
spectra: (i) No thiol stretching band is found in the
spectrum for either complex, (ii) For the complex 
[Cd(H2glu)Cl]n a C=0 stretching band is observed at 
1720cm"1 which is also observed for glutathione, 
indicating that there is no coordination between the
carboxylate group and the cadmium(II) in this complex,
(iii) For the complex [Cd3 (glut)2]n the carboxyl
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stretching band at 1720cm x is missing but there is a band
— 1 « *at 1570cm , the position of which indicates strong
complexation of both the carboxyl groups to the metal.
Polymeric complexes [Cd(H2glut)Cl]n are most likely to 
have formed, having -Cl and -S- bridges while
[Cd3 (glut)2 ]n has -S- and -O- bridges. Possible 
structures are given in 3.27 and 3.28.
0
1
0 ( X : - p - C H 2-CH2-^NH-(jH-C-NH-CH2-C(X)H 3.27
™ + O CHL-S
\  C l
C d * - '
NH,
/  \
C l
..................
0  Ss°
\  y,c-ch-ch2-ch2-c-nh-ch-c-nh-ch2-c
/  I 1 /  i  OO NH, o  CH2 O .
V  \
/  \
n h 2 o  o s
' I
- C = °
3 . 3 . 1 . 4  T h i o l  d i - .  t r i -  a n d  t e t r a - p e p t i d e  c o m p l e x e s
Cadmium(II) complexes of cysteine-containing peptides have 
been of major interest for some while but despite this 
relatively little information is available on such 
systems. No cysteinyl peptides with the exception of
95
glutathione have been studied extensively in complexation 
with cadmium(II) possibly because these peptides are 
vulnerable to oxidation in the atmosphere and, like most 
peptides, are very hygroscopic. As this chapter 
concentrates on the isolation of thiol-complexes with 
cadmium(II), several of these complexes were synthesised.
Two cysteinyl dipeptides were complexed with cadmium(II), 
L-cysteinyl-L-cysteine (H3cys~cys) and glycyl-L-cysteine 
(H2gly-cys). Since both ligands oxidise readily in the 
atmosphere they were complexed immidiately after 
synthesis, in hot ethanol and under an inert atmosphere. 
In the case of Hgcys-cys there are several potential 
coordinating groups; these are the two thiol groups, the 
amino and carboxylate groups, and the peptide oxygen, 
while for H2gly-cys the complexation sites are the same 
except for one less sulphydryl group. Two complexes were 
isolated from H2gly-cys, Cd2 (Hgly-cys)Cl3 and Cd2 (gly- 
cys)Cl2 . In the formation of the Cd2 (Hgly-cys)C13 complex 
in ethanol, deprotonation and coordination of the thiol 
group to the cadmium(II) take place. The major
coordination sites are thought to be the carboxylate and 
thiolate groups, and peptide oxygen. The chloride anion 
and the sulphur are probably acting as bridging ligands 
forming distorted tetrahedral environments around the 
cadmium(II), as shown in structure 3.29.
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✓ °
+n h 3-ch2-c -n h -ch -c
II I \  -
0  CH2 O 3.29
1 A  /
“  N Cd
/  \  /  \
Cl Cl Cl
The complex formed in basic aqueous solution is of 
similar stoichiometry but has one less H and Cl. It is 
therefore proposed that deprotonation of the -NH3+ occurs 
and the -NH2 group coordinates to the metal displacing one 
of the Cl- ligands as in structure 3.30.
HXN I 3.30
For H3cys-cys the complexation arrangement is potentially 
different from that of H2gly-cys since two thiol groups 
are now available for coordination. In ethanol a 
complex of stoichiometry (Hcyscys)Cd2Cl2 was isolated by 
the addition of the ligand to CdCl2. The absence of -SH 
stretching bands in the infrared spectrum of the complex 
confirms that these groups are ionised and complexed to 
the metal ions. The position of the C=0 stretching band 
at 1580cm"1 also confirms coordination of the terminal
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carboxylate group to the metal. A possible structure for 
this complex is shown in 3.31. As in the case of the 
gly-L~cys complex the suspension of the above complex in 
aqueous ammonia results in deprotonation of the NH3+ 
group, loss of HC1 and the production of a complex of 
stoichiometry (L-cys-L-cys)Cd2Cl with its proposed
structure shown in 3,32.
Cd Cd
\  /  \
C l  C l
3.32
/ ° \
Cl s or Cl (neighbouring)
Although the infrared spectra of the complexes obtained 
above are not sufficiently clear to pin-point the 
coordination sites accurately, the spectra together with 
knowledge of previous structures, have been used to arrive 
at the likely structures. In these structures distorted 
tetrahedral geometry around the metal is proposed.
The p r e p a r a t io n  o f  th e  t r i -  and t e t r a -p e p t id e  com p lexes
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using the ligands gly-cys-gly, gly-cys-ala, gly-cys-val, 
leu-cys-leu and val-cys-val-val were carried out following 
the pH-metric studies described in Chapter 5. The pH of 
the solution was first adjusted to pH 6.5 - 7.0, and then 
the solution was concentrated and methanol was added in 
excess to precipitate the complex. The complex was 
filtered off and washed well with methanol and water to 
eliminate any sodium perchlorate which had been added to 
maintain constant ionic strength during the titration. As 
previously, the complexes isolated were found to be 
insoluble in all common solvents.
The elemental analyses for the complexes precipitated in 
the pH range 6 . 5 - 7  agreed with only one formulation, 
CdL.xH20, where H2L represents the tri- or tetra-peptide. 
The analyses are given in Table 3.3. From Table 3.4 
which contains the important infrared bands it is clear 
that the primary coordination sites are the carboxylate 
and thiolate groups as stretching bands due to SH groups 
are absent and those corresponding to carboxylate C=0 
stretching appear at lower wavenumbers than for the free 
ligands. Since the amino groups are in the free base form 
they too are likely to be involved in coordination. A 
possible structure for the tripeptide-cadmium(II) 
complexes is shown in 3.33a. This monomeric structure 
contains a central 6-membered ring flanked by a 7-membered 
ring with a 5-membered ring at the N-terminus and a 7- 
membered ring at the C-terminus. Alternative structures
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which contain pseudooctahedrally coordinated cadmium(II) 
are possible. One of these is shown in 3.33b and is 
dimeric. Since the analytical data show the presence of 
water molecules in these complexes it is possible that 
aqua ligands may be involved in structures 3.33a and 
3.33b.
COMPLEX
C
%FOUND 
H N
%CALCULATED j 
C H N
Cd(Gly-Cys-Gly)
Cd(C7H11N30 4S)
24.32 3.47 11.27 24.31 3.18 12.16
Cd(Gly-Cys-Ala)
Cd(C8H13N30 4S)
23.96 3.85 10.06 26.71 3.62 1 1.6 8
Cd(Gly-Cys-Ala).2H20 24.28 4.30 10.62
Cd(Gly-Cys-Val)
Cd(C10H17N3O4S)
29.13 4.75 9.98 30.97 4.39 10.84
Cd(Gly-Cys-Val).1.5H20 28.96 4.83 10.13
Cd(Leu-Cys-Leu)
Cd(C15H27N30 4S)
36.78 6.13 8 .0 0 39.35 5.90 9.18
Cd(Leu-Cys-Leu).2H20 36.48 6.28 8.51
Cd(Val-Cys-Val-Val)
Cd(C18H32N40 5S)
37.99 5.96 9.45 40.88 6.06 10.60
Table 3.3. Elemental analysis of peptide complexes
10 0
COMPOUND/COMPLEX v(-OH) vfyNEy v(-NH2) v(-NH) v(-SH) v(-C=0) v(-C=0)
H2Val-Cys-Val 3430 3340 3290
cm” 1
3080 2550 1680 1650
H3Gly-Cys-Ala+ 3295 2900 ----- 3100 2570 1680 1650
Cd(Gly-Cys-Gly) 3300(br)----- 3080 1600 1660
Cd(Gly-Cys-Ala) 3260(br)----- 3070 1590 1650
Cd(Gly-Cys-Val) 3280(br) — 3080 1590 1650
Table 3.4. Infrared bands of tripeptides and their complexes
O
3.33a
3.33b
Rj = R2 =H 
R1 = H R2 =-CH3 
r 1 = H R2= -CH(CH3) 2 
Rl = -CH(CH3) 2 R2 = -CH(CH: 
Rl = -CH2-CH(CH3) 2 R2 = -CH2-CH(CH
1 0 1
3 .3 .2  O r q a n o -th io l  com plexes
3 . 3 . 2 . 1  E t h a n e t h i o l  c o m p l e x e s
Although the preparation of two complexes was attempted by- 
using CdCl2 and Cdl2 only one could be characterised as 
the chloride complex was found to be very hygroscopic. 
The complex characterised has the empirical formula 
[Cd(SCH2CH3)I]n with which elemental analysis showed good 
agreement. The solid was insoluble in all common solvents 
leading to the conclusion that it is polymeric. Both the 
iodide and sulphur atoms can act as bridging ligands 
although for this complex the cubic arrangement shown in 
3.34 in which the thiolate group is triply bridging is 
more likely. The absence of SH stretching bands from the 
infrared spectrum of the complex confirms that 
deprotonation of the SH group has occurred. Another 
possible structure with sulphur and iodide bridges and 
tetrahedral cadmium(II) is shown in 3.35.
I
3.34
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3 . 2 . 2 * 2  C o m p l e x e s  o f  2 - t h i o l e t h a n o i c  a c i d ,  m e t h v l - 2 - f c h i o l -  
e t h a n o a t e  a n d  e t h v l - 2 - t h i o l e t h a n o a t e
2-Thiolethanoic acid was found to yield two complexes i.e 
[Cd(SCH2COOH)Cl]n in ethanolic solution and [Cd(SCH2COO)]n 
in water. In ethanol the carboxylic acid group remains 
undissociated as shown by the appearance of the -C=0 
stretching band at 1700cm"1 in the infrared spectrum of 
the complex. The position of this band is only slightly 
shifted relative to the free ligand, indicating that the 
-C02H group is not coordinated to the metal. The absence 
of an SH band confirms deprotonation of the SH group and 
by implication coordination of S" to the metal. The 
complex formed between thiolethanoic acid and cadmium(II) 
in water has carboxylate and thiolate coordinating groups 
as shown by the stoichiometry of the complex by the 
absence of an SH stretching band, and the position of the 
v(C=0) carboxylate band. A polymeric structure with 
thiolate (and possibly carboxylate) bridging ligands is 
proposed.
Methyl-2-thiolethanoate and ethyl-2-thiolethanoate both 
form 1:1 complexes with cadmium(II). The positions of the
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v(C=0) ester bands occur at slightly lower wavenumbers 
than for the free ligand and it is postulated that these 
are weakly coordinated. The absence of SH stretching 
bands again confirms deprotonation of the SH group and by 
implication thiolate coordination to the metal. A
polymeric structure involving thiolate and chloride 
bridging ligands is proposed.
3 . 2 . 2 . 3  C o m p l e x e s  o f  1 . 2 - e t h a n e d i t h i o l  a n d  1 , 3 - p r o p a n e  
d i t h i o l
Complexes of 1,2-ethanedithiol and 1,3-propanedithiol were 
isolated by the addition of an aqueous solution of CdCl2 
to a solution of the dithiol also in water. The complexes 
isolated were of the form (S(CH2 )2S)Cd and (S(CH2 )3S)Cd. 
Both complexes gave good C, H and Cd analysis assuming 
that about 1/4 molecule of water is present per molecule 
of complex. The absence of -SH stretching bands confirms 
Cd-thiolate coordination, and a possible structure for 
the complexes is shown in 3.36.
Attempts were also made to isolate a complex from the 
reaction of ethanedithiol with CdCl2 in EtOH rather than 
water* However, results from elemental analysis indicate 
that the product formed is mainly Cd2 (S(CH2 )2S)C12 with 
small contamination by Cd(S(CH2 )2S ). The structure of
this complex is considered in Section 3.2.2.4 where 
complexes of the same formulation with similar 
dithiolate ligands are discussed.
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(neighbouring) / \ / \
H
3 . 2 . 2 . 4  C o m p l e x e s  o f  t r a n s - 1 . 2 - d i t h i o l c v c l o h e x a n e  a n d
1 . 4 . 8 . 1 1 - t e t r a t h i a u n d e c a n e
The reaction of CdCl2 with 1,4,8,11-tetrathiaunedecane 
LH2 in a 1:1 mole ratio in water produced a white 
precipitate which analyses correctly for a 1:1 complex,
ethanol also using a 1:1 mole ratio of reactants a complex 
of stoichiometry LCd2Cl2 .H20 was obtained. Both complexes 
lack SH stretching bands in their infrared spectra 
implying deprotonation and coordination of the S“ group. 
Possible structures for these complexes are shown in 3.37 
and 3.38a. An alternative structure to that shown in 
3.38a for LCd2Cl2 .H20 has the ionic chlorides coordinated 
to give species with mixed coordination numbers such as in 
3.38b. Water may also be coordinated.
CdL. When the reaction was carried out in absolute
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C12.H20
3.38a
3.38 b
The reaction between CdCl2 and cyclohexane dithiol LH2 in 
ethanol afforded LCd2Cl2 and in water LCd. From the 
stoichiometry and the absence of SH stretching bands the 
structures in 3.39 and 3.40 are proposed.
3 . 2 . 3  C o n c l u s i o n s
Monocarboxylate monothiol ligands form two different types
of complexes complexes;
(i) [Cd(HL)X]n in ethanol and
(ii) [Cd(L)]n water (where H2L = neutral ligand
and X = halide),
resulting in pseudoctahedral or distorted tetrahedral
§  (neighbouring)
0 } (neighbouring) 3 ' 3 9
(neighbouring) §
3.40
§  (neighbouring)
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com p lexes in  w hich  X, S and 0 a c t  as b r id g in g  atom s.
Di and mono-thiol ligands favour distorted tetrahedral
complexes. Two complexes were isolated with dithiol
ligands;
(i) Cd2 (L)X2 in ethanol and
(ii) Cd(L) in water. (where H2L - dithiol neutral
ligand and X = chloride)
Attempts to prepare the iodide complex in ethanol failed.
and a mixture of complexes was obtained.
Many of the complexes prepared are assumed to be polymeric
on the basis of their insolubility in most common solvents
and their high decomposition points (>300C). Sulphur 
atoms are the most effective bridging coordination sites.
Cysteinyl peptide ligands form similar complexes to those 
of organothiol complexes with cadmium(II). The carboxyl 
group were found to coordinate in an aqueous media, by 
deprotonation to the -COO" group but stay unionised in 
ethanolic/methanolic media. Polymeric complexes of
distorted tetrahedral or pseudoctahedral arrangement are 
formed as high decomposition points and insolubility of 
the complexes were evident.
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PEPTIDES AND PFIPTTDF, SYNTHESIS
4 . 0  P e p t i d e s  a n d  P e p t i d e  S y n t h e s i s
4 . 1  I n t r o d u c t i o n
Peptides and proteins exhibit the largest structural and 
functional variation of all classes of biologically active 
macromolecules and are of prime importance in regulating 
and maintaining biological processes. The essential 
structural features of peptides and proteins are chains of 
amino acids linked to one another by amide bonds (4.1).
Peptide synthesis requires the linkage of several amino 
acid residues in a sequence of amide bonds. Although the 
linking of a carboxyl group to an amino group is easy 
enough problems arise when functional groups are 
incorporated into the side chain, e.g in the case of 
lysine which has two amino groups and aspartic acid which 
has two carboxyl groups. Two different protecting groups 
are therefore required, one being more labile than the 
other. Other amino acids which create similar problems are 
cysteine and arginine. Cysteinyl peptides tend to oxidise 
in the atmosphere, and this has to be prevented.
Peptide synthesis has been an area of challenge for 
organic chemists since the 1920’s. It is essential to 
synthesise peptides and proteins efficiently and in a pure
i> , j .  f .
H 0 H H 0 H H 0 H H 0
4.1
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form so as to be able to study biological systems. An 
efficient high yield method long eluded chemists and only 
within the last twenty five years was a major
breakthrough made, by the use of solid phase peptide
synthesis (SPPS), by Merrifield and later by Sheppard. 
The synthetic methods were formulated some time ago but 
have only recently come into wide use; and now they have
been successfully automated. The method is not cheap but
is efficient and reliable; a peptide of ten amino acid 
residues can be synthesised in as little time as a week. 
By products are minimised by using highly pure solvents 
and reagents, and this reflects in the yields which can be 
as high as 98%.
Purification to 99.7 ± 0.3% has always been a problem but 
with the advent and use of High Performance Liquid 
Chromatography (HPLC) and with the development of semi­
preparative and preparative columns, purification is 
becoming easier, faster and more efficient.
4 . 2  T h e  P e p t i d e  B o n d
Peptide synthesis requires the formation of amide bonds 
from amino acids. The amide linkage has been found by X- 
ray crystallography to occur in cis ■ and trans 
forms.149'150 The torsion angles of some polypeptides 
have been studied by Winkler and Dunitz.151
C r y s ta l  s t r u c tu r e  d e te rm in a tio n s  o f  v a r io u s  p e p t id e s  have
1 1 0
shown that similar conformations occur in various 
peptides,152 and a particular peptide can have a number of 
different conformations in the same unit cell involving 
different types of hydrogen bonding.153 Although in the 
solid state it was believed that the peptide linkage is 
planar it has more recently been shown, by X-ray 
crystallography, that most peptides have non-planar 
peptide linkages.154'155 In solution the peptide tends to 
fold into a 3-dimensional conformation, where hydrogen 
bonding occurs between the -NH and -C=0 groups, as shown 
for the tripeptide Pro-Leu-Gly-NH2 in dimethyl sulphoxide 
by 300MHz 1H nmr studies.156
4 . 2 . 1  C l e a v a g e  o f  t h e  p e p t i d e  b o n d
Peptides can be degraded to their individual amino acids 
by various techniques including acid or base hydrolysis 
and enzymatic degradation. Cleavage of the peptide bond 
is essential for validation of the peptide composition but 
unfortunately, peptide sequence is more difficult to 
clarify. Traditionally the technique of acid and base 
hydrolysis has been most used by chemists although the 
method of enzymatic degradation is gaining in popularity 
largely because of the specificity of cleavage sites.
4 . 2 . 2  H y d r o l y s i s  o f  t h e  p e p t i d e  b o n d
Peptides are hydrolysed to a-amino acids and the 
mechanisms of both base (Scheme 4.1) and acid (Scheme 4.2)
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Scheme 4.1. Base hydrolysis of dipeptides
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Scheme 4.2. Acid hydrolysis of dipeptides.
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hydrolysis are similar to those of ester hydrolysis. Base 
hydrolysis is not used as widely as acid hydrolysis. The 
rate of acid hydrolysis can vary depending on 
electrostatic effects.157 Liquid hydrogen fluoride 
cleavage of the peptide bond has been used. Although it is
a very powerful solvating liquid it was found to change
I  C Q  *| /T  Athe structure and reactivity of some amino acids.
4 . 2 . 3  F o r m a t i o n  o f  t h e  p e p t i d e  b o n d
Many methods for peptide bond synthesis have been 
developed. Both the biosynthetic and chemical routes are 
described although the former is by no means fully 
understood. More emphasis is placed on chemical
synthesis.
4 . 2 . 3 . 1  B i o s y n t h e s i s  o f  p e p t i d e s
Biosynthesis of peptides was first thought to be achieved 
by the simple action of several enzymes. Thermodynamic 
studies showed that the position of the equilibrium is
heavily on the hydrolysis side, thus the simple theory of
enzyme action alone was abandoned.161
As messenger (mRNA) and transfer (tRNA) ribonucleic acids 
(RNA) became understood a new hypothesis developed. 
Amino acids are activated individually by enzymes and an 
enzyme-bound complex forms with the liberation of 
pyrophosphate (PP). The amino acid is then transferred 
to the tRNA with the liberation of adenosine monophosphate
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(AMP) and the regeneration of the free enzyme. The AA-tRNA 
complex now formed is of high energy. Protein
biosynthesis then takes place via several steps: (1)
formation of an mRNA-ribosome-initiator-tRNA complex, (2) 
binding of aminoacyl-tRNA, (3) peptide bond formation, (4) 
translocation, (5) termination. The synthetic process was 
found to be carried out on the ribosome. Scheme 4.3
shows the mechanism.
AA1 + ATP + En1 ---------- ►  En1' .AA'-AMP + PP
En1' .AA'-AMP + tRNA1 ---------►  AA’-tRNA1 + AMP + Energy
AA’ -tRNA1 + AAn-tRNAn  ►  tRNA1 -AA'-AA11 + tRNAn
tRNA1 -AA'-AA11 + tRNAm-AAra— ► tRNAl-AAI-AAn-AAm + tRNA03 
Scheme 4.3. Biosynthetic route for peptides and proteins.
4 . 2 . 3 . 2  C h e m i c a l  s y n t h e s i s
The major process of chemical synthesis is the acylation 
of the amino group of one amino acid with the carboxyl 
group of a second amino acid. Although acylation is 
straightforward for monosubstituted amines and carboxylic 
acids, three major problems arise when amino acids are 
involved. These are protection of the amino and/or 
carboxyl group, activation of the amino and/or carboxyl 
groups, and preservation of the a-carbon chirality and of
114
any fu n c t io n a l  s id e  ch a in  on th e  amino a c id .
To prevent racemisation especially, many different methods 
have been developed, for example a bulky protecting group 
is frequently used. Synthesis is based on electrophilic 
acylation. Generally the amino group on one amino acid is
protected while the carboxylic acid group on the same
amino acid is activated (Scheme 4.4). Activation of the 
carboxyl group occurs either by replacing the hydrogen 
atom or the OH group. The hydrogen, RCOO-H, is usually 
replaced by alkyl, aryl or acyl groups: carboxyl
activation by replacement of the hydroxyl group usually 
falls into two categories, RCO-XR' where XR'- azide, 
diimines, azoles, and RCO-X' where X 1 = chloride, bromide, 
cyanide.
P^-NH-Ol-COO-Act1 + H2N-CH-COOPrn P^-NH-OI-^-hHi-CH-CXXOPr11
R j  R i  O  R 2
Scheme 4.4. Chemical peptide synthesis
The mechanisms of peptide bond formation depend on the 
activating group, as in Scheme 4.5163 and Scheme 4.6.164
The latter mechanism, scheme 4.6, has been argued against
I f O  fby Satchell,x but kinetic evidence has shown the 
intermediate to exist for 10“9 - 10”10 seconds.
-C O -X  + H2N -  -C-NH- + HX
Scheme 4.5. Mechanism of peptide bond formation, where X = OCOR
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-c-x
(  —
H-N-H
I
Scheme 4.6. Second mechanism of peptide bond formation , where X = OH
Studies have been carried out in systems where acetic acid 
and other carboxylic acids accelerate the rate of reaction 
of activated esters.105'106 Acid catalysis was found to 
be effective in non-polar solvents such as THF, but 
negligible in polar solvents such as DMF.100 Other 
compounds such as N-hydroxybenzotriazole (HOBt) were found 
to catalyse the reaction in DMF.107
4 . 3  R a c e m i s a t i o n  o f  t h e  g - c a r b o n
Racemisation of the amino acid a-carbon during peptide 
synthesis is a difficult problem since the chiral 
integrity must be preserved when synthesising a peptide. 
It must be considered first with the individual amino 
acids. In basic solution enolisation occurs via
the hydroxide-catalysed reaction while in acidic media the 
protonation mechanism applies. The a-inversion process is 
usually very slow, involves the carbonyl group (Scheme 
4.7); and depends on groups X, Y and R as well as the 
temperature and pH of the solution. Peptides seem to have 
a greater tendency to racemise than amino acids and a
P
-C-X
H-N-H
0
I
-C
I
H-N
I
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5 (4H)-oxazolone is an intermediate involved in the 
racemisation (Scheme 4.8).
¥f __
X-NH-^-C-Y ------------  X-NH-C=C-Y + - Racemate
R i  R ,
Scheme 4.7. Racemisation of the a-caibon via the keto-enol equilibrium for 
amino acids and peptides
P  H PI
Rr C-N-^-C-X + HX
H R 2
OH
EPIMER3C PRODUCTS
Scheme 4.8. 5(4H)-Oxazolone intermodiate which forms in peptide to yield 
die epimers
Some compounds will racemise through enolisation and/or 
5 (4H)-oxazolone formation. This can make synthesis 
tedious because the reaction conditions usually favour 
either or both of the two mechanisms.
Several reagents have been developed to introduce bulky X 
and Y groups (Scheme 4.7, 4.8) which will inhibit
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epimeric racemisation (see Section 4.5.6). The bulky 
groups also act as protecting and activating groups, but 
once deprotection occurs the peptide is vulnerable to 
racemisation. To prevent this efficient coupling must 
occur and the peptide must not be allowed to remain too 
long in solution.
4.3.1 Controlling racemisation in peptide synthesis
The first rule in solid phase peptide synthesis for 
preventing racemisation is to use a tertiary amine in 
linking the active amino acid to the resin but avoid
salts. The bulkier the amine the less is the racemisation. 
Hindered amines tend to inhibit the enolisation pathway 
but promote the 5 (4H)-oxazolone racemisation pathway.170
Racemisation in SPPS will occur after the addition of 
dicyclohexylcarbodiimide (DCCI) to activate the protected 
amino acid unless prevented by forming the HOBt ester.171 
The HOBt reacts with the carbonyl group and its bulk 
reduces racemisation to as little as 0.1% of the final
yield.
Other coupling agents which suppress racemisation include 
3*-hydroxy-4-oxo-3,4-dihydroquinazoline (4.2) and 3- 
hydroxy-4-oxo-3,4-dihydro-l,2,3-benzotriazine (4.3). These 
two compounds are not as efficient as HOBt in preventing
epimer formation, and other disadvantages include lower
y i e l d s  on c o u p lin g  and g e n e r a t io n  o f  im p u r it ie s .
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4 - 4  P e p t i d e  S y n t h e s i s
Peptide synthesis requires the condensation of amino acids 
through the amino and carboxyl groups. Two amino acids, 
I and II, without any functional side groups, could form 
four different dipeptides, I-I, I-II, II-I, II-II. This 
can be pevented by protecting the functional groups which 
are not required to react and activating those which are 
to react (Scheme 4.9). Deprotection then produces the 
desired dipeptide (Scheme 4.10). Selective deprotection 
can cleave the X or the Y group and allow more amino 
acids to couple and lengthen the peptide. Groups and
R2 could contain amino, hydroxyl, sulphydryl or carboxyl 
groups which must be selectively protected and 
deprotected.
The two major methods of peptide synthesis are solution 
phase (SolPPS) and solid phase (SPPS) peptide synthesis. 
The solution phase methods are now little used because by
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Scheme 4.9. Activation and protection of the carboxyl and amino groups
HN-CH-COZ H2N-CH-C0(0)Y
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Scheme 4.10. Condensation and deprotection of a dipeptide
these methods it is difficult to prepare long chain 
peptides, by-products remain in solution and therefore 
contaminate the final product, racemisation is likely 
because the peptide is always in solution, the method is 
tedious and wasteful, and on extending the peptide chain 
insolubility problems occurr.
1 2 0
As the solution phase method was not used extensively only 
a brief description of it is given later.
4 . 5  S o l i d  P h a s e  P e p t i d e  S y n t h e s i s
SPPS was designed and developed by Merrifield,172'173 and
■ 17/1 — 178recently improved by Sheppard.x x/° The method uses a
solid support which is never in solution and is coupled
to the first amino acid residue. It is an ingenious chain
elongation strategy (Scheme 4.11).
The main advantages over solution phase include the high 
speed at which syntheses can occur, being possible to 
compile up to 6 amino acid residues per day, there are no 
insolubility problems, it is easy and convenient to use, 
and it has been automated.
The solid support is activated by a group X (X = Cl", 
0H~). The first amino acid residue, with a labile N- 
protecting group, is coupled to the polymer and then 
deprotected. Deprotection conditions are mild so as to 
leave other protecting groups intact. A cycle can now 
start where more protected amino acid residues are added 
and then deprotected so as to increase the peptide chain. 
When the entire blocked peptide has been assembled on the 
polymer support, a different reagent is applied to cleave 
the peptide from the polymer.
1 2 1
P-NH-^H-|-OH 
Rj O
X-Polymer
P'NH-CH-C-O-Polymer
I ii
Rj O
HX
Amino group deprotection
H-NH-CH-C-O-Polymer
I II ^
Rj O
Couple with second amino acid
P-hffl[-<jR-C-NH-(j!H-C-0-Polymer 
R2 O Rj O
O
Several similar steps can be repeated to 
lengthen the peptide chain
P - h f f l - m - C - ( N H - ( p - C ^ N H - ( R - C - 0 - P o l y ^  
Rn+i Rn O Rj O
O
Deprotection
H-NH-CH-C-(NH-CH-C)-NH-CH-C-0-Polymer 
I I II n I II
n^+l Rn 6  Rj O
o
Cleave from polymer
H-NH*CH-C-(NH-CH-C)-NH-CH-C-OH I II n i ii
R n+i Rn O Rj O
Scheme 4 .1 ! General procedure of SPPS
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Any functional group in the amino acid side chain, such as
“NH2 or -COOH must be protected with a group which will
stay intact until cleavage from the polymer occurs. It is 
essential that every deprotection and coupling stage goes 
fully to completion so as to prevent the formation of 
smaller fractional peptides. This requires excess
reactants at individual stages.
Several different polymer supports and different
protecting groups are used. There are also various amino 
acid coupling methods and different reagents for
deprotection of the labile groups. Each stage is discussed 
separately.
4 . 5 . 1  T h e  p o l y m e r  s u p p o r t
The polymer support must have several characteristics and 
properties that will allow SPPS to occur. The particles 
must be of a certain physical size and shape. On
addition of the reaction solvent, usually DMF or DCM, the 
polymer must stay out of solution and swell as to allow 
facile flow of all reagents and ensure high yields.
Furthermore the polymer should not interact in any
deleterious way with any reagent or with the peptide
prepared.
4 . 5 . 1 . 1  C r o s s - l i n k e d  p o l y s t y r e n e
Merrifield first used a resin prepared by co­
polymerisation of styrene with 2% of divinyl benzene
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(DVB). The beads were of 20-50jj in diameter. He later 
found that 1% DVB gave better swelling. However more than 
1% DVB is necessary to prepare the polystyrene support 
otherwise it is too soft and cannot be manipulated in the 
usual way. If pure styrene is used then the polymer is 
soluble in the organic solvents used. Chloromethylation 
to activate the resin must be carried out with care at 
low temperatures.
4 . 5 . 1 . 2  P o l y a m i d e  r e s i n s
Larger peptides cannot be prepared using polystyrene 
resins, and Sheppard suggested179 that the cause is 
incompatibility between the polystyrene resin and the 
growing peptide probably because the polystyrene resin is 
hydrophobic and the peptide chain is hydrophilic. Although 
the resin is well solvated by organic solvents, such as 
DCM, the peptide chain is not and Sheppard suggested that 
the resin could collapse and no longer be active. Peptides 
which are well solvated can collapse the polystyrene 
matrix, preventing adequate access to reagents. Sheppard 
suggested a new resin to overcome such problems. This is 
a cross-linked polyamide, the physical nature of which 
resembles a peptide. It was expected that solvation of 
the matrix and the peptide would be similar.
The polyamide resin is activated with either a reference 
amino acid or a diamine. The reference amino acid is used 
when automating the method, and the reaction is a
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s t r a ig h t fo r w a r d  amide bond fo rm a tio n  (Scheme 4 .1 2 ) .
H 2N -(C H 2 )2 -N H 2
Polymer-OCH3 Polymer-NH-(CH2)2-NH2
0
ii
Polymer-NH+CH^-NH-C-CHj-O-a
+ DCCI + HOBt 
CH2OH
Scheme 4.12. Activation of the polyamide resin
4 . 5 . 2  P e p t i d e - r e s i n  l i n k
4 . 5 . 2 . 1  P o l y s t y r e n e  b a s e d  r e s i n
The first amino acid is linked to the resin via the
method of Merrifield the triethyl amine salt of the 
tertiary-butoxycarbonyl (Boc-AA) is heated in ethanol with
is very slow therefore reflux is required for one to two 
days. This promotes the formation of quaternary ammonium 
salts on the polymer with the triethyl amine which would 
not allow full replacement of the chloride by the Boc-AA. 
The formation of the quaternary ammonium salts is 
prevented by the Boc-aa being first converted to its 
tetraethylammonium or cesium salt. The reaction was found 
to be faster in DMF which promotes nucleophilic reactions. 
Addition of KF also catalyses the reaction. Amino acids 
such as histidine, cysteine and methionine cause problems
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carboxyl group forming an ester. In the traditional
the chloromethylated resin (Scheme 4.13). The reaction
in esterification as their side chain functional groups 
are protected by benzyl esters. The above problems were 
avoided by using hydroxymethyl resin for attachment of the 
first amino acid, which is obtained by reacting the 
chloromethyl resin with potassium acetate and hydrazine.
Scheme 4.13. Formation of the peptide polystyrene resin link
Esterification of the amino acid is achieved by using DCCI
4-dimethylaminopyridine (DMAP) is used as a catalyst. DMAP 
promotes racemisation and therefore the amount added must 
be restricted to catalytic levels only. Before the second 
Boc-aa is coupled all remaining free hydroxyl groups are 
benzoylated or acylated to prevent further reactions, this 
is termed capping.
Unfortunately the activated polystyrene resins were found 
to be slightly labile, in that on deprotection of the 
amino acid residue from the Boc-group by 25% TFA solution 
in DCM, 1% of the amino acid residue is found to cleave 
from the resin to reform the HOCH2-P. Other polystyrene
resins have been investigated but found to be expensive
■ < 1 8  0and have various other disadantages.
Boc-aa
which forms the symmetrical anhydride. As the coupling 
of the first amino acid anhydride to the resin is slow
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The first amino acid is linked to the activated polyamide 
resin as in Section 4.7.3.
Polyamide resins although more expensive are now widely 
used.
4 . 5 . 3  P r o t e c t i o n  o f  t h e  a - a m i n o  g r o u p
4 . 5 . 3 . 1  P o l y s t y r e n e  b a s e d  r e s i n s
The most widely used a-amino protecting group has been the 
tertiary butyl oxycarbonyl group (Boc) (4.4). Boc is an
4 .5 .2 .2  Polyam ide based  r e s in s
acid-labile protecting group and is displaced by TFA 
acidolysis. Other acid (TFA) labile a-amino protecting 
groups successfully used in peptide synthesis are: 2-(3,5-
4.4
« 1 ft 1dimethoxyphenyl)propyl(2)oxycarbonyl (4.5),±0± 2-phenyl-
propyl(2)oxycarbonyl (4.6),182 2,4,5-trimethyl-2-phenyl-
1 OQ aethyl(2)oxycarbonyl (4.7). They are expensive and not
commercially available.
4.5
c h 3o
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4 . 5 . 3 . 2  P o l y a m i d e  b a s e d  r e s i n
9-Fluorenylmethyloxycarbonyl (Fmoc) (4.8) is a base-labile
• 1 7  Q 1 8 4  . ■ ■protecting group.x Agitation with a secondary
amine such as piperidine in DMF allows deprotection of
the a-amino group to the free amine. Fmoc cannot be used
as a protecting group with the Merrifield method as the
peptide-resin link and the resin would not be stable to
concentrated solutions of amines. Fmoc is used in the
Sheppard method where excess of amine does not affect the
polyamide peptide link.
4 .8
Although Fmoc is the most frequently used a-amino 
protecting group in the Sheppard peptide synthesis, 2- 
nitrophenyl-sulphenyl and dithiasuccinoyl have also been 
used.185
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4 * 5 .5  P r o t e c t io n  o f  th e  s id e -c h a in  fu n c t io n a l  group
Side-chain protecting groups must be labile to a different 
deprotection reagent from that used for the cx-amino 
protecting group. It is useful if cleavage from the resin 
and deprotection occur simultaneously. The Merrifield 
method uses benzyl-derivatised side chain functional 
groups. They are acid-labile and by treatment with HF at 
the end of the synthesis both deprotection and resin 
cleavage occur. If no resin cleavage is required the 
protecting groups are removed by HBr acidolysis.
Fmoc peptide synthesis uses the Boc protecting group, most 
widely, for protection of the side-chain functional 
groups. As this group is acid labile, and the peptide is 
cleaved by acidolysis from the resin, a convenient acid 
which satisfies both reactions was found to be TFA. This 
method is preferred as the peptide is not exposed to 
strong acids such as HF and HBr.
Individual amino acids have different protecting groups 
for the side chain functionalities. Each amino acid is 
discussed separately. Greater emphasis is placed on 
amino acid residues used to build up the peptides which 
were complexed to cadmium(II) (Chapter 5), especially L- 
cysteine.
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4 .5 .4 .1  P r o t e c t io n  o f  th e  su lp h y d ry l group
The sulphydryl group of cysteine must be blocked 
effectively when involved in peptide synthesis. The 
choice of the protecting group depends largely on the 
final peptide required, yielding either the disulphide or 
the thiol group after deprotection. For small peptides 
deprotection occurs when cleavage from the polymer is 
carried out. For larger peptides where disulphide
bridging occurs the protecting group needs to stay intact 
even after polymer cleavage. Deprotection to yield the 
thiol-peptide can then take place just before it is used 
in an experiment. In the Merrifield method an S-benzyl 
protecting group is used (4.9) which is not HF labile but 
can be removed by NH3 (1)/Na solutions. This causes 
problems since the basic environment promotes atmospheric 
oxidation to the disulphide and NH^Cl must be used to 
remove excess sodium.
Acetamidomethyl (Acm), also used as a thiol protecting 
group (4.10), is relatively stable to HF and HBr 
acidolysis. Deprotection of Acm takes place with 
mercury(II) or iodine followed by H2S.
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h3c -c-nh-ch2-s
1
4,10
Other sulphur protecting groups include p-methylbenzyl 
(4.11) cleaved by HF, and p-methoxybenzyl (4.12), cleaved 
by HF and TFA.
The most useful protecting group for sulphydryl in modern 
peptide synthesis is the triphenylmethyl (trityl) group 
(4.13). It is widely used in Fmoc synthesis and yields the 
thiol group instead of the sulphide on cleavage with TFA. 
When the trityl group is cleaved with TFA the stable 
carbocation (Ph)3C+ is reversibly formed. To prevent 
recombination with the -SH group dithioethane and anisole 
are used (Scheme 4.14) as scavengers to react with the 
trityl carbocations.
4.11
4.12
4.13
1 3 1
Scheme 4.14. Deprotection of sulphur to the thiol group using scavengers
4 . 5 . 4 . 2  P r o t e c t i o n  o f  s i d e  c h a i n  a m i n o  g r o u p s
In the Merrifield peptide synthesis the most widely used 
protecting group for the e-amino group in lysine is Boc or 
substituted Boc. The most succesful has been o- 
chlorobenzyloxycarbonyl (4.14).
When a more labile system is used such as in Fmoc 
synthesis the e-amino group is protected by Boc. Here 
simultaneous cleavage of the peptide from the polymer and 
cleavage of the Boc group are carried out by TFA
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acidolysis. If lysine is the last amino acid residue to be
placed on the peptide chain the a- and e-amino protecting
groups can both be of higher lability, i.e two Fmoc
protecting groups can be used.
4.5.4.3 Protection of the side chain carboxyl groups
The most widely used protecting group in the Boc synthesis 
for the carboxyl functional group is benzyl which forms 
the ester. Cleavage takes place by HF acidolysis. In 
situations where aspartic acid is followed by glycine, 
alanine or serine, a ring closure occurs which yields the 
succinimide, then opening of the ring gives the ft-aspartyl 
peptide. Two blocking groups are used to prevent this 
occurrence, cyclohexyl ester and phenacyl ester. Cleavage 
of the protecting groups takes place by HF acidolysis.
In the Fmoc method the Boc ester is formed with the amino 
acid where cleavage is carried out by TFA acidolysis.
Glutamic acid is protected in the same manner as aspartic 
acid without the problems of forming the succinimide ring.
4.5.4.4 Protection of side chain hydroxyl group
Protection of the hydroxyl group in the Boc SPPS is 
provided by the benzyl group forming the benzyl ether. 
It is thought to be an adequate protecting group except 
for very long peptides. For greater stability
halogenated benzyl derivatives can be used. The benzyl
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ethers are cleaved by HF or HBr acidolysis.
For the Fmoc SPPS, the Boc ether is formed and cleaved by
TFA acidolysis.
4.5.4.5 Miscellaneous protecting groups
The protection of miscellaneous side chain groups such as
guanidine and imidazole is not discussed because these
■ • 1 8 6  1 8 7groups were not involved m  the present work. '
4.5.6 Coupling reaction
Merrifield used DCCI as the first coupling agent. DCCI 
has remained the most widely used coupling agent even for 
modern day SPPS. Some problems have been encountered but 
have been overcome by either forming the symmetrical 
anhydride or the active esters.
An ideal coupling agent must have the following 
characteristics: general applicability, ease of use,
rapid and efficient coupling and freedom from side- 
reactions and racemisation. It is advisable to avoid 
prolonged coupling in order to minimise racemisation.
4.5.6.1 Carbodiimide coupling
Coupling to the polymer usually takes place in DCM/DMF 
solution by the addition of DCCI alone to produce the 
reactive protected symmetrical amino acid anhydride which 
is thought to form via a reactive isourea intermediate
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(Scheme 4.15). The symmetrical anhydride is formed when 
the first protected amino acid is attached to the 
activated polymer. The process is quite fast and 95% of 
the reaction is found to be completed within 15 minutes. 
Once coupling has taken place the by-product formed is DCU 
which is soluble in DMF and can easily be washed away. 
Since the isourea intermediate can rearrange
spontaneously to the N-acyl urea (Scheme 4.15) especially 
in polar aprotic solvents such as DMF it is best to use 
small amounts of DMF when dealing with DCCI-mediated 
coupling reactions.
The symmetrical anhydride method can be used to couple the 
second protected amino acid to the first but due to the 
expense as two moles of the protected amino acid are used 
and the anhydride promoting racemisation, an alternative 
procedure has been developed. This is by the formation 
of an active ester with N-hydroxybenztriazole (HOBt) 
(Scheme 4.16). The active ester is used because it 
increases the rate of reaction and inhibits racemisation. 
Another advantage over the symmetrical anhydride method is 
that the active HOBt ester can readily be synthesised in a 
different vessel and then added to the reaction mixture. 
Another active ester which has been used is formed from N- 
hydroxysuccinimide.
Although some good results have been obtained from this 
method the disadvantages are greater.
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4 . 5 . 6  C leavage  o f  a -am in o and s id e  ch a in  fu n c t io n a l
protecting groups
For the classical SPPS of Merrifield acidolysis TFA is 
most commonly used to deprotect the a-amino and side-chain 
functional groups. All Boc groups were cleaved by using a 
25% solution of TFA in DCM and full deprotection occurred 
within 30 minutes at room temperature. Originally 
anhydrous HC1 in dioxane was used. Side-chain functional 
protecting groups such as benzyl derivatives are removed 
by using either HF or HBr solutions in DCM which also 
cleave the peptide from the resin.
In Fmoc synthesis the a-amino protecting group is cleaved 
by agitation with a secondary amine such as piperidine in 
DMF (Scheme 4.17). The major advantage of Fmoc synthesis 
is that the side-chain functional groups are acid labile 
and most conveniently TFA labile.
o
Scheme 4.17. Deprotection of the Fmoc group
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The traditional method of SPPS due to Merrifield1 70 " 178 is 
now being rapidly replaced by the more convenient method 
of Sheppard. Fmoc synthesis has several advantages over 
Boc synthesis. Fmoc SPPS uses a polyamide resin in 
contrast to the polystyrene used in the Boc synthesis. 
The polyamide resin is much more hydrophilic and therefore 
is penetrated easier by polar aprotic solvents such as 
DMF. As the resin resembles the peptide backbone on 
swelling due to the solvent, it allows the reactants to 
penetrate and build the peptide chain. The method is 
outlined in Scheme 4.18.
Cleavage of the final peptide from the resin in the Fmoc 
SPPS is carried out by using 95%+ TFA. The Boc SPPS 
suffers from the disadvantage that HF used to cleave the 
peptide from the resin is dangerous and requires a costly 
HF line.
When the a-amino group is protected by a base-labile 
protecting group, simple agitation with a secondary amine 
such as piperidine is all that is required for cleavage. 
Boc is an acid labile group and acidolysis by TFA is 
required to release the a-amino group. The Fmoc SPPS 
uses the Boc as a secondary side chain protecting group. 
As Boc cleavage occurs by TFA acidolysis there is a major 
advantage as peptide cleavage from the polymer also 
occurs.
4 . 5 . 7  The Fmoc s o l i d  phase p e p tid e  s y n th e s is
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Automation of peptide synthesis is simpler by the Fmoc 
method. The Fmoc SPPS is automated by monitoring the 
fluorene chromophore which absorbs very strongly at 300- 
320nm.178 Once the amino acid residue is deprotected the 
fluorene chromophore is washed away and no absorption 
remains. Monitoring SPPS ensures that one reaction is 
complete before the next begins. This ensures fewer by­
products and a purer final product in high yield.
The Fmoc SPPS has major disadvantages. If one of the 
coupling or deprotection stages does not go to 99%+ 
completion then too many unwanted by-products will form. 
The protected amino acids, the polyamide resin and the 
solvents are costly. The purification of the peptide is 
time consuming. In addition, capping is possible for the 
Boc SPPS where the uncoupled groups on the polymer are 
reacted with another group and phased out. This is not 
yet possible for Fmoc SPPS.
The main unwanted by-products of Fmoc SPPS are shorter 
chain peptides. Purification of the peptide is carried 
out by HPLC, which has recently become more efficient.
4.6 Solution Phase Peptide Synthesis
As little use is now made of SolPPS only a brief account 
will be given here. SolPPS is an efficient method for 
the preparation of small chain peptides of 10-15 amino 
acid residues. The most appropriate way of building up
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the peptide chain is by segment condensation. Smaller 
peptides of appropriate smaller sequences are condensed 
together so as to form an intermediate for final assembly. 
Successive incorporation of single amino acid residues via 
the carboxyl terminus can be more difficult, more time 
consuming and poorer yields are obtained. Segment 
condensation allows greater flexibility in the choice of 
protecting groups and coupling methods.
Although segment peptide synthesis has been successful in 
preparing peptides of up to 60 amino acid residues there 
are several difficulties which are encountered, i.e 
increased danger of racemisation, poor solubility of 
larger protected peptides, low coupling speed and side 
reactions involving the solvents. Due to frequent side 
reactions in SolPPS the functional side groups have to be 
well protected and therefore minimum protection cannot be 
considered.
Two dipeptides were prepared using the Zervas, Rydon et
18 8 • al. method. The method was found to be tedious and
time consuming. SolPPS was found to be unsuitable for
the preparation of cysteinyl peptides as the protecting
group of the sulphur is usually a benzyl derivative
cleaved in a basic environment which promotes oxidation.
Oxidation of the sulphydryl was found to be promoted in
the solution phase.
The SolPPS carried out is given in Scheme 4.19.
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Two peptides were prepared by SolPPS while the tripeptides 
and tetrapeptides were prepared by Fmoc SPPS. The 
tripeptides and tetrapeptides were fully characterised as 
the thiol group was found to be stable to oxidation. The 
dipeptides were not isolated and were complexed in an 
inert atmosphere with a cadmium(II) salt.
Special equipment was required for SPPS as the automated 
apparatus was not available. The protected amino acids 
were purchased from Milligen, Cambridge as was pepsyn gel 
resin, which was activated by diaminoethane prior to 
coupling. DMF was purified by distillation prior to use. 
DCM (analar grade) was used as purchased and diethyl ether 
was dried over sodium wire. Other chemicals such as DCCI, 
HOBt and DMAP were purchased from Aldrich.
4.7.1 Equipment
For the synthesis of the tripeptides and tetrapeptides a
t • 1 RQ"bubbler" reaction vessel (Figure 4.1) was used. The
resin suspension was introduced at the top opening. A 
three-way tap was used which enabled drainage of unwanted 
solvents. Nitrogen was bubbled continuously to agitate 
the reaction mixture and to maintain an inert atmosphere. 
Vacuum was applied when needed at V.
Purification of the peptides was carried out by HPLC. A 
reverse phase RP C18 (250x25mm) column was used (Waters
4 .7  E xperim en tal
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Figure 4.1. A "bubbler" reaction vessel for SPPS.
Ltd)• A mixture of acetonitrile and water was used to 
elute the peptides. The composition of the eluent mixture 
depended on the peptide side chains. Solutions were 
concentrated by removing the solvent on a rotary 
evaporator.
4.7.2 Activation of the resin
Pepsyn gel resin (5.0g, 5mmol, Milligen) was added to 
ethylenediamine (250cm3, GPR), swirled and left to react 
overnight. The derivatised resin was filtered off, 
washed with DMF (5x40cm3), 20% triethylamine in DMF
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• » litAt this stage the washings gave a negative (-ve) Kaiser 
reagent test while the resin gave a positive (+ve) test.
4-Hydroxymethylphenoxyacetic acid (3.64g, 20mmol) and N- 
hydroxybenztriazole (2.7g, 20mmol) were dissolved in DMF
O o(15cm ). DCM (45cm°) was added followed by a solution of 
DCCI (4.12g, 20mmol) in DCM (20cm3). The mixture was
stirred for 10 minutes when the DCU precipitated. It was 
filtered off and washed with DCM (20cm3). The filtrates 
were collected and further diluted with DMF (150cm°). The 
resin was added to the filtrate, swirled gently and left 
overnight. The resin was collected by filtration and 
washed with DMF (10x40cm3).
At this stage the resin gave a -ve Kaiser reagent test.
The resin was then washed with DCM (5x40cm3) followed by
> « • *3sodium dried diethyl ether (3x40cm ) and pulled dry on the 
sinter. Yield, 6 grams.
* The Kaiser test is a qualitative colour test with 
ninhydrin. Kaiser reagent: Ninhydrin (lg) dissolved in
O #ethanol (80cm°); phenol (80g) dissolved m  ethanol
(20cm°); potassium cyanide, 2cm° of stock 0.001M solution
• 1 , , , diluted to 100cm with pyridine.
(2 x 4 0cm3 ) and rewashed w ith  DMF (5 x 4 0cm3 ) .
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Derivatised resin (0.56g, 0.5mmol) was added to a sinter 
and agitated with DMF (2 0cm3).
Fmoc-gly(OH) (0.97g, 3.3mmol) was dissolved in DCM (10cm3) 
and DMF (5cm3). A solution of DCCI (0.345g, 3.3mmol) in 
DMF (5cm3) was added and the mixture stirred for 30 
minutes**. The DCU which precipitated was filtered off 
and washed with a 50:50 mixture of DCM/DMF (2x10cm3). The 
combined filtrates and washings were evaporated to remove 
the DCM. The residual DMF solution was added to the 
resin followed by a solution of DMAP (0.021g ; 0.OlSmmol), 
to promote coupling, in DMF (2cm3). The mixture was 
agitated on the sinter for 3 hours. The resulting resin- 
glycine adduct was washed with DMF several times 
(10x2 0cm3).
At this stage a -ve Kaiser reagent test was obtained.
The resin-amino acid was then agitated with a 20% solution 
of piperidine in DMF (2x25cm3), first for a three minute 
period and then for a seven minute period.
** Usually less DMF and more DCM is used to prevent 
racemisation at this step. Fmoc-gly symmetrical
anhydride is insoluble in DCM therefore excess DMF is 
required to dissolve the anhydride. This only happens with 
Fmoc-gly and not any other Fmoc-protected amino acid.
4 . 7 . 3  S y n th e s is  o f  g l v c v l -L -c v s t e i n v lg lv c i n e  TFA s a l t
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The piperidine solution was filtered off and the resin 
washed with DMF (10x20cm3).
A +ve Kaiser reagent test was obtained at this stage.
Fmoc-L-cys(trit) (1.17g, 2mmol) and N-hydroxybenztriazole 
(0.32g, 2mmol) were dissolved in DCM (15cm3) and DMF 
(2cm3). A solution of DCCI (0.41g, 2mmol) in DCM (3cm3), 
was added and the mixture stirred for 10 minutes. The DCU 
solid formed was filtered off and washed with DCM 
(2x10cm3). The combined filtrate and washings were 
evaporated to remove the DCM. The remaining solid was 
dissolved in DMF (30cm3), added to the deprotected amino 
acid and agitated for a further 3 hours. The DMF solution 
was filtered off and the resin washed with DMF (10x20cm ).
A -ve Kaiser reagent test was obtained at this stage.
The resin was again agitated with 25% piperidine solution 
in DMF (2x25cm3), first for a three minute period and then 
for a seven minute period. The piperidine solution was 
finally filtered off and the resin washed with DMF 
(10x2 0cm3).
A +ve Kaiser reagent test was obtained at this stage.
Fmoc-gly(OH) (0.60g, 2mmol) and HOBt (0.33g, 2mmol) were
dissolved in DCM (15cm3) and DMF (3cm3). A solution of 
DCCI (0.41g, 2mmol) in DCM (5cm3) was added and the 
mixture stirred for 10 minutes. The DCU solid which
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precipitated was filtered off and washed with DCM 
(2x10cm3). DCM was removed from the combined filtrate 
and washings by evaporation. The residual solid was 
dissolved in DMF (30cm3) by heating and the solution added 
to the resin* Further agitation was carried out for 3
t Qhours. The resin was then washed with DMF (10x20cm ).
A -ve Kaiser reagent test was obtained at this stage.
The resin was agitated with 25% piperidine in the usual 
manner and then washed with DMF (10x20cm3). The resin 
was further washed with DCM (3x25cm3), dry diethyl ether 
(5x50cm3) and sucked dry on the sinter.
The resin was agitated with TFA (50cm3) containing 2% 
ethanedithiol and 3% anisole as scavengers to cleave the 
tripeptide from the resin. This procedure was carried out 
three times and the filtrates combined. The TFA was 
removed by vacuum distillation. Dry diethyl ether was 
added to the residual solution which was stirred for 3-4 
hours. The white precipitate which formed was filtered 
off and washed with small portions of diethyl ether. To 
the solid on the sinter distilled water (20cm3) was added 
and left to dissolve the tripeptide. Then the solution 
was filtered, the filtrate was freeze-dried and the solid 
obtained was purified by HPLC. Yield of crude tripeptide; 
120mg (70.6%).
P u r i f i c a t io n  was c a r r ie d  ou t by e lu t io n  w ith  a 95% w ater
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5% acetonitrile mixture containing 0.01% TFA to prevent 
oxidation of the sulphydryl group to the disulphide. The 
peptide was eluted in 4.8 minutes by using a 3cm3/min 
flow. Detection of the peptide was carried out at 230nm. 
The chromatograms of both the crude and purified 
tripeptides are shown in Chromatograms 4.1a, 4.1b
respectively. Yield of pure tripeptide, 80mg (47%). 
%Calc. for C9H14N306SF3: C, 30.94; H, 4.05; N, 12.02.
%Found: C, 30.99; H, 4.09; N, 11.98. Fast atom
bombardment mass spectrum (FAB) (FAB Spectrum 4.1) was 
obtained of the pure peptide: Molecular ion calc: 236.
Found: 236.
4.7.4 Synthesis of glvcvl-L-cvsteinvl-L-alanine TFA salt
Derivatised resin (0.56g, O.Smmol) was added to a sinter 
and agitated with DMF (30cm3).
Fmoc-ala(OH) (1.66g, 4mmol) was dissolved in DCM (10cm3) 
and DMF (2cm3). A solution of DCCI (0.41g, 2mmol) in DCM 
(5cm3) was added and the mixture was stirred for ten 
minutes. The DCU precipitate was filtered off and washed
« O . . .with DCM (10cm°). The combined washings and filtrate 
were evaporated to remove the DCM, and the residual solid
• q ,was diluted with DMF (30cm°). The DMF solution was added 
to the agitated resin followed by a solution of DMAP 
(0.025g, 0.025mmol) in DMF (2cm3). The mixture was
agitated on the sinter for three hours.
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Chromatograms 4.1a,b. HPLC chromatograms of (a) crude and (b) pure
(H3gly-cys-gly)+.
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FAB Spectrum 4.1. Fast atom bombardment mass spectrum of (H3gly-cys-gly)H
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4.7.3. Yield of crude product, 143.2mg (78.9%).
The peptide was eluted by a 90%H2O:10%CH3CN mixture. The 
elution time was found to be 4.5 minutes. Yield of pure 
material, 89.4mg (49%). %Calc. for C1qH16N306SF3: C,
33.20; H, 4.41; N, 11.29. %Found: C, 33.06, H, 4.45, N,
11.56. FAB molecular ion calc.: 250, Found: 250.
4.7.5 Synthesis of qlvcvl-L-cvsteinvl-L-valine TFA salt
The preparation of (H4gly-cys-val)+ was as in Section
4.7.4. The amino acid residue coupled to the resin was 
valine. Coupling was carried out as in Section 4.7.4 and 
the complete building of the peptide chain was carried out 
as in Section 4.7.3.
Yield of crude product, 154.3mg (79%). The tripeptide 
was eluted by a 85%H20:15%CH3CN mixture. The elution time 
was found to be 4.8 minutes. Yield of pure material, 
90.3mg (46%). %Calc. for C12H19N306SF3: C, 33.20; H, 4.41; 
N, 11.29. %Found: C, 37.47; H, 4.92; N, 10.79. FAB
molecular ion calc: 278. Found: 278.
4.7.6 Synthesis of L-valvl-L-cvsteinvl-L-valine TFA salt
The synthesis of (H^val-cys-val)+ was carried out as in 
Sections 4.7.3 and 4.7.4. Yield of crude product, 
89.9mg (41.5%). The tripeptide was eluted by a
80%H20:20%CH3CN mixture. The elution time was found to be
4.7 minutes. Yield of pure material, 62.0mg (29%). %Calc.
The r e s t  o f  th e  s y n th e s is  was c a r r ie d  ou t as in  s e c t io n
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C, 40.75; H, 6.28; N, 9.47.
4.7.7 Synthesis of L-leucvl-L-cvsteinvl-L-leucine TFA salt
The synthesis of (H4leu-cys-leu)+ was carried out as in 
Sections 4.7.3 and 4.7.4. Yield of crude product, 60.7mg 
(27%). The tripeptide was eluted by a 70%H2O:30%CH3CN 
mixture. The elution time was found to be 5.08 minutes.
Yield of pure material, 46.3mg (20%). %Calc. for
C12H19N3°6SF3: C' 44.24; H, 6.57; N, 9.10. %Found: C,
43.92; H, 6.82; N, 9.17. FAB molecular ion calc: 348. 
Found: 348.
4.7.8 Synthesis of L-threonvl-L-cvsteinvl-L-valine TFA 
salt
The synthesis of (H3thr-cys-val)+ was carried out as in 
Sections 4.7.3 and 4.7.4. Yield of crude product;
119.1mgs (54.7%). The tripeptide was eluted by a
80%H20:20%CH3CN mixture. The elution time was found to be
5.0 minutes. Yield of pure material, 86.4mgs (40%).
%Calc. for C14H24N307SF3: C, 38.61; H, 5.57; N, 9.65.
%Found: C, 38.33; H, 5.48; N, 9.49. FAB molecular ion
calc: 322. Found: 322.
4.7.9 Synthesis of L-lvsvl-L-cvsteinvl-L-valine TFA salt
The synthesis of (H3lys-cys-val)+ was carried out as in 
Sections 4.7.3 and 4.7.4. Yield of crude product; 106.3mgs 
(36.8%). The peptide was eluted by a 90%H20:10%CH3CN
fo r  C15H26N30 6SF3 : C, 4 1 .5 6 ;  H, 6 .0 6 ;  N, 9 .6 9 .  %Found:
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mixture. The elution time was found to be 4.9 minutes. 
Yield of pure material, 88.2mg (31%). %Calc. for
C18H30N3°8SF6! C' 37.50; H, 5.26; N, 9.71. %Found: C, 
36.97; H, 5.39; N, 9.74. FAB molecular ion calc: 349. 
Found: 349.
4.7.10 Synthesis of L-aspartvl-L-cvsteinvl-L-valine TFA salt
The synthesis of (H^asp-cys-val)+ was carried out as in 
Sections 4.7.3 and 4.7.4. Yield of crude product, 
125.2mgs (55.7%). The tripeptide was eluted by a
95%H20:5%CH3CN mixture. The elution time was found to be
6.4 minutes. Yield of pure material, 88.2mg (31%). %Calc. 
for C18H30N3O8SF6: C, 37.41; H, 4.94; N, 9.35. %Found: C,
37.15; H, 5.02; N, 9.19. FAB molecular ion calc: 336. 
Found: 336.
4.7.11 Synthesis of L-valvl-L-cvsteinvl-L-valvl-L-valine 
TFA salt
The synthesis of (H3val-cys-val-val)+ was carried out as 
in Sections 4.7.3 and 4.7.4. Yield of crude product, 
187.6mgs (70%). The peptide was eluted by a
70%H2O:30%CH3CN mixture. The elution time was found to 
be 5.4 minutes. Yield of pure material, 132.4mg (50%). 
%Calc. for C20H35N4O7SF3: C, 45.10; H, 6.64; N, 10.51.
%Found: C, 44.69; H, 6.55; N, 9.96. FAB molecular ion
c a l c :  4 1 9 . Found: 4 1 9 .
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4.7.12 Synthesis of L-valvl-L-valvl-L-cvsteinvl-L- 
valine TFA salt
The synthesis of (H3val-val-cys-val)+ was carried out as 
in Sections 4.7.3 and 4.7.4. Yield of crude product, 
210.Omg (79%). The peptide was eluted by a
70%H20:30%CH3CN mixture. The elution time was found to be
5.2 minutes. Yield of pure material, 181.2mg (67.7%). 
%Calc. for C20H35N407SF3: C, 45.10? H, 6.64? N, 10.51.
%Found: C, 44.82; H, 6.80; N, 10.37. FAB molecular ion
calc: 419. Found: 419.
4.8 Solution Phase Peptide Synthesis Experimental Work
The method was found to be tedious and complicated, as the 
final product had to be stored under nitrogen. A 
schematic synthesis is given in Scheme 4.19.
4.8.1 Preparation of L-cvsteinvl-L-cvsteine
S-Benzyl-N-benzyloxycarbonyl-L-cysteinyl-S-benzyl-L- 
cysteine benzyl ester (4.0g, 6.4mmol) was suspended in 
liquid ammonia (250cm°) and treated with sodium metal 
(1.34g, 64mmol) when a blue colour formed. The mixture 
was left stirring under nitrogen for about one hour. To 
the ammoniacal solution, ammonium chloride (3.00g, 6mmol) 
was added with caution and the liquid ammonia was 
evaporated by blowing nitrogen through. To the residue 
deoxygenated hot absolute ethanol was added (250cm3).
The product in ethanol was complexed to cadmium(II)
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4.8.1.1 Synthesis of S-benzvl-N-benzvloxvcarbonvl-L-
cvsteinvl-S-benzvl-L-cvsteine benzyl ester
S-Benzyl-N-benzyloxycarbonyl-L-cysteine hydrazide (1.6g, 
4.5mmol) was dissolved in 50% acetic acid (50cm3) 
containing 2M HC1 (5cm ). The solution was cooled and
treated dropwise, with stirring, with a solution of sodium
< > • 8 • nitrite (0.30g, 4.5mmol) m  water (5cm ). The insoluble
azide formed was extracted with diethyl ether and the
solution was dried with anhydrous sodium sulphate.
A suspension of S-benzyl-L-cysteine benzyl ester 
hydrochloride (1.5g, 4mmol) m  ether (25cm ) was shaken 
with triethylamine (0.44g, 4.4mmol) and water (10cm3), 
until the free ester had passed into the ether layer. The 
ether layer was separated and dried with anhydrous sodium 
sulphate.
The two ethereal solutions were mixed, reduced in volume 
and kept at 5°C overnight when a white solid precipitated. 
Recrystallisation of the solid was carried out from a 
benzene/ light petroleum mixture. Yield, 2.21g (80%); 
m.p., 124°C (lit188129-130°C). %Calc. for C35H36N205S2:
C, 6 6.86; H, 5.78; N, 4.45. %Found: C, 66.25; H, 5.93; N, 
4.87.
The compound seems to be slightly hygroscopic. Important 
infrared absorption bands are: 3280(s, br), v(-NH);
c h lo r id e  s tr a ig h ta w a y .
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1645(s, sp), v(-C=0); 3030(w, sp), v(-CH) benzene; 1600(s, 
sp) 6 (-NH); 1745(s, sp), v(-C=0).
4.8.1.2 Synthesis of S-benzvl-N-benzvloxvcarbonvl-L- 
cysteine hvdrazide
S-Benzyl-N-benzyloxycarbonyl-L-cysteine ethyl ester
• 3(2.15g, 5.8mmol) was dissolved in ethanol (100cm0).
Hydrazine hydrate, 99-100%, (0.3g, 6mmol) was added to the
ethanolic solution. The mixture was refluxed for three
hours. The ethanol was evaporated off and to the
remaining solid dried diethyl ether was added. The solid
was filtered off and recrystallised from absolute ethanol.
Yield, 1.33g (64%); m.p. 133-134°C (lit188 134°C).
%Found: C, 59.86; H, 5.92; N, 11.22; %Calc. for
C18H21N3°3S: C' 60.14; H, 5.90; N, 11.68. Important
infrared stretch bands: 3310(s, sp) , v(-NH); 1705(s, sp),
v(-C=0) amide; 3250(s, sp), v(-NH); 1630(s, sp), v(-C=0);
3170 (w, sp), v (~NH2)? 1530 (s, sp), <5(-NH)w; 3030(w, sp) ,
v(-CH) benzene.
4.8.1.3 Synthesis of S-benzvl-N-benzvloxvcarbonyl-L-
cvsteine ethyl ester
S-Benzyl-L-cysteine ethyl ester hydrochloride (2.65g,
Q10.7mmol) was dissolved in chloroform (150cnr). The
solution was cooled in an ice-salt bath to 0°C and shaken
• • • 3vigorously with 2M sodium hydroxide solution (4.8cm ) and
benzyl chloroformate (1.1cm3). To the mixture IM sodium
ca rb o n a te  s o lu t io n  ( 4 . 8cm3 ) and a fu r th e r  p o r t io n  o f
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benzyl chioroformate (1 .1cm3) were added and the whole was 
shaken intermittently for two hours whilst being cooled in 
the ice-salt bath. The chloroform layer was separated 
from the aqueous layer and washed with dilute hydrochloric
( q , f Bacid (2x50cm*3), a saturated sodium bicarbonate solution 
(2x50cm3) and distilled water (2x50cm3). The chloroform 
layer was then dried over anhydrous sodium sulphate and 
filtered. The chloroform was evaporated off and a 
viscous liquid remained. Petroleum ether (80°-100°) was 
added to the liquid and a white precipitate formed on 
stirring. The precipitate was filtered off and washed with 
80°-100° petroleum ether. Yield, 2.81g (70.4%); m.p. 48- 
50°C (lit188, 51°C). %Calc. for C20H23NO4S: C, 64.31; H,
6.22; N, 3.75. %Found: C, 64.01; H, 6.32; N, 3.51.
Important infrared bands: 3330(s, sp), v(-NH); 1530(s,
sP)f 6 (-NH); 3030(w, sp), v(-CH) benzene; 1190(m, br), v(- 
OCH2CH3); 1 7 7 5 ( s ,  sp), v(-C=0) ester; 1040(m, br), v(- 
OCH2 .Ph); 1705(s, sp), v(-C=0) amide.
4.8.1.4 Synthesis of S-benzvl-L-cvsteine ethvl ester 
hydrochloride
S-Benzyl-L-cysteine (1.5g, 7.1mmol) was suspended in 
absolute ethanol (100cm*3) and the suspension was saturated 
with a vigorous stream of dried hydrogen chloride gas. 
When the solid dissolved a yellow solution resulted. The 
ethanolic solution was filtered and nitrogen gas bubbled 
through for one hour. The ethanol was then evaporated 
off, and to the residual solid dry diethyl ether was
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added. The solid was filtered off, washed with diethyl 
ether and dried under vacuum 60°C. Yield, 1.90g (97%); 
m.p. 155-156°C (lit188,156-157°C). Important infrared
bands: 3060(s, br), v(NH3+ ); 1165(s, br), v(-0CH2CH3);
1725(s, sp), v(-C=0); 1575(m, br), k(-NH); 575(s, sp), 6 (- 
CH) benzene.
4.8.1.5 Synthesis_____of______S-benzvl-L-cvsteine-N-
carboxvanhvdride
S-Benzyl-L-cysteine (2.5g, 11.8mmol) was suspended in
sodium-dried dioxan (100cm°) and phosgene was passed 
through the suspension for approximately twenty minutes. 
During this time the solid dissolved to give a yellow 
solution, and after disconnecting the phosgene gas the 
solution was stirred for 45 minutes. The solution was then 
filtered and the dioxan distilled off under nitrogen. A 
white precipitate remained and 60-80° petroleum ether was 
added. The solid was then filtered off and dried under 
vacuum. Yield, 2.28g (81.4%); m.p. 102-104°C, (lit188, 
104°C). Important infrared bands: 3250(s, br), v(-NH);
1635(s, sp), v (-C=0); 1665(s, sp), v(-C=0); 1585(s, br), 
6 (-NH);
4.8.2 Synthesis of glvcvl-L-cvsteine
Glycyl-L-cysteine was prepared in the same way as L- 
cysteinyl-L-cysteine and the preparation is therefore not 
described in detail. The schematic procedure is given in 
Scheme 4.20.
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4 .9  C o n c lu sio n s
The peptides glycyl-L-cysteinylglycine , glycyl-L- 
cysteinyl-L-alanine, glycyl-L-cysteinyl-L-valine, L-valyl- 
L-cysteinyl-L-valine, L-leucyl-L-cysteinyl-L-leucine, L- 
threonyl-L-cysteiny1-L-valine, L-lysyl-L-cysteinyl-L-
valine, L-aspartyl-L-cysteinyl-L-valine, L-valyl-L-
cysteinyl-L-valyl-L-valine and L-valyl-L-valyl-L-
cysteinyl-L-valine were all synthesised as
trifluoroacetate salts in high states of purity and in 
high yields by the Fmoc solid phase method (Fmoc SPPS). 
The solution phase method was used for the synthesis of L- 
cysteinyl-L-cysteine and glycyl-L-cysteine.
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DETERMINATION OF DISSOCIATION AND ' 
COMPLEX START!,TTY CONSTANTS OF SOME 
CYSTETNYT. TRI— AND TETRA-PEPTTDE
LIGANDS
5.0 Determination of Dissociation and Complex Stability 
Constants of some Cvsteinvl Tri- and Tetra-peptide 
Ligands
5.1 Introduction
Much work has been carried out on the determination of
stability constants of complexes of cadmium(II) and other
metal ions. It has been established that cadmium(II)
forms several different complexes with thiol and non-thiol
amino acids over a wide range of pH. The complexes with
thiol amino acids and thiol peptides vary from the 
4- •[Cd(HL)] species in acidic media (where H2L is the 
neutral ligand) to the anionic [Cd(L)(0H)]~ species in 
basic media. 9 0 ' 109' 1 1 0 ' 190' 191 Other complexes such as 
[Cd(L)2]2” and [Cd(HL) 2 ] 82' 89' 9 0' 109' 1 1 0 ' 190-193 are also
formed when excess ligand is used. Mixed ligand complexes 
have also been investigated both with thiol and non-thiol 
ligands.194-T98
Potentiometric studies have been carried out on (i) 
cadmium(II) and cysteinyl peptide systems, 1 0 9 ' 1 1 0 ' 1 1 4 ' 199
(ii) cadmium(II), cysteinyl and cysteinyl-related 
systems, 82' 89" 9 1 ' 96' 1 1 0 ' 199-205 (iii) cadmium(II) thiol 
and non-thiol mixed ligand systems, 194" 198 (iv) 
cadmium(II) and non-thiol amino acid systems, 1 0 3 ' 206-214 
and (v) cadmium(II) and non-thiol peptide
systems. 1 9 1 ' 1 9 3 ' 199' 208' 2 1 2 ' 215-218
P o la ro g ra p h ic  methods have a ls o  been w id e ly  used  t o  stu d y
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the solution chemistry of cadmium ions with cysteine 
and related compounds, 220' 221 thiol amino acids, 221" 225 
non thiol peptides, 220 and mixed ligands. 2 27" 229
Calorimetry is another method used extensively for 
solution studies of complexes. Despite this, very little 
work has been carried out on cadmium (II) and its 
complexes.
As this chapter concentrates on cysteinyl and cysteinyl 
peptides, a brief introduction to their complexes is 
required. The main complexes that form between 
cadmium(II) and L-cysteine at 1:1 ligand-to-metal ratio 
are [Cd(HL)]+ at low pH, 91 [Cd(L)] at physiological
pH , 8 2 ' 91 and [Cd(L)(OH)j" at high pH89' 90 (where H3L+ is 
the L-cysteine cation). The first two complexes have 
been isolated in the course of this work, the first from 
an aqueous/ethanol medium and the second from an aqueous 
medium. In both cases the L-cysteine seems to coordinate 
in a tridentate fashion. By using other ratios of ligand 
to metal the following complexes have been isolated: 
[Cd(HL)2] at low pH , 82' 89 [Cd(L)2]2- and [Cd(L)3]4" at 
physiological pH. 90 Other less important complexes have 
also been found to exist in solution in smaller 
quantities. 90 Furthermore, polynuclear complexes of L- 
cysteine were found to exist in solution. 82
Stability constants for complexes of cadmium(II) with 
derivatives of L-cysteine such as S-methyl-L-cysteine, S-
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ethyl-L-cysteine and related compounds, such as
penicillamine and other thiol ligands have been
determined, and some solid complexes have been 
isolated 78,90,91,110,114,192,200-204,220,221
As the biological importance of cadmium(II) binding to 
proteins was realised more studies of the complexation of 
cadmium(II) with cysteinyl and non~cysteinyl
oligopeptides were carried out. The thiol group of the 
tripeptide glutathione is sufficiently stable to oxidation 
to allow determination of dissociation and complexation 
constants. The complexes formed between glutathione (H3L) 
and cadmium(II) at a 1:1 molar ratio in an aqueous medium 
have been found to be [Cd(HL)] at low pH, [Cd(L )]” at
physiological pH and [Cd(L)2 (OH)]2- at high pH.109'218. At 
a 2:1 ratio the complexes formed are [Cd(HL)2]2_ at low 
pH, and [Cd(L)2]4- and [Cd(L)(OH)]5- at physiological
1 A Q  O I OpH. Some polynuclear complexes of cadmium(II) and
glutathione have also been determined. 109 The complex 
Cd(H2L)Cl was isolated in the course of this work and is 
described in Chapter 3.
Other cysteinyl peptides proved difficult to prepare until 
the advent of new techniques in peptide synthesis. This 
chapter describes the complexation of tri- and tetra- 
cysteinyl peptides with cadmium(II) in aqueous media of 
0.1M sodium perchlorate at 25°C. The peptides used were 
glycyl-L-cysteinylglycine, glycyl-L-cysteinyl-L-alanine,
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glycyl-L-cysteinyl-L-valine, L-valyl-L-cysteinyl-L-valine, 
L-leucyl-L-cysteinyl-L-Teucine, L-seryl-L-cysteinyl-L-
valine, L-aspartyl-L-cysteinyl-L-valine and L-lysyl-L- 
cysteinyl-L-valine. The first five peptides have amino 
acid residues with hydrophobic side chains while the last 
three have hydrophilic side chains*
In addition the two tetrapeptides, L-valyl-L-valyl-L- 
cysteiny1-L-valine, L-valy1-L-cysteiny1-L-valy1-L-valine, 
were synthesised and complexed with cadmium(II).
5.2 The Chemistry of Ionisation and Complex Equilibria
5.2.1 The theory of______dissociation/ionisation
constants252'253
Dissociation constants of acids give an indication of 
their strengths. The lower the pKa value (-log1QKa) the 
stronger the acid.
Considering the dissociation of an acid in solution:
KaHA >  H+ + A" 5.1)
and applying the law of mass action to the dissociated 
acid, relationships 5.2 and 5.3 result.
[H+] [A-]K =   5.2)
[HA]
pKa = pH + l ° g 10 [HA] /  [A- ] 5 .3 )
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Applying the law of mass action to the protonation of a 
base, 5.4, gives
Kb ^A + H20 —  AH + OH 5.4)
[AH][OH-]K  --------  5.5)
[A"]
and so,
KaKb = *w or PKa + pKb = pKw 5*6>
For simplicity it is preferable to express dissociation 
constants as pKa 's, but pK^'s can easily be calculated 
using this equation. However, on determining
dissociation constants the final result can vary depending 
on the concentration of the compound in solution. This is 
due to the electrostatic forces introduced between ionic 
species in solution. It is therefore best to determine 
and describe the constants in terms of their activities.
For HA  ■ H* + A'
T (aH+) (aA-)K l   -----------------------  5 . 7 )
(aHA)
where K_T is the thermodynamic ionisation constant.
It is advisable to determine dissociation (pKa 's) 
constants in dilute solutions to minimise the 
electrostatic forces, since at infinite dilution the 
concentration constant becomes numerically equal to the 
thermodynamic constant.
165
5.2.2 The theory of complex equilibria and equilibrium 
constants254 ~
The formation of a complex MAn can be expressed by;
KnM + nA —  MAn 5.9)
where Kn = stability constant 
Applying the law of mass action,
[MAn]
K  -------  5.10)
[M] [A]n
In solution various complexes can exist in stepwise
equilibria:
K1M + A ^  ""-MA 
K.k2MA + A <  = ^ MA2
Kn
M + n - l )  + A ^ = ^ M&n
Usually, one of the above species is present in higher 
concentration than the others. Bodlander was the first to 
realise this and he attempted to calculate stability 
constants using both solubility and potentiometric 
methods. By using a suitable concentration cell he 
determined the concentration of the free metal ion at 
various pH's.
Consider a metal (M) in solution with excess ligand (A) . 
The complex most likely to form is the one with the 
maximum number of ligands coordinating to the metal
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Kqr.qM + rA ^      MgAr,
(MqAr ) .  A p p ly in g  th e  law o f  mass a c t io n  t o
[MqAr]K ™  = ----   5.11)
^  [Mil [A]r
Varying the concentration of the metal ion or the ligand;
[M A ]x . [A2]r   — 2------------  5.12)
[M2]<3 [Mq Ar ] 2 . [Ax]r
Maintaining the concentration of the ligand (A) constant,
1 * 1  1? = I W i  5 . 1 3 )
[M2]‘3 [MgAr ] 2
and therefore the e.m.f of a concentration cell, E, is 
given by
RT [M-,] RT [M Ar3-, i /q
E = —  I n  = -- In { — 3----> 5.14)
nF [M2] nF [ MqAr ] 2
As the ligand is in excess all the metal (M) present is in
the form of MgAr and
[MgAr] = Tm 5.15)
Thus if the e.m.f, E, of the cell is known then;
RT [M„Ar]l RT Tm  1/‘3E = —  In {  --- > = —  In { --- > 5.16)
nF [MqAr ] 2 nF TM2
where Tj^ = analytical concentration of the metal in the 
first experiment 
Tm2 = analytical concentration of the metal ion in the second experiment.
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Therefore q can be calculated and by varying the ligand 
concentration and fixing the metal concentration the 
experimental r value can be calculated and therefore the 
ratio of q/r can be determined.
Jaques first explained that from a series of electrode 
potential measurements at different concentrations of 
excess ligand to metal stability constants and 
concentrations of each complex species can be determined 
in solution.
the sum
5.17)
5.18)
The total concentration of the metal ion (T^ ) is 
of the concentrations of each species
Tm * [M] + [MA] + [MA2] + ..... + [MAn]
when n is the maximum number of A ligands.
Using overall stability constants (K^):
[M] [A] [M] [A] 2 [M][AJn
Tm  = [M] + ------ +  + ....... + -------
K! *1*2 *1*2 *«Kn
and for a particular experiment
[A-J [Ax ] 2 [A-j]"
T„ = [M,] [ 1 +  + ----- + ...... + -------  ] 5.19)
KX K lK2 KjK2 . .K n
For a second experiment varying the ligand concentration
[A2] [A2 ] 2 [A2]n
Tm = [M2] [ 1 + --- + ----- + ......+ ------  ] 5.20)
K1 K1K2 KlK2 ” Kn
168
Hence, measurement of the free metal ion concentration at 
n different ligand concentrations enables calculation of 
the stability constants. The ligand has to be added in 
vast excess otherwise the basic condition [L] = TL fails. 
It must also be noted that the activity was not taken into 
consideration. Little recognition was given to this work 
until the later investigations of Niels Bjerrum, and Debye 
and Huckel.
The discovery of the glass electrode led to Jannik 
Bjerrum's analysis of complex equilibria from 
potentiometric investigations. Leden was the first to 
publish a paper on cadmium(II)-halide complex equilibrium 
constants determined from emf measurements.
5.2.2.1 Types of complex equilibria in solution254
Complexes as indicated in equations 5.22 to 5.24,
[Co(H20)6]2+ + NH3 k. — [Co(H20)5NH3 ] 2 + + H20 5.22)
[Co(H20)5 (NH3) 32+ + NH3^=^[Co(H 20)4 (NH3)2]2+ + H20 5.23) 
[Co(H20)(n.x)(NH3 )x32++(n-x)NH3^ [ C o(NH3)n]2+ + H20 5.24)
where n is equal to the maximum coordination number, can 
exist in stepwise equilibria in solution. The intermediate 
complexes 5.23 can be termed mixed ligand complexes. As
the water molecule need not be considered since the 
complexation is carried out in water, the complex can be 
regarded as a mononuclear binary complex.
Other complex equilibria include the complexation of 
unidentate anions when the positive charge of the metal 
ion is neutralised, resulting in complex anion:
Al3+ + F~ (AlF)2* 5.25)
(A1F)2+ + F“ ^ = ^ ( A 1 F 2)+ 5.26)
(A1F5)2~ + F~ ^  (A1F6)3" 5.27)
Ligands with more than one coordination site such as amino 
acids and peptides are termed chelating agents and the 
resulting complexes are chelates. Polydentate ligands can 
restrict maximum coordination unless sterically 
favourable. The successive complex formation is
analogous to stepwise protonation of the ligands,
“OOC-COCT + — HOOOCOCT 5.28)
HOOC-COO" + —  HOOC-COOH 5.29)
Two conclusions can be drawn from this.
The mathematical treatment of acid/base equilibria is the 
same as that of complex equilibria, and there is 
competition between protons and metal ions for the ligand.
Protonation of multidentate ligands does not necessarily 
mean the break-up of the complex. This also applies to 
hydroxy complexes,
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A ligand can also coordinate to two metal ions acting as 
a bridge between them. Complexes which have more than one 
metal atom are termed polynuclear;
[Zn(0H)]+ + Zn2+ ►  Zn-O-Zn 5.31)H
Ag+
[NH2 (CH2 )2NH2Ag]+---— ►  [AgNH2 (CH2 ) 2NH2Ag ] 2 +  5.32)
Polynuclear complexes can be either homo- or hetero- 
polynuclear depending on whether the metal centres are 
the same or different.
Outer sphere complexes can also form in solution where a 
counter ion is associated with the complex,
[Co(NH3)6]3+ + Cl"---- ►  { [Co (NH3 ) 6 ] ,C1}2+ 5.33)
Displacement reactions are also possible where ligand and 
central metal ion substitution can occur,
[HgCl4]2" + 41“---- ►  [Hgl4]2" + 4C1" 5.34)
and central metal ion substitution,
[Cdl]+ + Hg2+---- ►  [Hgl]+ + Cd2+ 5.35)
It is therefore clear that many complexes can form in 
solution and must be considered. This complexity makes 
mathematical analysis of data to establish the existence 
of such complexes extremely difficult without the use of 
high speed computers and reliable computer programs.
[Fe(H20 ) 5OH]2+ + H+ : ^ = = i [ F e ( H 20 ) 6 ] 2+ 5 . 3 0 )
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Considering the simplest form of complex formation,
K
M + ML 5.36)
and applying the law of mass action:
[ML]K = -----  5.37)
[M][L]
Stepwise formation constants of a complex are,
Kx = [ML] / [M][L] 5.38)
K2 = [ML2] / [ML][L] 5.39)
Kn - [MLn] / [MLn-1][L] 5.40)
The product of the stepwise stability constants to a
given stage gives the overall stability constant, Br to
that stage:
Bi = Kx = [ML] / [M][L] 5.41)
Bo = K-i = fMLol
®n = KlK2  Kn = [“ in] / tM ) lLln 5-43>
In general,
n
Bn = n  5.44)
1
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Considering a reaction where the metal ion reacts with the 
acidic ligand:
K
MLn-i + HL MLn + H+ 5.45)
or
 ___ 4 .M + nHL ^  MLn + nH+ 5.46)
the stability constant equations are:
[MLn][H+]*K = ---------  5.47)
[ MLn_ ! ] [ HL]
[MLn][H+]n
*6    5.48)
[M][HL]n
*Kn = Kn-Ka 5*49>
*Bn = V Kan 5-50>
*K„ = product of stability constant and Ka * acidity
n a constant
where
Kn = [MLn] / [MLn.-iniT] 5.51)
and
J3n = [MLn] / [M)[L"]n 5.52)
The equilibrium constant of a ligand substitution
reaction
ML + X MX + L 5 . 5 3 )
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i s  th e  r a t i o  o f  t h e i r  coresp on d in g  s t a b i l i t y  c o n s t a n t s ,
[MX][L]
K “ " *MX / kML 5.54)[ML][X]
5.2.2.3 Equilibrium constants involving concentrations and 
activities
The law of mass action is only completely valid when 
activities are used and not concentrations. The activity 
of a species is equal to the product of its concentration 
and its activity coefficient. Therefore a relationship 
between the stoichiometric equilibrium constant and the 
thermodynamic equilibrium constant exists involving 
activities °Kn:
{ML } %Ln-l • fL°Kn  ------------  K   5.55)
{ M L ^ H L }  fMLn
where {} = activities and f = activity coefficients.
In general, it can be said that electrochemical methods 
give activities, while optical methods give concentrations 
as activities can be obtained directly from pH 
determinations.
In conclusion, thermodynamic constants are therefore 
obtainable by (i) studying very dilute solutions (less 
than 10”3M), where the combinations of the activity 
coefficients are practically equal to unity, (ii) by 
studying dilute solutions where the activity coefficients
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can be obtained theoretically, and (iii) by determining 
equilibrium constants at different ionic strengths and 
extrapolating to infinite dilution.
The first method is limited to very stable complexes. In 
dilute solutions as in the second and third methods the 
activity coefficient of a given solute is the same in all 
solutions of the same ionic strength.
The ionic strength is defined by equation 5.57 where c^ = 
concentration of ions of charge Zj_.
I = 1/2 S Cty.Zj^  5.56)
The ionic strength is usually kept constant by using a 
strong electrolyte such as sodium perchlorate or potassium 
nitrate. The electrolyte must be inert and comply with 
the following rules:
(1) It must be a strong electrolyte.
(2) Its cation must not associate with the ligand and 
with the complex species formed.
(3) Its anion must not associate with the metal ion 
and with the complex species.
(4) Redox reactions via the inert electrolyte and the 
central ion or ligand must not take place.
(5) Its solubility has to be very large.
(6) Its contribution to the measured physical or 
chemical property must be negligible.
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Most of the mathematical methods developed for the 
calculation of stability constants are based on or closely 
related to the quantity called the complex formation 
function (% distribution of complex). As stability 
constants cannot be measured directly a relationship 
involving concentrations of products and reactants needs 
to be developed. The total concentrations of the ligand 
and the metal ion are known, while the concentrations of 
the free metal ion and free ligand are accessible by 
potentiometric measurements.
The total concentration of the metal ion is the sum of the 
free metal ion in solution and the metal ion involved in 
the various complexes,
n
Tm = [M] + [ML] + [ML2] + ..... + [MLn] * 2 MLj_ 5.57)
i=0
and similarly for the ligand,
n
Tl = [L] + [ML] + 2[ML2] +.+ n[MLn] = [L] + 2 i[ML^] 5.58)
i = l
Combining equations 5.57 and 5.58 with equations 5.41, 
5.42 and 5.43, the stability constants can be obtained in 
terms of the total analytical concentrations of the metal 
ion and ligand,
Tm = M + fll[M][L] + B a W C I . ] 2 +   + fljJMHL] 11
5 . 2 . 2 . 4  The com plex fo r m a tio n  fu n c t io n 254
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= [M] 2 [L ]1
n
5 . 5 9 )
i=0
and
Tl = [L] + Bi[M][L] + 2fl2 [M][L] 2 + ....  + nBn [M][L]n
= [L] + {[M] 2 IBitL]1}
n
5.60)
i=l
Two important conclusions can be drawn from equations 5.59 
and 5.60, (i) measuring the free ligand concentration for
at least n different total ligand concentrations permits 
the calculation of a complete set of stability constants, 
and (ii) the formation function, or average coordination 
number, is independent of the total concentrations of 
central ion and/or ligand.
The extent of complex formation can be characterised by 
the complex formation function introduced by Niels 
Bjerrum;
[ML] + 2[ML2] + .... + n[MLn] Tl - [L]
T,  ----------------------------------------------------------------- ---- -------------------
[M] + [ML] + [ML2] + ... +[MLn] Tm
5.61)
Taking into consideration equations 5.59 and 5.60:
Z if i j-tL ]1
n
i=l
5 . 6 2 )
n
i = o
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n
2 iffifL] 1 
i=l
T\ =   5.63)
n
1 + 2 iBjJL] 1 
i=l
The degree of formation of a system is defined by the 
ratio
fta  --  5.64)
N
while the degree of formation of the n complex is given 
by
tL 1n“n  ----  5.65)
TM N
The degree of formation above is of the basic form. Other 
degrees of formation equations can be derived for more 
complex species, which can include statistical 
considerations and other factors.
5.2.2.5 Calculation of complex stability constants254
Besides the complex formation function 5.62) other 
relations between complex formation and stability 
constants have been used to calculate stability constant 
relationships. Some are 5.66) due to Ledens, and 5.67) due 
to Fronaeus.
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[M] N
F(L)
[M][L]
—  -  2 ^ [ 1 ] ^
i] 1
5 . 6 6 )
Combining equation 5.67 with 5.62,
N
[2 i[ML±] - Tj[M]
1
F(L) 5.68)
The above relationships with some other relationships are 
used to determine stability constants by graphical 
and numerical methods, and with high speed computers, all 
based on the relative concentration changes of the 
different species.
The graphical methods require the determination of many 
experimental data to reduce the experimental error. Three 
graphical methods are available:
(i) linear extrapolation,
(ii) elimination method, and
(iii) curve fitting.
The larger the coordination number (N), the more difficult 
it is to calculate the stability constants directly. For 
N<3 corresponding formulae have been established by 
McIntyre. When N=3 other expressions have been 
formulated. Very accurate results are required for the
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n u m erical m ethods.
Previous stability constant determinations have been based 
on absolute concentrations of one or more species in 
solution. It is also possible to evaluate constants 
using relative concentration data.
The main method used for analysis of the data to 
provide stability and formation constants is by computer. 
Several computer programs have been established in recent 
years and are described in Section 5.3.1.
5.3 Calculating Dissociation and Stability Constants 
using Computer Programs
5.3.1 Introduction
Life has been made easier in the recent twenty years by 
the use of computer programs to refine dissociation 
constants and stability constants. Most computer
programs now available are very efficient and very 
accurate resulting in minimum error. The programs are 
written using a high level language "FORTRAN" which 
enables the use of complex generalised least squares 
minimisation techniques. 2 3 0 ' 231
The first of these programs was "LETAGROP" . 232 It uses 
the "pitmapping" refinement method and calculates 
association constants for complexes, mixed ligand 
complexes and polynuclear complexes from pH titration 
data. It is a particularly versatile program, consisting
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of two parts. The major part is a generalised function 
minimisation routine which takes a function of N variables 
and finds the values of X^ which give the smallest value 
for U,
u = F(Xjf j=lf N ) 5.69)
The second part of the program is a subroutine which 
calculates the value of U for any set of values of X^. The 
first part of the program then uses this subroutine to 
find the values of X^ which minimise U.
It was found that Letagrop convergence to the minimum was 
unreliable and a new program "LETAGROP-VRID" was 
introduced. Again some false refinements were
OOOencountered.
Other refinement methods have how appeared. Most
programs now use the "GAUSS-NEWTON" method. One of the 
early and most influential programs was "GAUSS11, 234 which 
was a development of a previous program written by Tobias 
and Yasuda. 235 This program calculated dissociation and 
association constants from pH-metric data. Unfortunately 
"GAUSS" was limited to one metal, one ligand stability 
constant refinement, and this was altered by Sayce, who 
developed a sister program "SCOGS" . 230 "SCOGS" could now 
refine complex association constants of mixed ligand, 
hydrolysed, polynuclear and hydroxy complexes. Several 
corrections to "SCOGS" have since been developed. 237 
"LEAST" was the next program to be published which
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calculated partial derivatives analytically. 238 "LEAST" 
is capable of using either the NEWTON-RAPHSON or the 
GAUSS-NEWTON refinement methods and it calculates 
constants by pH titration measurements but for only one 
metal, one ligand systems.
"STEM" is a program which has the same qualities as
"Least" but uses the "DAVIDON-FLETCHE-POWELL" method of
. . .  . 7 "39minimisation
"MINIQUAD" was the next program to be developed, 240 and a 
newer version "MINIQUAD-75" is widely used. 241 Both 
programs are discussed in more detail in section 5.3.2 as 
"MIN I QUAD-7 5" was used to study the complexation and 
dissociation constants of the peptides prepared. Recently 
"MINIQUAD-75" has been further improved and given the name 
of "SUPERQUAD" . 242 "SUPERQUAD" is used in preference to 
"MINIQUAD-75" for compounds which cannot be purified 100%. 
Experimental errors can be accounted for within the 
program by calibration of the pH glass electrode and the 
delivering burette.
5.3.2 The "M1NI0UAD" computer program240'241
Miniquad was devised by A.Sabatini, A.Vacca and P.Gans. 241 
The program can be applied to all types of potentiometric 
data, including multi-reactant and multi-electrode 
systems. "MINIQUAD" comes from the Italian word "LEAST 
SQUARES" and can treat data that indicate mononuclear,
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The theory behind the program begins by stating the mass 
balance equation,
Ti = ci + S qij C'j 5.70)
There are n^ formation constants Bj of which are to be 
refined.
For each of the reactants the above mass balance
equation is valid (where T^ = total analytical 
concentration of reactant i, = concentration of free
(uncomplexed) reactant, C'j = concentration of the complex
j) /
and
C*j = Bj 7T Ck (3(3K) 5.71)
(where q(jK) = indices are the stoichiometric coefficients 
of the reaction).
The program then uses the Gauss-Newton least squares 
method to determine the accuracy of the stability 
constants. The sum of squares, U, to be minimised is,
m . n m
U = S (T*calc - Tj ) = d (STjJ2 5.72)
1 1
(where U = sum of squared residuals for all the mass 
balance equations).
The authors emphasise that equal weights are used.
p o ly n u c le a r , h y d ro ly se d  and h y d r o x y l-c o n ta in in g  co m p lex e s .
183
This means that all pH-measurements are equally 
considered. Therefore in the present work once a model was 
refined for each set of titration results, some pH- 
measurements at the beginning and end were omitted.
Usually the model refined more accurately and a smaller
standard deviation was obtained. Although the standard
deviation decreased the stability constants altered only
slightly. Therefore the method of disregarding was not 
employed. The computer program analyses each pH 
measurement individually by the least squares method 
comparing it with the ideal pH measurement for the model
introduced. If the comparison yields a large U then
the model is rejected. Design matrices are also used to
refine the least squares function.
"MINIQUAD" has many advantages over other computer
programs. The main advantages include (a) the use of the
Gauss-Newton least squares refinement method which is
241preferred to the Newton-Raphson method, (b) the
program uses all titration points therefore no bias 
results between a certain pH range of the titration, (c) 
the program is extremely flexible and can deal with 
mononuclear, polynuclear, hydrolysed and mixed ligand 
complexes, with up to 300 titration points and 20 complex 
species in equilibrium, and (d) the residuals of the mass- 
balance equations are analysed statistically to show how 
close to a Gaussian distribution each species can be
accommodated.
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A Gaussian distribution has the following properties:
(i) Arithmetic mean = 0.
(ii) Standard deviation = 0.
(iii) Mean deviation = (V(2/nr))e.
(iv) Moment coefficient of skewness = 0.
(v) Moment coefficient of Curtosis * 3.
(vi) X2 - Goodness of fit factor (closer to 0 the
better the model).
(vii) R factor significance test (closer to 0 the better 
the model).
5.4 Experimental
5.4.1 Equipment
A Radiometer automatic titration apparatus was employed 
for the pH-metric titrations. The titration assembly 
consisted of three sections.
(I) pH Meter
A PHM 82 standard pH meter from Radiometer, Copenhagen 
was used. Three adjustments were necessary before each 
set of titrations.
(a) "Buffer" - the electrode was standardised with a
basic buffer (borax),
(b) "Sensitivity" - the electrode was standardised
with an acidic buffer (sodium hydrogen 
phthalate),
(c) "Temperature" - the temperature of the reaction was
set at (25°C).
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The pH measurements were made to 0.01 of a pH unit.
Two electrodes make up the complete cell. The main pH- 
determining electrode is a glass electrode filled with 
hydrochloric acid and a platinum wire suspended within the 
acidic solution. The second electrode, which completes 
the cell, is a silver/silver chloride electrode immersed 
in saturated potassium chloride. When not in use the pH 
glass electrode was suspended in a dilute solution of 
hydrochloric acid (0.1M) and the silver chloride electrode 
in a saturated solution of potassium chloride.
(II) Autoburette (ABU 12)
An ABU 12 autoburette from Radiometer, Copenhagen, was 
used. Eight different speeds were available for the
introduction of the base into the titrants. The
autoburette can deliver a minimum amount of O.OOlcnrf but
q  t ( ,0.0lcm was delivered for each reading to be obtained. In 
all 80 to 150 readings were taken for each titration.
(III) Titration Assembly (TT A60)
The titration mixture was placed in a double jacketed
< • *3 >reaction vessel and was approximately 50cm m  volume. 
Water circulated from a constant temperature water bath 
was used to keep the reaction mixture at constant
temperature. The titration assembly had five inlets. Two 
were for the pH and silver chloride electrodes, one for 
the burette, and one for keeping a constant flow of
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nitrogen over the reaction mixture to maintain an inert 
atmosphere. The last inlet was stoppered but can be used 
when information is required from more than one electrode. 
A stirrer was included to ensure good mixing of the 
reactants.
5.4.2 Reagents
5.4.2.1 Preparation and standardisation of solutions
All solutions were prepared with doubly distilled 
deionised water. Two solutions were prepared for the 
standardisation of the pH electrode prior to the 
titrations carried out. The two solutions were borax 
(sodium tetraborate decahydrate) (AR) (3.8137g/l, 0.01M)
and potassium hydrogen phthalate (AR) (10.211g/l, 0.05M).
The former solution has a pH of 9.18 at the above molar 
concentration, while the latter has a pH of 4.01 at 25°C.
Sodium hydroxide solutions were prepared from ampoules 
(500cm3, 0.1000M) purchased from BDH. The solution was
further diluted to approximately 0.05M. Standardisation 
of the sodium hydroxide solution (0.05M) was carried out 
by titration against standard hydrochloric acid (0.1M), 
prepared from a BDH ampoule (500cm , 0.1000M). Several
titrations were carried out and the three most consistent
qresults (+ 0.05cm ) were averaged.
Sodium perchlorate solution (14.046g/l, 0.1M) (BDH, analar 
grade) was used to maintain a constant ionic
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oconcentration. A fixed amount (40cm ) was used and the 
ionic factor (pKw * 1.6596 x 10- 1 4 (-13.78)) was corrected 
for at the computing stage.
L-Cysteine (Aldrich) was purified by recrystallisation 
from an ethanol/water mixture. %Found: C, 29.64; H, 5.94; 
N, 11.38. %Calc. for C3H7N02S: C, 29.74; H, 5.83; N,
11.56.
Glutathione (Aldrich) was converted to the
trifluoroacetate by suspending it in 0.1M trifluoroacetic 
acid and purified by HPLC. The final product was obtained 
by freeze drying. %Found: C, 34.05; H, 4.64; N, 10.27. 
%Calc. for C12H18N308SF3: C, 34.20; H, 4.31; N, 10.57.
5.4.2.2 Titration conditions
The temperature of the reaction vessel was maintained at 
25°C by a water jacket sourrounding the reaction mixture. 
The ionic strength of the solution was maintained at 0.1 
molar by the addition of sodium perchlorate.
5.4.2.3 Synthesis of cadmium (IIT trifluoroacetate
Cadmium(II) hydroxide (2g ; 0.0137mol) was suspended in
distilled water (40cm3) and stirred at ~ 60°C). To this 
solution trifluoroacetic acid (~ 98%, Aldrich) was added 
dropwise until almost all the cadmium(II) hydroxide went 
into solution. The solution was left to stir at ~60°C 
for half an hour and filtered while warm. The water was
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evaporated leaving a white solid. The solid was suspended 
in toluene, filtered off and dried in a vacuum oven at 
8 0 °C .
Yield, 4.52g (93%). %Found: C, 13.54; H, 0.88. %Calc. for 
C4CdH2Fg05: C, 13.47; H, 0.57. The product was thought
to be the monohydrate Cd(CF3COO)2 .H20 so this formula was 
used in all calculations.
Cadmium(II) trifluoroacetate was found to be very 
hygroscopic; soluble in organic solvents such as diethyl 
ether, ethanol, and methanol, but insoluble in toluene.
Cadmium(II) trifluoroacetate was used for all titrations,
of Cd2+/peptide mixtures instead of any other cadmium(II)
salt for the following reasons. (I) Cadmium(II)
trifluoroacetate is fully dissociated in water. This was 
1 i q ,confirmed by Cd nmr since the peak was observed at the 
same chemical shift as that of cadmium(II) perchlorate 
which is said to dissociate fully in aqueous solution and 
is used as a standard for nmr studies. (II) As the 
complexes formed at physiological pH were to be isolated 
after the titrations were completed it was thought best to 
have only one counter ion within the system. (Ill) No 
interfering insoluble complexes of trifluoroacetate form 
over the pH range (3.5 - 10.00) of the titrations. This 
was shown by titrating, Cd(CF3C00)2.H20 against NaOH, TFA 
against NaOH, and Cd(0H) 2 /TFA against NaOH. The plots 
of pH against sodium hydroxide added are shown in Figures
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5.1. These plots show that no insoluble complexes form 
over the pH range where cadmium(II)-peptide interaction 
takes place.
0.0 0.2 0.4 0.6 0.8 !0
NaOH / cm3
Figure 5.1. Plots of (a) Cd(TFA)2* (*>) Cd(OH)2f (c) TFA 
against NaOH (0.05M).
5.5 Dissociation Constants of L-Cysteine. Glutathione, Tri 
and Tetra-Peptides
Three dissociation constants were obtained for all the 
hydrophobic peptides and four were obtained for some of 
the peptides with hydrophilic side chain. As the
peptides were in their trifluoroacetate form the pH of the 
starting solution was found to be quite low (pH 3-4). The 
values of the dissociation constants were obtained by
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titrating the amino acid/peptide against 3 or 4 mole 
equivalent of sodium hydroxide at constant ionic strength. 
The data pH / volume of NaOH added was analysed using a 
Miniquad-75 program. Five pieces of information were 
obtained:
(i) the acid dissociation constants, of the functional 
groups on the peptide,
(ii) the percentage dissociation of each species 
in solution as the pH increases,
(iii) a % distribution of each species in solution against 
pH. The closer this is to a "Gaussian curve" the 
more "ideal" the system is. A Gaussian curve 
indicates few experimental errors, a "good fit" for 
the model, and good refinement of the dissociation 
constants,
(iv) a plot of pH versus volume of sodium hydroxide 
added, which gives an approximate value of the 
dissociation constants and which can be used for 
fitting a model (some of the curves obtained were 
superimposed to highlight the small difference in 
the dissociation constants of the peptides), and
(v) a statistical analysis- of the results is given so as 
to ascertain the validity of the dissociation 
constants.
Only four titrations per ligand were carried out due to
small amounts of the ligand available. Agreement between
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each set of results was found to be very good, but any 
outliers were rejected.
Most of the previous work has been carried out on 
commercially available ligands such as L-cysteine, 
glutathione and D-penicillamine, and dissociation
constants of the first two have been determined for 
comparative purposes. L-Cysteine was purified by
recrystallisation before use and two forms of glutathione 
were used, recrystallised reduced glutathione and 
glutathione trifluoroacetate.
5.5.1 L-Cysteine dissociation constants
The interaction of cadmium(II) with L-cysteine in aqueous 
solution has been thoroughly investigated. The
biological importance of this ligand is partly portrayed 
by the soft donor atom, of the thiol group which forms 
various complexes with a variety of metals in solution. It 
has three dissociable protons. Their dissociation
constants were found to be pKal = 1.96 (literature value, 
1=0.OM at 25°C), pKa2 = 8.24, pKa3 = 10.47 (Table 5.1). 
pKal is assigned to the deprotonation of the carboxyl 
group (-C00H -C00“) while pKa2 and pKa3 are assigned to a 
combination of the microprocesses of NH3+ and SH
deprotonation (Scheme 5.1) . 244
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Titr. P*al Pka2 pka3 R-Factor
-COOH -n h3+ -SH
1 -- 8.229+0.006 10.456+0.005 0.0043
2 -- 8.236+0.006 10.463+0.006 0.0048
3 -- 8.235+0.006 10.456+0.005 0.0040
4 -- 8.230+0.006 10.465+0.006 0.0046
5 8.248+0.006 10.491+0.005 0.0041
Avg. -- 8.236+0.010 10.466+0.020
*Lit. 2.440+0.090 8.784+0.040 10.709+0.020
*Lit.;110 I = 3.0M NaCl04 .at 25°C
Table 5.1. Dissociation constants of L-cysteine as
determined for five titrations (NaC104, 
1=0.IM, 25°C)
r 2-c -c h -co o
I I +HS Nl-fy
HS NH2
R = H L-Cysteine 
R = -CH3 Penicillamine
Scheme 5.1. Schematic representation o f microscopic dissociation constants o f L-cysteine
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D-Penicillamine, an analogue of L-cysteine, was found to 
have a slightly higher basicity (pKa2 pen > pKa2 cys, pKa3 
pen > PKa3 cys) '  due to Presence °f the electron 
releasing methyl group.
The results obtained for the dissociation constants of L- 
cysteine are similar to those reported in the literature 
(Table 5.1). The standard deviation obtained from the 
computer program (Table 5.1) is not an indication of the 
experimental error but a sign of the "good fit" of the 
model. The experimental standard deviations are obtained 
by averaging the results from all titrations carried out. 
Another indication of the "good fit" of the model is the 
R-factor, from the computer program. A small R-factor 
indicates a good model (R < 0.05).
A plot of pH against sodium hydroxide added for L-cysteine 
is shown in Figure 5.2. The end-point of the final 
dissociation constant is not clear but can be estimated.
The initial pH of cysteine in solution was found to be 
around 7.5 (Figure 5.3). 80% of the ligand is found to
be in the neutral form, H2cys (102), while 20% is in the 
anionic form, Hcys“ (101). As the pH is increased by the 
addition of sodium hydroxide the concentration of the 
neutral species decreases and the anionic species 
increases. At pH ~ 8.3, equal amounts of H2cys (50%) 
and Hcys" (50%) are in solution. At pH ~ 10 no neutral 
species exists in solution. The anionic species reaches
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NaOH/cm3
Figure 5.2. pH against NaOH (0.05M) for pKa determination 
of (a) L-cysteine and (b) glutathione.
pH
Figure 5.3:- %Distribution against pH for L-cysteine 
showing its various ionic species.195
maximum concentration (85%) at pH ~ 9.5. As it decreases
. . . .  9 —in concentration a new anionic species, cysx (1 0 0),
• 9 — ■increases rapidly in concentration. Cys begins to form 
at pH ~ 8.5. The plot of %distribution against pH gives 
good "Gaussian" curves, indicating the "good fit" of the 
model.
5 . 5 . 2  Glutathione dissociation  constants
Glutathione is a naturally occurring tripeptide with the 
amino acid sequence L-glutamyl-L-cysteinyl-glycine. The
dissociation constants of its four groups that undergo 
ionisation in the .pH range 1 to 12 have been determined by 
several workers in different reaction media.109'110'245- 
249 The two lower dissociation constants (pKal, PKa2 )
have been assigned to the carboxylic acid groups, while
• • + pKa3 and pKa4 are a combination of the NH3 and the SH
groups. Microscopically there are eight dissociation
constants which have been evaluated by proton nmr
spectroscopy (Scheme 5.2) . 249 The microscopic constants
' + ■ for the thiol and the NH3 have been obtained also from
spectrophotometric titrations. 250' 251 The overall
dissociation constant mechanism can be represented in a
simpler macroscopic form of four constants (Scheme 5.3).
Four dissociation constants were calculated for
glutathione trifluoroacetate, pKai = 2.50, pKa2 = 3.70,
pKa3 = 8.86, pKa4 = 9.77 (Table 5.2), and three for
glutathione, PKal “ 3*64' pKa2 = 8*81' pKa3 “ 9.74
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Scheme 5.2. Microscopic dissociation constants of glutathione.
PK.1 PKtf p K j  nK
H4L+ — .....  ■ H3L --------- -------  H2L- V  HL2- - P *  • L3-
Scheme 5.3. Macroscopic dissociation constants of glutathione.
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Titr. pKal PKa2 PKa3 PKa4 R-Factor
-COOH -COOH -n h 3+ -SH
1 2 .412+0.15
2 2 .520+0.15
3 2 .573+0.15
3.667+0.033
3.710+0.039
3.715+0.040
8.862+0.012
8.850+0.014
8.859+0.016
9 .762+0 .015
9 .744+0 .015
9 .770+0 .030
0 .0112
0 .0103
0 .0120
Avg. 2 .500+0.17 3.700+0.020 8.860+0 .010 9 .770+0 .030
♦Lit.2.895+0.02 3.718+0•020 9•162+0.018 9•881+0•020
• 1 1 0♦Lit.j I = 3.0M NaC104 at 25°C.
Table 5.2. Dissociation constants of glutathione
trifluoroacetate as determined for three 
titrations (NaC104, I = 0.1M, 25°C).
(Table 5.3). The constants obtained are very close to 
literature values. Due to the high R-factor and the
high standard deviations obtained for the carboxylate 
dissociation constant (PKal) when using glutathione 
trifluoroacetate, the results were compared with those in 
the literature but they were not used in any further 
calculations.
A plot of pH against sodium hydroxide added was compared 
to that of asp-cys-val (Figure 5.4). The (H4glut)+ plot 
was found to be higher than for the other tripeptide at 
higher pH indicating higher values for P&a2' PKa3 and 
PK 3 4 -
The most stable ionic species (over a wide pH range) in 
solution is the monoanionic, H2glut"" (102). At low pH 3.5,
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Titr. P*al
-COOH
PKa2
-n h3+
PKa3
-SH
R-Factor
1 3.710+0.015 8.849+0.005 9.772+0.006 0 .006
2 3.573+0.009 8.835+0.004 9.767+0.005 0 .005
3 3.632+0.011 8.801+0.005 9.703+0.005 0 .005
4 3.598+0.011 8.798+0.006 9.718+0.006 0 .006
5 3.662+0.009 8.759+0.004 9.746+0.005 0 .005
Avg. 3.635+0.050 8.808+0.030 9.741+0.040
Table 5.3. Dissociation constants of glutathione as
determined for five titrations (NaCl04, 
1=0.IM, 25°C)
NaOH / cm3
Figure 5.4. pH against NaOH (0.05M) for pKa determination 
of (a) glutathione and (b) (H4asp-cys-val)+ .
199
only 8% is found to be in the cationic, H4glut+ (104) 
form, 20% in H2glut- and 72% in the neutral H3glut (103) 
form. At pH ~ 4.5 H4glut+ is at 0% concentration. H2glut“ 
increases in concentration at this pH, while H3glut 
decreases rapidly. At pH ~ 5.5 the most stable species, 
H2glut” (102), increases to 100% and remains at this 
concentration until pH ~ 8.0. On increasing the pH further 
the concentration of H2glut“ reduces slowly. At pH ” 8 a 
new species Hglut2- (101) begins to form and it reaches a 
maximum concentration of 60% at pH ~ 9.5, while at pH
8.5 the last anionic species glut3- (100) forms and 
increases as H2glut" and Hglut2- decrease in concentration 
(Figure 5.5). The neutral glutathione ligand (H3glut) also 
shows a very similar distribution (Figure 5.6), where the 
predominant most stable species is found to be (H2glut)-. 
Deprotonation therefore is most likely to take place via 
the Kal, Ka(1)2, Ka(lf2)3, Ka ( l r 2 f 3 ) 4  route (Scheme 5.2).
5 . 5 . 3  T r i -  and tetra -peptide  dissociation  constants
All of the hydrophobic tri- and tetra-peptides prepared 
and one hydrophilic tripeptide (H2thr-cys-val) are 
assigned to three macroscopic and five microscopic 
dissociation constants (Scheme 5.4). The lowest 
dissociation constant (PKai) due to tbe carboxyl
deprotonation while the other two (PKa2' PKa3  ^ are a 
combination of the NH3+ and the thiol deprotonation steps.
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pH
Figure 5.5. %Distribution against pH of glutathione.TFA 
showing its various ionic species.
pH
Figure 5.6. %Distribution against pH of glutathione
showing its various ionic species.
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Two of the tripeptides synthesised, (H4lys-cys-val}2+, and 
(H4asp-cys-val)+, have four macroscopic dissociation 
constants (Scheme 5.5), due to the presence of
acidic/basic side chains in one of the residues.
COOH
SH
p K a j
— SH
NH3
Scheme 5.4. Microscopic dissociation constants of hydrophobic tripeptides
2+ PKai . PKa2 pKa3 _  pKa4
H 4L  ^ = 3  H 3L  —  —  H 2L  — -  —  H L ^ =  -
Schem e 5 .5 . M acroscopic dissociation constants o f  (li^ lys-cys-va l)'2 +
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n h 2
L
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(H^asp-cys-val)+ has eight microscopic dissociation 
constants (Scheme 5.2), as it is similar to glutathione. 
The first two dissociation constants (P*al' P*a2 ) are 
assigned to the carboxyl groups. The last two (PKa3 ' 
pKa4) are a combination of the thiol and NH3+ 
disssociation constants.
(H4lys-cys-val)2+ has sixteen microscopic dissociation 
constants (Scheme 5.6) but only the four macroscopic can 
be determined by pH-metric titration (Scheme 5.5). The 
first dissociation constant (P*ai) assigned to the 
carboxylic acid deprotonation while the latter three 
(P*a2' P*a3 ' P*a4  ^ are an avera9e ike two protonated
amino groups and the thiol group. For unknown reasons it
was only possible to evaluate three out of the four
7+dissociation constants, for (H4lys-cys-val)* . These 
titrations need to be repeated using larger concentrations 
of the peptide.
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PKa1234
CO2H
SH pKax
NH3
NH3
—  NH3
+ a  pKai43—  NH3 vXF 1
NH3
C O f  PK a 1432
1NH3
nh2
Scheme 5.6, Microscopic dissociation constants of (H4lys-cys-val)2+
204
5.5.3.1 Dissociation constants of (H^qlv-cvs-glv)— .
(Hgqly-cys-ala)- and (Hgqly-cys-val)—
By superimposing plots of pH against volume of sodium 
hydroxide added (Figure 5.7) for the three tripeptides it 
can be concluded that their dissociation constants are 
very similar. The dissociation constants for (H3gly-cys- 
gly)+ (5.1) were found to be, P*al = 3*67r P*a2 ” 8*05' 
pKa3 = 9.27 (Table 5.4); for (H3gly-cys-ala)+ (5.2) pKal = 
3.72, pKa2 = 8.11, pKa3 = 9.38 (Table 5.5) and for (H3gly- 
cys-val)+ (5.3) pKal = 3.73, P^a2 = 8.16, pKa3 “ 9.39
(Table 5.6).
The pKal values for all the peptides are very similar and 
independent of the nature of the side chains on the amino 
acid residues. The fact that the acidic hydrogen is 
separated from the side chain, i.e. that on the C-terminal 
amino acid, by three atoms may account for the absence of 
an effect of changing the side chain on pKa-j. Since the 
-SH and NH3+ groups are even more remote from the changing 
side chain the pKa values corresponding to their 
ionisations should be even less influenced by the change.
SH
I
CH2
+  I y
H3N-CH2-C-NH-CH-C-NH-CH2-C
o
\
5.1
o o
OH
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CH, , 0+  I AT
H 3N-CH-C-NH-CH-C-NH-CH-C f
" I OH
H O O CH,
5.2
+
SH
I
CH,
✓
O
H 3N-CH-C-NH-CH-C-NH-CH-C .
| ^ OH
H O
0  / \  
h 3c  c h 3
5.3
Fiqure 5.7. pH against NaOH added for (a) (H3gly-cys- 
gly) , (b) (H3gly-cys-ala) , (c) (H3gly-cys-
 1 * *4*val) .
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Titr. P*al
-COOH
pKa2
-n h3+
pKa3
-SH
R-Factor
1 3.639+0.006 8.050+0.003 9.257+0.006 0.0023
2 3.674+0.007 8.063+0.003 9.279+0.004 0.0027
3 3.686+0.008 8.084+0.004 9.315+0.005 0.0031
4 3.690+0.007 8.006+0•004 9.244+0.004 0.0039
Avg. 3.672+0.020 8.051+0.030 9.274+0.030
Table 5.4. Dissociation constants of glycyl-L-
cysteinylglycine trifluoroacetate as
determined for four titrations (NaC104, I = 
0.1M, 25°C)•
Titr. pKal
-COOH
PKa2
-n h3+
PKa3
-SH
R-Factor
1 3.719+0.011 8.081+0.006 - 9.343+0.006 0.0031
2 3.719+0.011 8.116+0.006 9.386+0.008 0.00353 3.730+0.010 8.118+0.006 9.392+0.007 0.00314 3.718+0.010 8.112+0.006 9.389+0.007 0.0028
Avg. 3.721+0.010 8•107+0.020 9.378+0.020
Table 5.5. Dissociation constants of glycyl-L-cysteinyl-L-alanine trifluoroacetata as 
determined for four titrations (NaC104, I = 
0.1M, 25°C)•
Titr. pKal
-COOH
PKa2
-nh3+
pKa3
-SH
R-Factor
1 3.727+0.014 8.149+0.007 9.377+0.008 0.0051
2 3.734+0.014 8.160+0.007 9.398+0.008 0.00533 3.740+0.013 8.157+0.007 9.390+0.008 0.0059
Avg. 3.734+0.010 8.155+0.010 9.388+0.010
Dissociation constants of glycyl-L- 
cysteinyl-L-valine trifluoroacetate
determined for three titrations (NaClO„, I 0.1M, 25°C). 4'
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Considering the plot of %distribution against pH for 
(H3gly-cys-gly)+ (Figure 5.8) at the initial pH ~ 3.75,
4 3% of the tripeptide is present as (H3gly-cys-gly)+ 
while the remaining 57% is in the neutral form H2gly-cys- 
gly. As the pH is increased the cationic species depletes 
and is no longer present in solution at pH ~ 5.75. As the 
pH increases the predominant species (H2gly-cys-gly) 
increases in concentration until at pH ~ 5.75 100% is
present. Further increases in pH cause depletion of the 
neutral species until pH ~ 9.5 none remains. It can 
therefore be concluded that (H2gly-cys-gly) is found over 
the wide pH range, 3.5 to 9.5. As (H2gly-cys-gly) 
depletes, (Hgly-cys-gly)~ begins to form at pH ~ 6.25. The 
first anionic species reaches maximum concentration (~ 
70%) at pH ~ 6.25 and then steadily depletes. The final
« « O *  ,dianionic species, (gly-cys-gly)^  begins to form at pH
7.6 and steadily rises as the pH increases.
The pKa values can be approximately extrapolated from the 
above plots, as pKa * pH at 50% dissociation. All 
species in solution show a "Gaussian" distribution and a 
low R-factor is obtained. This indicates a "good model 
fit".
(H3gly-cys-ala)+ (Figure 5.9) and (H3gly-cys-val)+ (Figure 
5.10) also show similar species distribution where the 
neutral molecules, (H2gly-cys-ala) and (H2gly-cys-val), 
are predominant especially at the physiological pH.
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pH
Figure 5.8. %Disitribution against pH of (H^gly-cys- 
gly) showing its various ionic species.
pH
Figure 5.9. %Distribution against pH of (H^gly-cys-
ala)+ showing its various ionic species.
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pH
Figure 5.10. %Distribution against pH of (H3gly-
cys-val) showing its various ionic species.
5.5.3.2 Dissociation constants of (H3val-cvs-val)— and 
(H3leu-cvs-leu)— ~~
A hydrophobic side chain was introduced near the -NH3+ 
group in this case. The dissociation constants were 
found to be; for H3val-cys-val+ (5.4), pKal = 3.75, pKa2 = 
7.87, pK&3 = 9.38 (Table 5.7); H3leu-cys-leu+ (5.5), pKal 
= 3.78, pKa 2 “ 7*80r P*a3 = 0 , 3 8 (Table 5.8). The second 
dissociation constant (PKa2 ) shows the most variation 
indicating that P*a 2 mostly corresponds to NH3+ 
deprotonation. The pKal values of val-cys-val (3.75) and 
leu-cys~leu (3.78) are almost identical and both are very 
similar to that of gly-cys-val (3.72). It has already
210
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been pointed out in 5.5.3.1 that the ionisation of a 
carboxylic acid group is unaffected by changes in the 
amino acid side chains even when these occur in the C- 
terminal amino acid residues. The pKa2 values are the ones 
most affected by the side chain alterations in the above 
peptides. The value of pKa2 for gly-cys-val (8.15) is 
slightly higher than the pKa2 value for val-cys-val 
(7.87) or for leu-cys-leu (7.80) indicating that the 
introduction of alkyl substituents into the side chain of 
the N-terminal amino acid enhances the acidity of the
adjacent NH3+ group. Three substituent effects may be 
anticipated. The weak electron releasing properties of 
the alkyl group should raise the pKa but on the other hand 
steric effects on replacing an a-H by an alkyl group
should promote ionisation and lower the pKa. In addition 
the hydrophobic nature of the alkyl groups might reduce 
solvation of the adjacent NH3+ group thus destabilising 
the conjugate acid species and lowering the pKa. Clearly 
the combined steric and hydrophobic effects outweigh the 
electronic effects.
The pKa3 values for all three peptides are virtually 
identical (9.37, 9.38, 9.38). The alteration in pKa2 and 
the constant values of pKa3 on changing the side chain in 
the N-terminal amino acid supports the view that pKa2
refers to ionisation of NH3+ (closer to the side chain 
being altered) while pKa 3 refers to the thiol group
ionisation.
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For val-cys-val and leu-cys-leu distribution of species 
are very similar to the peptides in Section 5 . 4 . 3 . 1 .  The 
most predominant species, being stable over a wide pH 
range, 3 . 5  to 9 . 5 ,  are the neutral molecules, (H2val-cys- 
val) (Figure 5 . 1 1 )  and (H2leu-cys-leu) (Figure 5 . 1 2 ) .  
Other ionic species formed are (H3val-cys-val) (pH <
5 . 5 ) ,  (H3leu-cys-leu)+ (pH < 5 . 5 ) ,  (Hval-cys-val)" (pH 6 . 0  
-  1 0 . 5 ) ,  (Hleu-cys-leu)" (pH 6 . 0  -  1 0 . 5 ) ,  (val-cys-val)2"
(pH > 8 . 0 )  and (leu-cys-leu)2" (pH > 8 . 0 ) .
Titr. P*al
-COOH
PKa2
-n h3+
PKa3
-SH
R-Factor
1 3.740+0.017 7.868+0.009 9.387+0.009 0.0057
2 3.758+0.017 7.874+0.009 9.403+0.009 0.00573 3.757+0.015 7.879+0.008 9.372+0.00 0.00554 3.747+0.010 7.858+0.008 9.367+0.006 0.0049
kvg. 3.751+0.010 7.870+0.010 9.382+0.010
Table 5.7. Dissociation constants of L-valyl-L-
cysteinyl-L-valine trifluoroacetate as
determined for four titrations (NaC104, I = 
0.1M, 25°C).
Titr. PKal
-COOH
PKa2
-n h3+
PKa3
-SH
R-Factor
1 3.750+0.012 7.771+0.007 9.379+0.005 0.0054
2 3.801+0.015 7.818+0.008 9.383+0.006 0.00563 3.782+0.013 7.793+0.007 9.382+0.006 0.00564 3.771+0.012 7.798+0.007 9.380+0.006 0.0057
Avg. 3 • 776+0.020 7.795+0.020 9.381+0.010
Table 5.8. Dissociation constants of L-leucyl-L-cysteinyl- 
L-leucine as determined for four titrations (NaC104, 1=0.IM, 25°C)
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pH
Figure 5.11. %Distribution against pH of (H3val-
cys-val)+ showing its various ionic species.
pH
Figure 5.12. %Distribution against pH of (H3 leu-
cys-leu)+ showing its various ionic species.
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5.5.3.3 Dissociation constants of (H^val-cvs-val-valT— and 
(H^val-val-cvs-valT—
The acid dissociation constants for both tetrapeptides 
were expected to be similar to those of (Hgval-cys-val)+ 
and (H3leu-cys-leu)+. Their dissociation constants were 
found to be (H3val-cys-val-val) + , PKal “ 3*76r PKa2 = 
7.79, PKa3 = 9 ,3 8 (Table 5.9); (H3val-val-cys-val)+, pKa-^ 
= 3.75, pKa2 = 7.80, pKa3 =9.42 (Table 5.10).
Distributions of species are very similar to the peptides 
in Section 5.4.3.1. The most predominant species, being 
stable in the pH range 3.5 - 9.5 are the neutral molecules 
(H2val-val-cys-val) (Figure 5.13) and (H2val-cys-val-cys) 
(Figure 5.14). Several other ionic species form over a 
wide pH range and are similar to those described for 
(H3val-cys-val)+ .
5.5.3.4 Dissociation constants for (H^asp-cys-valT— and 
(H^thr-cvs-valT— ~
Both tripeptides (H^asp-cys-val)+ and (H3thr-cys-val)+ 
have a hydrophilic side chain, the former having a 
carboxyl group and being a similar tripeptide to 
glutathione, while the latter has a hydroxyl group. The 
dissociation constants for the NH3+ and the thiol group 
are expected to be different from those peptides with 
hydrophobic side chains. The dissociation constants for 
(H4asp-cys-val)+ were found to be pKal = 2.94, P^a2 =
3.91, pKa3 = 7.90, pKa4 = 9.51 (Table 5.11). The first
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Titr. PKal
-COOH
PKa2
-NH3+
PKa3
-SH
R-Factor
1 3.702+0.010 7.766+0.005 9.377+0.004 0.0038
2 3.749+0.011 7.799+0.006 9.405+0.005 0.00403 3.798+0.011 7.808+0.006 9.390+0.005 0.00414 3.790+0.012 7.800+0.006 9.378+0.005 0.0041
Avg. 3.760+0.040 7.793+0.020 9.388+0.010
Table 5.9. Dissociation constants of L-valyl-L-
. cysteinyl-L-valyl-L-valine trifluoroacetate 
as determined for four titrations (NaC104, I 
= 0.1M, 25°C).
Titr. PKal
-COOH
PKa2
-n h3+
PKa3
-SH
R-Factor
1 3.771+0.016 7.798+0.006 9.428+0.004 0.0042
2 3.726+0.013 7.804+0.007 9.401+0.004 0.0040
3 3.740+0.011 7.798+0.006 9 • 422+0.004 0.0040
Avg. 3.746+0•020 7.798+0.010 9.415+0.010
Table 5.10. Dissociation constants of L-valyl-L-valyl-L- 
cysteinyl-L-valine trifluoroacetate as
determined for three titrations (NaC104, I = 
0.1M, 25°C).
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. PHFigure 5.13. %Distribution against pH of (H^val- val-cys-val) showing its various ionic
species.
pH
Figure 5.14. %Distribution against pH of (H^val-
cys-val-val) showing its various ionic
species•
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two dissociation constants are assigned to the two 
carboxylic groups. The pKal (2.94) is assigned to the f t -  
C02H group of the Asp and the pKa2 (3.91) to the terminal 
carboxylic acid group. Hence the pKa2 value is similar 
to the pKal values (3.72, 3.75) of the tripeptides with
C-terminal valyl residues reported in the previous 
section. On the basis of the assignments for the 
tripeptides the last two dissociation constants are 
most likely due to the deprotonation of the NH3+ and the 
thiol groups, the former being the more acidic.
There are five different species in solution between pH
3.5 and 9.5. The small amount of (H4asp-cys-val)+ found 
at pH ~ 3.5 disappears at pH ~ 4.5. The neutral species 
(H3asp-cys-val) is not predominant and depletes rapidly 
from 60% at pH ~ 3.5 to 0% at pH ~ 6.0. The predominant 
species is the anion, (H2asp-cys~val)~, distribution of 
which increases rapidly from 28% at pH “ 3.5, to maximum 
concentration (100%) between pH ~ 5.5 and 7.0, and then 
decreases to 0% at pH ~ 9.5. The dianionic species,
9 — >(Hasp-cys-val)^  begins to form at pH ~ 6.0, and reaches a 
maximum (~ 80%) at pH ~ 8.7. At pH > 8.7 the dianionic 
species begins to deplete and the trianionic species,
'3— • • •(asp-cys-val) increases rapidly (Figure 5.15). All the 
species in solution show good "Gaussian" curves.
The three dissociation constants for (H3thr-cys-val)+ are 
pKal = 3.71, pKa2 = 7.26, pKa3 = 9.34 (Table 5.12). The
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Titr. pKal 
-COOH
PKa2
-COOH
PKa3
-n h3+
pKa4 R- 
-SH
■Factor
1 2.850+0.027 3.905+0.013 7.907+0.006 9.510+0.005 0.0024
2 2.978+0.025 3.941+0.015 7.926+0.007 9.544+0.006 0.0033
3 2.992+0.018 3.894+0.011 7.873+0.005 9.473+0.005 0.0024
4 2•957+0.022 3.902+0.013 7.900+0.006 9.497+0.005 0.0028
Ag. 2.944+0.060 3.911+0.020 7•902+0.020 9.505+0.030
Table 5.11. Dissociation constants of L-asparty-L-
cysteinyl-L-valine trifluoroacetate as
determined for four titrations (NaC104, I = 
0•IM, 25°C).
pH
Figure 5.15. %Distribution against pH of (H3asp-
cys-val) showing its various ionic species.
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Titr. PKal
-COOH
PKa2
-NH3+
PKa3
-SH
R-Factor
1 3.774+0.020 7.232+0.011 9.289+0.007 0.006
2 3.719+0.018 7.271+0.010 9.329+0.007 0.005
3 3.697+0.017 7.247+0.009 9.327+0.006 0.005
4 3.706+0.016 7.262+0.009 9.340+0.006 0.005
5 3.723+0.016 7.276+0.009 9.356+0.006 0.005
Avg. 3•711±0.010 7.264+0.010 9.338+0.010
Table 5.12. Dissociation constants of L-threonyl-L-cysteinyl-L-valine trifluoroacetate as
determined for five titrations (NaCl04, I = 
0.1M, 25°C).
Figure 5.16* %Distribution against pH of (H3 thr-
cys-val) showing its various ionic species.
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dissociation constant of the carboxylic acid group is as 
expected, while that for the NH3+ is much lower than 
anticipated. This effect is also shown in the amino acid 
threonine which has a pKa for the NH3+ ionisation of 9.1 
compared to glycine for which the pKa is 9.8. This effect 
is probably due to the electron withdrawing effect of the 
hydroxyl group. A contributing factor could be
stabilisation of the amine conjugate base through strong 
intramolecular hydrogen bonding (5.6).
SH
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c h 2
h 2n -c h -c -n h -c h -c -n h -c h -c
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An unusual %distribution is shown by this tripeptide 
(Figure 5.16). The anionic species, (Hthr-cys-val)",
seems to be more stable than that formed by the 
hydrophobic side chain peptides. It is present between pH
5.5 and 11.0, with a maximum of 86% at pH ~ 8.5. At low 
pH (< 3.5) the predominant species was again the neutral 
one (H2thr-cys-val) which reaches a maximum at pH 5.8 
and is exhausted by pH 9.0. The cationic species, 
(H3thr-cys-val)+, depletes, as the pH is increased, from 
40% at pH ~ 4.0 to 0% at pH ~ 5.5. Traces of the dianionic
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species, (thr-cys-val)2“, form at pH ~ 7.5, and rapidly 
increase in concentration to 70% at pH ~ 9.5.
Pept./Amino Acid pkal
-COOH(1)
pka2 
-COOH(2)
pka3
-NH3+/SH
pka4
-SH/NH3+
L-Cysteine
Glycine*
---- 1.96* 8.24+0.02 10.47+0.02
2.35 9.78 — — — — —
Alanine* 2.35 9.87
Valine* 2.29 9.74
Leucine* 2.33 9.74
Threonine* ---- 2.09 9.10
Aspartic*
acid
1.99 3.90 9.90
Glutathione ___— 3.46+0.05 8.81+0.03 9.74+0.03
Glutat.TFA 2.50+0.17 3.70+0.02 8.86+0.0 2 9.77+0.03
Asp-cys-val 2.94+0.06 3.91+0.02 7.90+0.02 9.51+0.03
Gly-cys-gly ---- 3.67+0.02 8.05+0.03 9.27+0.03
Gly-cys-ala 3.72+0.01 8.11+0 . 0 1 9.38+0.02
Gly-cys-val 3.73+0.01 8.61+0.01 9.39+0.01
Val-cys-val 3.75+0.01 7.87+0.01 9.38+0.01
Leu-cys-leu ---- 3.78+0.02 7.80+0.02 9.38+0.01
Val-cys-val--val ---- 3.76+0.04 7.79+0.02 9.39+0.01
Val-val-cys--val ---- 3.75+0.02 7.80+0.01 9.42+0.01
Thr-cys-val 3.71+0.01 7.26+0.01 9.34+0.01
♦Literature values
Table 5.13. Dissociation constants of amino acids and their 
peptides
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5.6 Conclusions
The dissociation constants obtained from pH-metric 
titrations are summarised in Table 5.13, together with pKa 
values for some amino acids from the literature. Results 
obtained for L-cysteine and glutathione are in good 
agreement with those in the literature.
Good "Gaussian" curves and small R-factors were obtained 
for all the distributions indicating the validity of the 
dissociation constants calculated.
The dissociation constants for (H3gly-cys-gly)+, (H3gly- 
cys-ala)+ and (H3gly-cys-val)+ are all very similar, thus 
indicating that only small differences in acidity and 
basicity arise on modifying the sidechain of the C- 
terminal amino acid.
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5.7 Stability Constant Determination
The interaction of L-cysteine and glutathione with 
cadmium(II) has been studied extensively in various ionic 
media and at different reaction temperatures. This work 
was repeated at metal to ligand ratios of 1 : 1 to 
establish reproducibility, and then all the other peptide 
complexes of cadmium(II) in solution were investigated at 
the same ratio.
Several complex species were looked for in the computer 
program, e.g. a two ligand to one metal (2 1), a one ligand 
to two metals (12) and others. These models were 
convincingly rejected and the model found to be most 
suitable was the one ligand to one metal (1 1 ) as expected. 
The results were then checked for polynuclear species 
such as two ligands to two metals (2 2), three ligands to 
three metals (33) etc. The latter, 33, was rejected while 
the former, 2 2, showed good convergence and in some cases 
a better refinement than that of 11. Both of these systems 
are therefore discussed.
As no emphasis is placed on the most accurate pH readings 
by the computer program some points were eliminated due to 
their high standard deviations. By rejecting these pH
values it was found that little difference was made to the
* • 9final result, while values such as the R-factor, X , U and
other statistical parameters changed for the better.
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Unfortunately the ligands (H2cys), (H3leu-cys-leu)+ and 
(H3gly-cys-gly)+ produced insoluble complexes on titration 
with cadmium(II). The insoluble complexes formed with the 
first two ligands did not redissolve at high pH, while the 
last did and enabled the calculation of the stability 
constant of a complex containing one ligand, one metal and 
one hydroxide ion (11-1). It must be emphasised that if 
precipitation appeared in the reaction vessel the pH 
values were not used in determining stability constants.
5.7.1 The 1-liqand to 1-metal complex (11)
Three complexes were assigned for model 11 over the pH 
range studied (3.5 - 10.5) for all the peptides used in 
complexation with cadmium(II). Their stability
constants, titration curves and %distributions are plotted 
and compared.
Characterisation of the coordinating sites is difficult as 
each hydrophobic tripeptide has six of these at pH > 7
(5.7) and five at low pH where the ~NH2 group is 
protonated. The most insoluble neutral complex,
o _  ,[Cd(II)(Tripepx )], was isolated for most of the peptides 
and an attempt was made to characterise the coordination 
sites by infrared spectroscopy. No other method of 
characterisation was possible as the complexes were found 
to be insoluble in most common solvents. A more detailed 
discussion of these complexes is given in Section 3.3.1.4.
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Several chemically favourable complexes are therefore 
possible. The coordination number of cadmium(II) in 
solution is six and it is therefore expected that all 
complexes formed are octahedrally arranged. The complex 
111 (L, M, H+) is proposed to have the structure 5.8 in
which the main coordination is through the sulphur atom 
but with the carbonyl and carboxylate atoms also 
coordinated. This type of complex forms at low pH (< 6.5). 
The other coordination sites are most likely occupied by 
water molecules although a thiolate ligand from another 
complex molecule may be involved in bridging. As the pH of 
the solution is increased the terminal amino group becomes 
available for coordination as a result of deprotonation. 
There are a number of possible structures that may be 
written for the 110 complex CdL but that shown in 5.9 is 
the most reasonable on chemical grounds. In this structure 
the peptide is pentadentate and gives a chelate containing 
one 5-membered ring, one 6-membered and two 7-membered 
rings. The last coordination site on the metal ion is 
probably taken up by a water molecule. On increasing 
the pH of the reaction mixture the water molecule is 
deprotonated to give the complex CdL which contains
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a hydroxy ligand as shown in 5.10.
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Another structure which should be considered for CdL is 
that shown in 5.11 which contains a deprotonated amide 
group N-coordinated to the metal with the terminal amino 
group coordinated. In this structure the ligand is 
pentadentate forming a chelate containing three 5-membered 
rings, a 6-membered ring and a 7-membered ring. However 
in view of the fact that there is no documented evidence 
of Cd(II)-promoted amide group deprotonation in the 
literature structure 5.9 is the one of choice for CdL.
On introduction of a hydrophobic side chain, as in the
increases. A schematic chemical route likely to take 
place, over the pH range studied is given in Scheme 5.7. 
Further work is required to identify fully the 
coordination sites of such intricate ligand complexes.
As two models showed good convergence, 11 and 22, all the 
statistical parameters produced by the program were taken
S
H2N
5.11
0 H 2
tripeptide (H^asp-cys-val)+, the coordination complexity
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into consideration.
Other complexes were included with the ones described 
above, such as 2 1 2, 211 and 210 in the hope of obtaining 
a better refinement. In some cases 211 was badly refined, 
while 212 and 210 were rejected at all times.
Plots of pH against sodium hydroxide added for all the 
complexes studied are given in Figures 5.17a,b,c,d. The 
plots for the complexes of (H3gly-cys-gly)+, (H3gly-cys- 
ala)+, (H3gly-cys-val)+ and (H3val-cys-val)+ are 
superimposed (Figure 5.17b) to show that their stability
constants are numerically similar. The same is observed
+ +  for (H3val-cys-val) , (H3val-cys-val~cys) , (H3val-val-
cys-val)+ complexes (Figure 5.17c). As the plots for
+ +(H3thr-cys-val) and (H4asp-cys-val) show a large
difference (Figure 5.17d) it can be concluded that their
stability constants are very different.
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Scheme 5.7. Possible octahedral coordination between Cd(II) and (H4asp-cys-val)2+ 
over the titration pH range.
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Figure 5.17a; Plot of pH against NaOH (0.05M) added forglutathione with cadmiuin(II) .TFA in NaC104 
solution.
Figure 5.17b; Plots of pH against NaOH (0.05M) added for (a) (H3gly~cys-gly)+, (b) (Hogly-cys-
ala) , Jc) (Hogly-cys-val) , (d) (Hoval- 
cys-val) each with cadmium(II) .TFA in 
NaC104 solution.
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Figure 5.17c. Plots of pH against NaOH (0.05M) added for/.* /t,  (b) (Hoval-val-cys
-val-val) each with
(a) (H3val-cys-val) ,val) (c) (H3val-cys
cadmium(II).TFA in NaC104 solution.
Figure 5.17d. Plots of pH against NaOH (0.05M) added for 
(a) (H3thr-cys-val) , (b) (H^asp-cys-val)* 
each with cadmium(II).TFA in NaCl04
solution. 2 3 2
On titrating (H3gly-cys-gly)+ with cadmium(II), a white 
precipitate formed at pH ~ 6.5 which redissolved at pH 
9.5. The precipitate was later characterised as the 
neutral complex, Cd(gly-cys-gly) (110). Analysis of the 
potentiometric data gave stability constants (Table 5.14) 
for the 111 complex of 14.04, for the 110 complex of 7.86 
and of the 11-1 complex of -1.58 (log values).
Plots of %distribution against pH were obtained for (i) 
the complexes formed (ii) the ionic (103) and neutral 
(1 0 2) forms of the ligand and (iii) the cadmium ion (0 1 0) 
depletion in solution over the pH range studied (3.5
10.5) (Figure 5.18). Interaction between the cadmium(II) 
and the ligand is not evident until pH 4.5, where the 
complex 111 begins to form in small quantities. At pH 
3.75 the ligand is in the form (H3gly-cys-gly)+ (~ 40%)
and (H2gly-cys-gly) (~ 60%) while all the cadmium(II) is
9 +  > . . .free, as Cd , in solution. The latter ligand species, 
H2gly-cys-gly, does not form in large concentrations over 
a wide pH range unlike in the absence of cadmium(II). As 
the concentration of cadmium(II) begins to deplete in 
solution the H2gly-cys-gly also depletes at the same rate 
(Figure 5.18). At pH ~ 4.5 the 111 complex begins to form
All values for stability constants are m  the log-, n
form.
5.7.1.1 Stability constants and species distribution of
(H3 qlv-cvs-qlvT— cadmium(IIT complexes
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Model Stability Constants Average
111 14.04+0.06 14.02+0•07 14.03+0.07 14.03+0.07
110 7.86+0.01 7.86+0.01 7.86+0.01 7.86+0.01
1 1 - 1 -1.60+0.02 -1.55+0.02 -1.58+0.02 -1.58+0.02
STATISTICAL ANALYSIS
U
R-fac.
X2
AM
MD
a
MCS
MCK
5.095E-9
0.008695
92.93
5•509E-7
3.201E-6
4.823E-6
0.59
4.57
5.488E-9
0.009039
108.20
6.231E-7
3.344E-6
5.006E-6
0.95
4.05
5•325E-9 
0.008921 
99.32 
5.911E-7 
3.284E-6 
4.915E-6 
0.82 
4.16
5.3029E-9
0.00885
100.15
5.884E-7
3.277E-6
4.915E-6
0.79
4.26
Table 5.14. Stability constants of 11 complexes of
(H2gly-cys-gly) with_cadmium(II).
Figure 5.18. %Distribution against pH of 1 1  complexes of
(Hagly-cys-gly)* with cadmium(II).
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and reaches a maximum concentration at pH ~ 6.5 of only 
18%. As the pH is further increased it reduces in
concentration and is believed to disappear at pH ~ 8.0.
The predominant complex is the insoluble 110, which begins 
to form at pH ~ 5.5 and increases rapidly in concentration 
with small pH increases. Because of precipitation of the
110 complex between pH 6.5 and 9.5 it is impossible to
know exactly the pH at which the species 11-1 begins to
form although 70% is present at pH 9.6.
From the plot of pH versus volume of sodium hydroxide 
added for this complex system (Figure 5.17b) compared 
with those of (H3gly-cys-ala)+ and (H3gly-cys-val)+, it 
can be concluded that all three peptides form complexes of 
similar stability constants.
5.7.1.2 Stability constants and species distribution of
(H^glv-cvs-ala)— cadmium(II) complexes
No precipitation occurred during the titration of a
solution of Cd(II) and (H3gly-cys-ala)+ and pH 
measurements were recorded in the range of 3.5 to 9.5. The 
stability constants were found to be as follows: for the
111 complex 14.61, for the 110 complex 7.87, and for the 
11-1 complex -1.58 (Table 5.15).
The %distribution of the ligand and the complex species
as a function of pH show similar patterns to (H3gly-cys- 
gly)+ and its complexes. At pH ~ 3.5 no complexation has 
taken place. The cationic complex 111 begins to form at pH
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4, lower than that of H2gly-cys-gly (pH ~ 4.5), and
reaches a maximum concentration of 40% at pH 6.5. The 
most stable complex over a wide pH range, ~5.5 to 10.5, is 
the neutral 110 species. At pH ~ 8.5, this reaches
maximum concentration (90%) and then reduces in 
concentration with increasing pH. 11-1 initially forms at 
pH ~ 7.5 and increases rapidly in concentration as the pH 
is increased. The concentration of cadmium(II) reduces 
with increasing pH in the same pattern as the neutral 
ligand concentration decreases. Good "Gaussian" 
distributions are observed for all the species (Figure 
5.19).
Model Stability Constants Average
111 14 .64+0.05 14.58+0•05 14.60+0.05 14.61+0.04 14.03+0.07
110 7.89+0.02 7.80+0.02 7.87+0.02 7.93+0.02 7.87+0.05
11-1 - 1 .73+0.04 -2.09+0.05 -1.84+0•04 -1.77+0.03 -1 .86+0 .02
STATISTICAL ANALYSIS
U 2•274E-8 2.548E-8 2.325E-8 2.476E-8 2.483E-8R-fac 0.018964 0.019229 0.017123 0.012874 0.01705X2 122.54 67.01 95.62 100.270 96.36AM 4.547E-7 3.566E-7 3.251E-7 2.879E-7 3.561E-7MD 5.564E-6 6.123E-6 5.156E-6 3.839E-6 5.170E-6o 8.800E-6 9.075E-6 7.954E-6 6.056E-6 7.970E-6MCS -0.07 -0.08 -0.04 -0 . 1 1 -0.08MCK 4.67 4.21 4.55 4.74 4.54Pts. 98 93 93 93pH 3.80-9.30 3.80-9.30 3.80-9.30 3.80-9.30range
Table 5.15. Stability constants of 11 complexes of
(H2gly-cys-ala) with cadmium(II).
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pH
Figure 5.19* %Distribution against pH of 11 complexes of 
(H3gly-cys-ala) with cadmium(II).
5.7.1.3 Stability constants and species distribution of 
(H3qlv-cvs-val)~ cadmium(II) complexes
The stability constants for the complexes formed between 
H2gly-cys-val and cadmium(II) are for the 111 complex 
14.54, for the 110 complex 7.83, and for the 11-1 complex 
-1.67 (Table 5.16). These results compare closely with 
those obtained for the previously described ligands. The 
%distribution of each complex and ligand species with 
respect to pH (Figure 5.20) closely resembles that of 
(H3gly-cys-ala)+/ cadmium(II), 5.7.1.2, except that lower 
levels of the 111 complex are formed, i.e 35% at pH 6.5 
compared to 40% at the same pH for the (H3gly-cys-ala)+ 
complex (Figure 5.20).
237
Model Stability Constants Average
111 14.54+0.04 14.48+0.05 14.54+0.04 14.52+0.05
110 7.89+0.02 7.78+0.02 7.83+0.01 7.83+0.05
1 1 - 1 -1•57+0•02 -1.81+0.03 -1.63+0.02 -1.67+0.10
STATISTICAL ANALYSIS
U 9.224E-9 9.008E-9 9.395E-9 9•2429E-9
R-fac. 0.012527 0.018144 0.013164 0.014611
X2 32.20 23.78 22.43 26.14
AM 1.346E-7 1.375E-7 1.364E-7 1.362E-7
MD 4.231E-6 6.283E-6 5.935E-6 5.487E-6
a 5.787E-6 8.382E-6 7.623E-6 7.262E-6
MCS -0.39 0.21 0.15 0.25
MCK 4.06 3.08 3.12 3.42Pts. 98 98 98pH 3.8-9.35 3.8-9.35 3.8-9.35
Range
Table 5.16* Stability constants of 11 complexes of
(H2gly“cys-val) with cadmium(II).
Figure 5.20* %Distribution against pH of 11 complexes of
(H3 gly-cys-val) with cadmium(II).
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5.7.1.4 Stability constants and species distribution of
(^val-cvs-val)— cadmium(II) complexes
The stability constants for the complexes formed between 
(H3val-cys-val)+ with cadmium(II) were found to be for the 
111 complex 14.32, for the 110 complex 7.53, and for the 
11-1 complex -2.29, (Table 5.17). The %distribution of 
the ligand and complex species formed (Figure 5.21) 
resembles that for the (H3gly-cys-val)+ system 5.7.1.3.
Model Stability Constants Average
111 14.31+0.06 14.30+0.06 14.37+0.04 14.31+0.06 14.32+0.06
110 7.48+0.03 7.50+0.03 7.61+0•02 7.51+0.03 7•53+0•07
1 1 - 1 -2.36+0.04 -2.33+0.04 -2.13+0.03 -2.32+0.04 -2.29+0.15
STATISTICAL ANALYSIS
U 1.707E-8 1.707E-8R-fac 0.022231 0.021599 0.016612 0.021517 0.02050X2 26.61 35.57 48.49 30.95 35.41AM 2.631E-7 2.182E-7 3.309E-7 2.560E-7 2.670E-7MD 7.634E-6 7.421E-6 5.520E-6 7.396E-6 6.993E-6a 1.027E-5 9.982E-6 7.661E-6 9.972E-6 9.470E-6MCS 0.06 0.13 0.01 0.06 0.07MCK 3.12 3.09 3.51 3.13 3.21Pts. 97 97 97 97
pH 3.80-9.40 3.80-9.40 3.80-9.40 3.80-9.40
Range
Table 5.17. Stability constants of 11 complexes of 
(H2val-cys-val) with cadmium(II).
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pH
Figure 5.21. %Distribution against pH of 11 complexes of 
(H3val-cys-val) with cadmium(II).
5.7 .1.5 Stability constants and %distribution of (^leu- 
cys-leu T cadmium(II) complexes —
The neutral complex of (H3leu-cys-leu)+ was found to be
insoluble and precipitation occurred on the addition of 
base. Only two stability constants were therefore 
determined. The value for the 111 complex is 14.42 and for
the 110 complex 7.86 (Table 5.18). The %distribution for
the ligand and complex species between pH 3.5 and 6.0 are 
given in Figure 5.22.
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Model Stability Constants Average
111 14.52+0.03 14.40+0.04 14.35+0.06 14.42+0.08
110 7.87+0.15 7.80+0.19 7.90+0.19 7.86+0.25
STATISTICAL ANALYSIS
U 2•800E-9 2.800E-9R-fac. 0.00815 0.00913 0.01228 0.00988X2 104.53 116.86 135.29 118.89AM 7.336E-7 9.186E-7 1.261E-6 9.711E-7MD 2.825E-6 3.218E-6 4.295E-6 6.277E-6<7 3.943E-6 4.409E-6 5.954E-6 4.770E-6MCS 1.15 1.19 1.25 1.97MCK 3.20 2.86 2.85 2.97Pts. 60 57 57pH 4.1-5.74 4.1-5.80 4.1-5.85Range
Table 5.18.- Stability constants of 11 complexes of
(^leu-cys-leu) with cadmium(II).
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Figure 5.22; %Distribution against pH of 11 complexes of
(H3 leu-cys-leu) with cadmium(II).
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5.7.1.6 Stability constants and species distribution of
(H3 val-cvs-val-valT— cadmium(IIT complexes
Three stability constants were obtained for this 
tetrapeptide complex. The stoichiometries of the 
complexes were found to be similar to those of the 
tripeptides. The stability constants were found to be for 
the 111 complex 14.43, for the 110 complex 7.16, and for 
the 11-1 complex -2.91 (Table 5.19). From the 
%distribution versus pH plot (Figure 5.23) it can be seen 
that appreciable amounts (~ 50%) of the 111 complex is 
formed at pH ~ 6.5. The dominant complex is again the 
neutral 110, with 90% formation at pH ~ 8.5. The general 
distribution of the ligand and complex species is similar 
to that of the H2val-cys-val system (5.7.1.4).
Model Stability Constants Average
1 11 14.47+0.05 14.40+0.05 14.41+0.06 14.43+0.06
110 7.22+0.03 7.15+0.03 7.10+0.04 7.16+0.10
1 1 - 1 -2.96+0.05 -2.68+0.04 -3•10+0.06 -2.91+0.20
STATISTICAL ANALYSIS
U 2.877E-8 2.877E-8
R-fac. 0.02136 0.02074 0.02551 0.02254
X2 31.50 16.64 17.07 21.94
AM 4.321E-7 1.215E-7 3.189E-7 2.911E-7
MD 7.516E-6 7.551E-6 9.133E-6 8.063E-6
o 1.010E-5 9.792E-6 1.206E-5 1.066E-6
MCS -0.22 0.09 -0.03 0 . 1 1
MCK 3.30 2.88 2.97 3.05
Pts. 100 100 100
pH 3.8-9.6 3.8-9.6 3.8-9.6
Range
Table 5.19. Stability constants of 11 complexes of
(H2 val-cys-val-val) with cadmium(II).
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Figure 5.23* %Distribution against pH of 11 complexes of 
(H3val-cys-val-val)+ with cadmium(II).
5.7.1.7 Stability constants and species distribution of 
(H^val-val-cvs-val)— cadmium(II) complexes
The stability constants (Table 5.20) of the (H3val-val- 
cys-val)+ complexes are for the 111 complex 14.16, for the 
110 complex 7.44, and for 11-1 complex -2.91 which are 
slightly different to those of the (H3val-cys-val-val)+ 
complexes. The %distribution of each complex species is 
also different. The complex 111 only reaches maximum 
concentration of 30% at pH 6.5, while the neutral 
complex 110 is stable over a wider pH range (~ 5.5 to
12.5), reaching maximum concentration of ~ 98% at pH 
9.0. Complex 11-1 begins to form at pH ~ 9.0 with only 
8% formation at pH ~ 10 (Figure 5.24).
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Model Stability Constants Average
111 14.19+0.03 14.19+0.07 14.10+0.09 14.16+0.09
110 7.56+0.01 7.39+0.03 7.37+0.03 7.44+0.12
1 1 - 1 -3.62+0.09 -3.71+0.09 -3.98+0.09 -3.77+0.15
STATISTICAL ANALYSIS
U 6. 320E-9 6.320E-9
R-fac. 0.01062 0.02451 0.02490 0.02001
X2 28.49 33.51 27.60 28.87
AM 2.678E-8 8.906E-7 8.096E-7 6.029E-7
MD 3.589E-6 8.248E-6 8.019E-6 6.620E-6
o 4.838E-6 1.105E-5 1.106E-5 9.000E-6
MCS 0.64 0.09 0.25 0.33
MCK 3.86 2 .8 8 2.62 3.12
Pts. 90 90 90
pH 3.8-9.9 3.8-9.9 3.8-9.9
Range
Table 5.20. Stability constants of 11 complexes of
(H2val-val-cys-val) with cadmium(II).
pH
Figure 5.24* %Distribution againgt pH of 11 complexes of
(H3 val-val-cys-val) with cadmium(II).
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(H3thr-cys-val)+ has a hydrophilic side chain in the N- 
terminal residue and therefore is expected to form 
complexes having different stability constants to the 
peptides with hydrophobic side chains in this residue. 
The stability constants for the complexes were found to be 
for the 111 complex 13.43, for the 110 complex 7.67, and 
for the 11-1 complex -1.61 (Table 5.21). The %distribution 
of the complexes is also found to be slightly different 
from that for hydrophobic peptide complexes (Figure 5.25). 
Only a small concentration of the complex 111 is formed (~ 
12%) at pH ~ 6.2. The dominant complex is 110, which 
begins to form at pH ~ 5.0, reaching maximum concentration 
at pH ~ 7.5 (90%) and then disappearing. Complex 11-1 
begins to form at pH ~ 7.0 and increases in concentration
5.7.1.8 Stability constants and species distribution of
(H3 thr-cys-valT— cadmiumfIIT complexes
as the pH is increased.
Model Stability Constants Average
111 13.45+0.10 13.38+0.15 13.50+0.08 13.45+0.08 13.43+0.15
110 7.55+0.02 7.49+0.02 7.61+0.01 7.64+0.01 7.57+0.07
11-1 - 1 .66+0.02 -1.78+0.03 -1 .56+0.02 -1.44+0.02 -1.62+0.15
STATISTICAL ANALYSIS
U 5.628E-9 5.628E-9
R-f ac 0.013458 0.019547 0.011708 0.009884 0.01330
X2 100.08 24.05 80.54 52.39 60.20
AM 1.986E-7 1.388E-7 2.993E-7 2.581E-7 2.047E-7
MD 3.089E-6 4.859E-6 2.640E-6 2.378E-6 3.161E-6
a 4.671E-5 6.806E-6 4.105E-6 3.452E-6 4.491E-6
MCS -0.71 -0.43 -0.67 -0.48 -0.58
MCK 4.69 3.81 4.80 4.42 4.42
Pts. 86 86 86 86
pH 3.90-9.30 3.90-9.30 3.90-9.30 3.90-9.30
Range
Table 5.21. Stability constants of 11 complexes of
(H2thr-cys-val) with cadmium(II).
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PH
Figure 5.25. %Distribution against pH of 11 complexes of 
(^thr-cys-val) with-cadmium(II).
5.7.1.9 Stability constants and species distribution of 
(H^asp-cys-val)— cadmium(II) complexes
(H4Asp-cys-val)+ was expected to have similar complexation 
properties to glutathione. This was not found to be the 
case. The stability constants of its cadmium(II)
complexes were found to be for the 111 complex 14.77, for 
the 110 complex 7.67, and for the 11-1 complex -1.76 
(Table 5.22). The data for complexes of (H4Asp-cys-val)+ 
showed better refinement than those for the complexes of 
the other peptides. The distribution of complexes is 45% 
of 111 at pH ~ 6.5, 85% of 110 at pH ~ 8.5 and the 11-1
species begins to form at pH ~ 7.5 (Figure 5.26). Although 
three stability constants were refined for (H4asp-cys- 
val)+ / Cd(II), only two constants were refined for 
(H4glut)+ / Cd(II) Section 5.7.1.10.
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Model Stability Constants Average
111 14.87+0.04 14.75+0.05 14.68+0.06 14.88+0.03 14.80+0.08
110 7.67+0.03 7.64+0.03 7.47+0.04 7.90+0.02 7.67+0.20
1 1 - 1 -1.75+0.03 -1.81+0.04 -2.00+0.04 -1.40+0•02 -1.74+0.25
STATISTICAL ANALYSIS
U
R-fac
X2
AM
MD
0
MCS
MCK
Pts.
pH
kange
9.905E-9
0.014168
60.16
1.459E-7
4.314E-6
5.746E-6
-0.06
3.42
100
3.60-9.70
0.016580
75.84
1.563E-7
4.914E-6
6.717E-6
-0.15
4.06
100
3.60-9.70
0.019799 
43.57 
4.687E-7 
5.943E-6 
8.040E-6 
0 . 1 0  
4.22 
100
3.60-9.70
0.010734
44.96
1.478E-7
3.271E-6
4.356E-6
0.02
2.83
100
3.60-9.70
9.905E-9
0.015292
56.13
2.297E-7
4.611E-6
6.206E-6
0.08
3.63
Table 5.22. Stability constants of 11 complexes of
(^asp-cys-val) with cadmimn(II).
pH
Figure 5.26. %Distribution against pH of 11 complexes of
(H4 asp-cys-val) with cadmium(II).
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The stability constants (log values) of glutathione 
complexes with cadmium(II) were found to be for the 111 
complex 16.27 and for the 110 complex 10.18. No stability 
constant could be obtained for the complex 11-1 in the pH 
range studied (3.5 - 10.0) (Table 5.23). The stability 
constants determined are very similar to those reported in 
the literature. Plots of %distribution of the complexes 
with respect to pH show complex 111 to form in high 
concentration (~ 60% at pH “ 6.5) and 110 to be the
predominant complex (100%) at pH 9 (Figure 5.27)
5.7.1.10 Stability constants and species distribution of
Hglutathione cadmium(II) complexes
Model Stability Constants Average
111 16.30+0.04 16.29+0.04 16.22+0.04 16.26+0.03 16.27+0.04
110 9. 04+0.03 9.03+0.03 8.90+0.03 9.01+0.03 8.99+0.05
1 1 - 1 Re j. Re j. Re j. Rej.
STATISTICAL ANALYSIS
U 1.770E-8 1.770E-8R-fac 0.017080 0.016411 0.018750 0.016368 0.017152X2 26.47 25.27 34.99 35.67 30.60AM 1.608E-7 1.679E-7 4.114E-7 4.166E-7 2.892E-7MD 6.824E-6 6.463E-6 7.083E-6 6.254E-6 6.655E-6
a 8.573E-6 8.006E-6 8.766E-6 7.923E-6 8.317E-6MCS 0.02 0.06 0.09 0.32 0 . 1 2
MCK 2.46 2.34 2.20 2.35 2.37
Pts. 94 94 94 94
bn 3.80-10.0 3.80-10.0 3.80-10.0 3.80-10. 0Range
Table 5.23. Stability constants of 11 complexes of
glutathione with cadmium(II).
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1 0 0
Figure 5.27. %Distribution against pH of 11 complexes of 
glutathione with cadmium (II).
5.7.1.11 Stability constants of ^cysteine / cadmium(IIT 
complexes “
The stability constants of (H2cys) complexes of 
cadraium(II) were found to be for the 111 complex 16.67, 
and for the 110 complex 10.22. These values compare well 
with those in the literature (Table 5.24).
Model Stability Constants Average
1 11 16.76+0.04 16.66+0.05 16.59+0.09 16.73+0.04 16.67+0.08
110 10 .24+0.2 10.25+0.2 10.38+0.22 10.30+0.16 1 0.21+0•22
STATISTICAL ANALYSIS
U 5.543E-9 5.543E-9
R-f ac 0.009870 0.011225 0.022565 0.010789 0.015774
X2 37.77 62.67 88.19 82.46 67.92
AM 2.021E-7 9.840E-7 2.342E-6 6.501E-7 1.433E-6MD 4.146E-6 4.943E-6 1.034E-5 4.184E-6 7.317E-6
<7 6.286E-6 7.038E-6 1.371E-5 6.622E-6 8.077E-6
MCS 0.71 0.85 0.97 0.83 0.89
MCK 4.81 3.83 2.58 4.88 3.62
Pts. 46 46 46 46
PH 3.50-5.50 3.50-5.50 3.50-5.50 3.50-5.50Range
Table 5.24. Stability constants of 11 complexes of L- 
cysteine.HCl with cadmium(II).
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The 22 complex model was found to refine for four and 
sometimes five complexes over the pH range studied (3.5
10.5). Some of the peptide-cadmium(II) complexes showed 
good refinement, while others did not. Complexes of this 
type are chemically feasible. The first complex refined, 
under acidic conditions, is 222 (5.12) Cd2 (HL)2. By
increasing the pH of the solution, the 222 complex goes to 
the 220 neutral complex, via the intermediate 221 (5.13). 
The peptide probably acts as a pentadentate ligand, with 
thiolate bridging. At pH above 8.5 the complexes 22-1 and 
22-2 form. The 22-1 complex is only found to refine for 
some peptide-complex systems, while 22-2 is refined for 
only one peptide-complex system.
Other complexes of the nature 211, 210, 21-1 were
introduced to the above system but were rejected.
5.7.2 The 2-ligand to 2-metal complex model (22)
+
H3N — CHj" C—NH “  C H -C —NH
n /  ii \
5.12
n h 3
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o
c h 2 II I ^ C “ CP 2
• N H - C — C H -N H  \  +
N H 3
Cd .Cd-
o
V
c %  || I / C - C H 2
‘N H -C  — C H -M i
I \  0
c n ,  \
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5.7.2.1 Stability constants and species distribution of 
(K^qlv-cvs-glv)— cadmium(II) complexes
Three 22 complexes refined for the H2gly-cys-gly / Cd(II) 
system. The stability constants were for the 222 
complex 32.42, for the 221 complex 25.72, and for the 220 
complex 19.30. The 22-1 and the 22-2 complexes were 
rejected (Table 5.25). Complex 222 begins to form at pH 
5.0 and reaches maximum concentration (30%) at pH 6.0. 
220 seems to be the dominant complex, while 221 forms over 
the same pH range but at very low concentration (~ 15%).
As no other complexes were refined and an insoluble 
complex formed, there is no data available at pH > 6.5
(Figure 5.28).
Model Stability Constants Average
222 32.41+0.08 32.43+0.09 32.42+0.09 32.42+0.10
221 25.76+0.15 25.69+0.20 25.72+0.20 25.72+0.20
220 19.28+0.08 19.31+0.08 19.30+0.09 19.30+0.10
2 2 - 1 Re j. Rej. Rej.
2 2-2 Re j. Rej. Rej.
STATISTICAL ANALYSIS
U
R-fac.
X2
AM
MD
a
MCS
MCK
2.753E-9
0.00659
120.15
7.008E-7
2.366E-6
3.786E-6
1.69
4.72
3.431E-9 
0.007375 
118.00 
7.855E-7 
2.642E-6 
4.228E-6
1.70
4.70
3.214E-9
0.007132
116.31
6.694E-7
2.493E-6
4.024E-6
1.58
4.63
3.130E-9
0.007033
118.00
7.816E-7
2.500E-6
4.013E-6
1.66
4.68
Table 5.25. Stability constants of 22 complexes of
(^gly-cys-gly) with cadmium(II) .
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Figure 5.28* %Distribution against pH of 22 complexes of 
(H3gly-cys-gly) with cadmium(II).
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« + / Four 22 complexes refined for the (H3gly-cys-ala) /
Cd(II) system. The stability constants of these are for
the 222 complex 32.61, for the 221 complex 26.39, and for
the 220 complex 18.97. The 22-1 complex was rejected and
for the 22-2 complex the constant was 0.29 (Table 5.26).
The %distribution of each complex was plotted between pH
3.5 and 10.0 as an insoluble complex did not form in this
case. 222 begins to form at pH ~ 5.0 and reaches maximum
concentration (24%) at pH ~ 6.5. 221 forms in larger
concentration (55%) at pH ~ 7.0 and depletes on increasing
the pH. 220 is the most dominant complex and begins to
form at pH ~ 6.0, reaching maximum concentration (90%) at
pH ~ 8.5 and depleting on increasing the pH further. At pH
> 8.5 the 22-2 complex begins to form rapidly (Figure
5.29). The curves do not follow a perfect "Gaussian"
distribution.
5.7.2.2 Stability constants and species distribution of
(Hgqlv-cvs-ala)— cadmium(II) complexes
Figure 5.29. %Distribution against pH of 22 complexes of 
(H3gly-cys-ala) with cadmium(II).
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Model Stability Constants Average
222 32 .66+0.07 32.42+0.11 32.60+0.08 32.74+0.05 32.61+0.15
221 26 .42+0.03 26.33+0.03 26.39+0.03 26.43+0.02 26.39+0.05
220 19.00+0.03 18.71+0.04 18.99+0.04 19.18+0.03 18.97+0.10
2 2 - 1 Rej. Rej. Rej. Rej.
2 2 - 2 0.26+0.03 0.22+0.04 0.22+0.04 0.46+0.03 0.29+0.015
STATISTICAL ANALYSIS
U 6.532E-9 6.532E-9R-fac 0.010164 0.017123 0.010138 0.010139 0.011875X2 61.65 95.62 1 1 . 2 1 26.86 48.84AM 3.226E-7 1.531E-7 2.236E-7 2.030E-7 2.256E-6
MD 3.322E-6 4.165E-6 3.502E-6 2.699E-6 2.672E-6
a 4.714E-6 5.457E-6 4.709E-6 3.771E-6 4•663E-6
MCS -0.37 -0.04 -0.33 -0.26 -0.25MCK 3.77 4.55 3.46 3.91 3.92
Table 5.26. Stability constants. of 22 complexes of
(H2gly-cys-ala) with cadmium(II).
5.7.2.3 Stability constants and species distribution of 
(Hgalv-cvs-valT— cadmiumdIT complexes
Five 22 complexes refined for the (H3gly-cys-val) /
cadmium(II) system. The stability constants are: for
the 222 complex 32.24, for the 221 complex 26.23, for the
220 complex 18.80, for the 22-1 complex 8.47, and for the
22-2 complex 0.052 (Table 5.27). The %distribution of 
each complex is identical to that for the cadmium(II)- 
H2gly-cys-ala system (Section 5.7.2.2) with the exception 
of the 22-1 complex. 22-1 begins to form at pH ~ 7.5 and
reaches maximum concentration of only 20% at pH 9.5
(Figure 5.30). At pH > 9.5 the concentration, of this 
complex depletes to yield the more favourable 22-2 
complex.
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Model Stability Constants Average
222 32.58+0.04 32.20+0.10 31.93+0.09 32.24+0.20
221 26.34+0.01 26.22+0.02 26.13+0.02 26.23+0.08
220 19•11±0.01 18.78+0.03 18.52+0.03 18.80+0.30
2 2 - 1 9•11+0•14 8.72+0.14 7.58+1.19 8.47+1.20
22-2 0.44+0.04 0.01+0.03 -0.30+0.04 0.05+0.30
STATISTICAL ANALYSIS
U 1.258E-9 1.258E-9
R-fac . 0.004724 0.008591 0.010417 0.007903
X2 31.12 30.73 21.33 27.730
AM 2.015E-8 1.118E-7 1.493E-7 9.375E-8
MD 1.545E-6 2.779E-6 3.360E-6 2.561E-6
O 2.182E-6 3.953E-6 4.726E-6 3.620E-6
MCS 0.49 0.59 0.70 0.59
MCK 4.77 4.85 4.70 4.77
Table 5.27* Stability constants of 22 complexes of
(H2gly-cys-val) with cadmium(II).
pH
Figure 5.30* %Distribution against pH of 22 complexes of
(H3 gly-cys-val) with cadmium(II).
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Four 22 com plexes r e f i n e d  f o r  th e  cadm ium (II) /  (H3v a l -  
c y s - v a l ) + sy stem . The s t a b i l i t y  c o n s ta n ts  a r e :  f o r  th e  
222 complex 3 1 . 8 8 ,  f o r  th e  221 complex 2 5 . 8 0 ,  f o r  th e  220  
com plex 1 8 . 2 2 ,  and f o r  th e  2 2 -2  complex - 0 . 8 5  (T a b le  
5 . 2 8 ) .  The 2 2 -1  complex was r e j e c t e d .  The % d is t r ib u t i o n  o f  
each complex s p e c i e s  formed in  s o l u t i o n  i s  s i m i la r  t o  t h a t  
o f  th e  (H3g l y - c y s - a l a ) + complex system  (F ig u re  5 . 3 1 )  
(S e c t io n  S . 7 . 2 . 2 . ) .
5 .7 .2 .4  S t a b i l i t y  c o n s ta n ts  and s p e c ie s  d i s t r i b u t i o n  o f
(H3v a l - c v s - v a l ) — cadm iu m (II) com p lexes
Model S t a b i l i t y  C on stan ts Average
222  32 . 0 8 + 0 . 0 5 3 1 .8 9 + 0 .1 1  3 1 . 7 7 + 0 .1 1 3 1 .7 8 + 0 .1 1 3 1 .8 8 + 0 .1 5
221  25 .8 9 + 0 .0 2 2 5 .7 8 + 0 .0 2  2 5 . 7 6 + 0 .0 3 2 5 .7 6 + 0 .0 2 2 5 .8 0 + 0 .0 6
220  18 .4 6 + 0 .0 2 1 8 .1 7 + 0 • 0 3  1 8 . 1 0 + 0 . 0 3 1 8 .1 5 + 0 .0 3 1 8 .2 2 + 0 .2 0
2 2 - 1 Re j . R e j . R e j . Re j .
2 2 - 2  - 0 . 5 1 + 0 .0 2 - 0 . 9 2 + 0 .0 3  - 1 . 0 1 + 0 . 0 4 - 0 . 9 5 + 0 .0 3 - 0 . 8 4 + 0 . 0 3
STATISTICAL ANALYSIS
U
R - f a c
X2
AM
MD
O
MCS
MCK
6 .7 3 2 E - 9
0 .0 0 6 4 2 6
3 4 .9 7
5 .5 8 9 E - 8
2 . 101E -6
2 .9 6 3 E - 6
- 0 . 1 8
3 .9 6
0 .0 1 0 3 7 8  0 .0 1 0 8 2 3  
3 0 .5 7  2 3 . 5 8  
1 .0 5 3 E -7  1 .2 5 6 E -7  
3 .4 0 9 E -6  3 .5 6 6 E - 6  
4 .8 0 9 E -6  4 . 709.E-6  
0 .4 9  0 . 5 5  
4 .1 4  4 . 2 2
0 .0 1 0 5 4 9
3 3 .1 5
1 .5 3 9 E -7
3 .3 7 8 E -6
4 .8 7 5 E -6
0 .7 6
4 .7 3
6 .7 3 2 E -9
0 .0 0 9 5 2 5
3 0 .5 7
1 .1 0 2 E -7
4 .1 5 1 E - 6
4 .3 3 9 E - 6
0 .5 0
4 .2 6
T a b le  5 . 2 8 .  S t a b i l i t y  c o n s t a n t s  o f  22 com plexes o f
(H2V a l - c y s - v a l )  w ith  c a d m iu m (II) .
256
co
m m  
*
3
JD
• MMV—
</)• H I
Q
vO
• —  22-2
A—  22-1
pH
F ig u r e  5 . 3 1 .  % D is tr ib u t io n  a g a in s t  pH o f  22 com plexes o f  
( H g v a l - c y s - v a l )  w ith  c a d m iu m (II) .
5 . 7 . 2 . 5  S t a b i l i t y  c o n s ta n ts  and s p e c ie s  d i s t r i b u t i o n  o f  
(H3 l e u - c v s - l e u ) — cadm ium (II) com plexes
Due t o  i n s o l u b i l i t y  o n ly  two s t a b i l i t y  c o n s t a n t s  were  
r e f i n e d  f o r  th e  (H3 l e u - c y s - l e u ) + -c a d m iu m (II ) sy ste m . The 
s t a b i l i t y  c o n s ta n ts  o f  th e  222 complex i s  3 2 .4 9  and o f  th e  
221 complex i s  2 6 .9 4  (T ab le  5 . 2 9 ) .  The % d is t r ib u t i o n s  f o r  
each complex between pH 4 . 0  and 5 . 5  are  g iv e n  in  F ig u re  
5 . 3 2 .
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Model S t a b i l i t y  C on stan ts Average
222 3 2 .5 0 + 0 .1 1 3 2 .1 2 + 0 .3 7 3 2 .8 5 + 0 .0 6 3 2 .4 9 + 0 .3 6
221 2 6 • 9 7 + 0 .0 4 2 6 .8 8 + 0 .0 7 2 6 .9 6 + 0 .0 4 2 6 . 9 3 + 0 .0 8
220 R e j . R e j . Rej •
STATISTICAL ANALYSIS
U
R - f a c .
X2
AM
MD
o
MCS
MCK
3 . 959E -10
0 .0 0 3 0 6 7
8 3 .2 0
2 .5 7 8 E -7
9 .4 7 5 E -7
1 .4 8 3 E -6
1 .6 2
4 .8 1
0 .0 0 5 2 1 3
1 2 5 .7 5
5 .0 0 8 E -7
1•618E -6
2 .8 5 1 8 - 6
1 .5 3
3 .9 0
0 .0 0 9 6 9 6
1 3 1 .6 4
1 .0 3 1 E -6
3 .3 4 8 E -6
4 .7 0 0 E -6
1 .3 3
3 .0 4
3 . 9 5 9 E -1 0  
0 .0 0 5 9 9 2  
1 1 3 .4 5  
5 .9 6 8 E - 7  
1 .9 7 1 E -6  
2 .9 0 0 E - 6  
1 .4 9  
3 .9 2
T a b le  5 . 2 9 .  S t a b i l i t y  c o n sta n ts  o f  22 com plexes o f
(H2 l e u - c y s - l e u )  w ith  c a d m iu m (II) .
222
—1------- 1 I | T ------- 1------- '------- 1
5.5 6.5 7.5 8 .5  9 .5
F ig u re  5 .3 2 .  % D is tr ib u tio n  a g a in s t  pH o f  22 com p lexes  o f
(H3le u - c y s - l e u ) *  w ith  ca d m iu m (II).
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The s t a b i l i t y  c o n s ta n ts  f o r  th e  22 cadmium( I I ) - (H2v a l -  
c y s - v a l - v a l ) com plexes over  th e  pH range 3 . 5  t o  1 0 .0  
were found t o  be f o r  th e  222 complex 3 1 . 7 3 ,  f o r  th e  221  
com plex 2 5 . 3 7 ,  f o r  th e  220 complex 1 7 . 0 0 ,  and f o r  th e  2 2 - 1  
complex 7 . 6 5 .  The 2 2 -2  complex was r e j e c t e d  (T ab le  5 . 3 0 ) .  
The 222 complex forms between pH ~ 5 . 0  t o  8 .0  and r e a c h e s  
maximum c o n c e n tr a t io n  a t  pH ~ 6 . 5 .  S u r p r is in g ly  th e  221  
com plex i s  produced in  eq u al amounts t o  th e  n e u t r a l  222  
com plex . The 221 complex forms between pH ~ 5 . 5  t o  9 . 5  and 
re a ch e s  maximum c o n c e n tr a t io n  a t  pH ” 7 . 5  ( "  7 0 % ) .  The
n e u t r a l  complex 220 o n ly  rea ch es  maximum c o n c e n tr a t io n  o f  
65% a t  pH ~ 8 . 5 .  The 2 2 -1  s p e c ie s  b e g in s  t o  form a t  pH
8 . 0  and in c r e a s e s  r a p i d ly  in  c o n c e n tr a t io n  as  th e  pH i s  
in c r e a s e d  (F ig u re  5 . 3 3 ) .
5 .7 .2 .6  S t a b i l i t y  c o n s ta n ts  and s p e c ie s  d i s t r i b u t i o n  o f
(H3v a l - c v s - v a l ~ v a l ) — cadm ium (II) com p lexes
Model S t a b i l i t y  C onstants Average
222 3 1 .9 6 + 0 .0 7 3 1 .8 1 + 0 .0 8 3 1 .7 7 + 0 .0 8 3 1 .3 7 + 0 .0 7 3 1 .7 3 + 0 .2 5
22 1  2 5 . 5 8 + 0 . 0 3 2 5 .4 5 + 0 .0 3 2 5 .4 3 + 0 .0 3 2 5 .0 3 + 0 .0 5 2 5 .3 7 + 0 .2 4
220  1 7 .3 3 + 0 .0 4 17•25+0•04 1 7 .0 0 + 0 .0 4 1 6 . 4 1 ± 0 .0 6 1 7 .0 0 + 0 .4 2
2 2 - 1  7 . 6 4 + 0 . 0 4 7 .9 7 + 0 .0 4 7 .3 4 + 0 .0 4 R e j . 7 .6 5 + 0 .3 2
2 2 - 2  R e j . R e j . R e j . R e j .
STATISTICAL ANALYSIS
U 7 . 3 2 5 E - 9  
R - f a c  0 .0 1 0 5 0 5  
X2 2 1 .3 8  
AM 2 .0 9 3 E - 7  
MD 3 .7 4 1 E - 6  
a 4 .9 6 9 E - 6  
MCS 0 .0 4 8  
MCK 3 .0 9
0 .0 1 1 1 5 0
1 6 .6 4
4 .6 2 1 E -7
3 .9 1 8 E -6
5 .2 4 7 E -6
0 .9 3
4 .2 2
0 .0 1 1 6 6 5
1 6 .6 4
5 .0 1 4 E -7
4 .0 3 9 E -6
5 .5 1 4 E - 6
0 .8 9
3 .7 9
0 .0 1 8 4 2 1
1 8 2 .4 4
7 .3 2 5 E -9
0 .0 1 2 8 2 5
5 9 .2 8
3 .9 0 9 E -7
3 .8 9 9 E -6
5 .2 4 3 E -6
1 .0 7
5 .2 3
2 .4 0
9 . 8 1
T a b le  5 .3 0 .  S t a b i l i t y  c o n s ta n ts  o f  22 com p lexes o f
( H2v a l - c y s - v a l - v a l ) w ith  cadmium( I I )•
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pH
F ig u r e  5 . 3 3 .  % D is tr ib u t io n  a g a i n s t  pH o f  22 com plexes o f  
( ^ v a l - c y s - v a l - v a l )  w ith  c a d m iu m (II ) .
5 . 7 . 2 . 7  S t a b i l i t y  c o n s ta n ts  and s p e c i e s  d i s t r i b u t i o n  o f  
(H3v a l - v a l - c v s - v a l ) -  cadm ium (II) com plexes
The s t a b i l i t y  c o n s ta n ts  o f  th e  22 (H3v a l - v a l - c y s - v a l ) + 
com plex were found t o  be as f o l l o w s :  f o r  th e  222 com plex
3 1 . 6 3 ,  f o r  th e  221 complex 2 5 . 4 0 ,  f o r  th e  220 com plex  
1 7 .9 4  and f o r  th e  2 2 -1  complex 7 . 5 6 .  The 2 2 -2  model was 
r e j e c t e d  (T ab le  5 . 3 1 ) .  These com plexes show d i f f e r e n t  
d i s t r i b u t i o n  p r o p e r t ie s  from th o s e  o f  th e  i s o m e r ic ,  H2v a l -  
c y s - v a l - v a l .  Complex 222 forms o n ly  in  sm a ll
c o n c e n tr a t io n s  w ith  a maximum o f  ~ 12% a t  pH 6 . 5  compared  
w ith  ~ 20% f o r  th e  isom er (F ig u re  5 . 3 3 ) .  The 221 com plex  
r e a c h e s  a low er c o n c e n t r a t io n ,  50% a t  pH ~ 7 . 0  compared  
w ith  70% f o r  th e  isom er (F ig u re  5 . 3 4 ) .  The dominant
2 6 0
complex f o r  H2v a l - v a l - c y s - v a l  i s  th e  n e u t r a l  on e , 2 2 0 .  
T h is  complex b e g in s  t o  form a t  pH ~ 6 . 0 ,  rea ch es  a maximum 
c o n c e n tr a t io n  o f  ~ 95% a t  pH ~ 9 . 0 ,  and th en  g r a d u a l ly  
d e c r e a s e s .  Complex 2 2 -1  b e g in s  t o  form a t  pH ~ 9 . 0  and 
in c r e a s e s  in  c o n c e n tr a t io n  s lo w ly .  The 221 cu rv e  does n o t  
f o l l o w  a "G a u s s ia n "  d i s t r i b u t i o n  (F ig u re  5 . 3 4 ) .
Model S t a b i l i t y  C o n sta n ts Average
222 3 1 .6 0 + 0 .0 6 3 1 .6 5 + 0 .1 4 Rej 3 1 .6 3 + 0 .1 4
221 2 5 .6 8 + 0 .0 1 2 5 .1 8 + 0 .1 3 2 5 .3 4 + 0 .0 7 2 5 .4 0 + 0 . 2 5
220 1 8 .4 0 + 0 .0 1 1 7 .7 0 + 0 .0 1 1 7 .7 1 + 0 .0 3 1 7 .9 4 + 0 .4 0
2 2 - 1 7 .5 6 + 0 .0 3 R e j . R e j . 7 . 5 6 + 0 . 0 3
2 2 - 2 R e j . R e j . Rej
STATISTICAL ANALYSIS
U
R - f a c .
X2
AM
MD
a
MCS
MCK
8•530E -10  
0 .0 0 3 9 0 1  
1 6 7 .9 3  
1 .6 3 0 E -7  
9 .8 5 8 E -7  
1•778E -6  
2 .0 7  
1 2 .2 2
0 .0 1 0 3 4 3  
1 5 2 .5 3  
8 . 346E -7  
3 . 456E -6  
4 . 832E-6  
1 .8 6  
1 0 .1 1
0 .014237
1 4 8 .4 0
1 .0 0 3 E -6
3 .7 4 4 E -6
5 .7 9 5 E -6
1 .7 6
7 .3 4
8 . 5 3 0 E -1 0  
0 .0 0 9 4 8 2  
1 5 4 .9 7  
6 .6 7 0 E -7  
5 .6 8 6 E - 6  
4 .1 3 5 E - 6  
1 .9 0  
9 .8 9
T a b le  5 . 3 1 .  S t a b i l i t y  c o n s ta n ts  o f  22 com plexes o f
(H2v a l - v a l - c y s - v a l )  w ith  c a d m iu m (II) .
2 6 1
F ig u r e  5 . 3 4 .  % D is tr ib u t io n  a g a i n s t  pH o f  22 com plexes o f  
(H3v a l - v a l - c y s - v a l ) + w ith  c a d m iu m (II ) .
5 . 7 . 2 . 8  S t a b i l i t y  c o n s ta n ts  and s p e c ie s  d i s t r i b u t i o n  o f  
( H3t h r - c v s - v a l )— cadm ium (II) com plexes
The s t a b i l i t y  c o n s ta n ts  o f  th e  22 (H3t h r - c y s - v a l ) + com plex  
f o l l o w  th e  same p a t te r n  as th e  o th e r  p e p tid e  c o m p le x e s .  
The s t a b i l i t y  c o n s ta n ts  o f  com plexes w ith  cadm ium (II)  
were found t o  be f o r  th e  222 complex 3 0 . 7 8 ,  f o r  th e  221  
com plex 2 5 . 3 8 ,  f o r  th e  220 complex 1 8 . 6 3 ,  f o r  th e  2 2 - 1  
com plex 1 0 .0 9  and th e  2 2 -2  complex was r e j e c t e d  (T a b le  
5 . 3 2 ) .  A lthough  a good r e fin e m e n t  was o b ta in e d  f o r  t h i s  
p e p t id e  th e  % d is t r ib u t i o n  o f  each s p e c ie s  does n o t  f o l l o w  
a good "G a u s s ia n "  d i s t r i b u t i o n  (F ig u re  5 . 3 5 ) .
2 6 2
Model S t a b i l i t y  C onstants Average
222 R e j . 3 0 .7 9 + 0 .8 3  3 1 .1 8 + 0 .4 2 3 0 .3 8 + 1 .8 8 3 0 .7 8 + 1 .8 8
221 2 5 .3 7 + 0 .0 8 2 5 .3 6 + 0 .0 8  2 5 .4 2 + 0 .0 8 2 5 .4 0 + 0 .1 0 2 5 .3 8 + 0 .1 0
220 1 8 .5 7 + 0 .0 6 1 8 .3 8 + 0 .0 7  1 8 .7 2 + 0 .0 8 1 8 .8 5 + 0 .0 8 1 8 .6 3 + 0 .1 8
2 2 - 1 1 0 .0 0 + 0 .0 8 9 .7 2 + 0 .0 9  1 0 .2 0 + 0 • 1 0 1 0 .4 4 + 0 .0 9 1 0 .0 9 + 0 .2 7
2 2 - 2 R e j , R e j .  R e j . Rej •
STATISTICAL ANALYSIS
U 1 .8 5 9 E -8 1 .8 5 9 E -8
R - f a c 0 .0 2 5 1 0 1 0 .0 2 6 9 5 0  0 .0 2 3 7 3 6 0 .0 2 3 7 3 6 0 .0 2 4 8 7 2
X2 1 1 2 .8 5 5 6 .5 4  1 2 6 .0 0 1 4 0 .5 7 1 0 8 .9 8
AM 6 .3 4 3 E -7 8 .4 0 1 E -7  3 .9 2 6 E -7 4 .7 3 5 E -7 5 .8 5 1 E -7
MD 5 .1 2 5 E -6 6 .1 2 0 E -6  4 .6 5 9 E -6 4 .6 5 2 E -6 5 .1 3 9 E -6
a 8 .7 1 3 E -6 9 .3 8 8 E -6  8 .0 9 4 E -6 8 .2 9 1 E -6 8 .6 2 2 E -6
MCS 1 .9 6 1 .3 6  2 .0 7 2 .5 4 2 .0 3
MCK 1 2 .4 3 8 .6 9  1 3 .4 8 1 6 .4 6 1 2 .9 8
T a b le  5 . 3 2 .  S t a b i l i t y  c o n s ta n ts  o f  22 com plexes o f
(H2t h r - c y s - v a l )  w ith  c a d m iu m (II ) .
pH
F ig u re  5 .3 5 . % D is tr ib u tio n  a g a in s t  pH o f  22 com p lexes  o f
(H3 t h r - c y s - v a l )  w ith  ca d m iu m (II) .
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The s t a b i l i t y  c o n s ta n ts  f o r  th e  22 (H4a s p - c y s - v a l ) + /
C d ( I I )  com plexes were found t o  be f o r  th e  222 com plex  
3 2 . 8 2 ,  f o r  th e  221 complex 2 6 . 5 2 ,  f o r  th e  220 com plex
1 8 . 5 0 ,  f o r  th e  2 2 -1  complex 9 . 8 5 ,  and th e  2 2 -2  com plex
was r e j e c t e d  (T ab le  5 . 3 3 ) .  The % d is t r ib u t i o n s  f o r  th e  
com plexes o f  t h i s  l ig a n d  are  d i f f e r e n t  t o  th o s e  o f  th e  
hydrophobic s id e  ch a in  p e p t i d e s .  The complex 222 Cd2 (HL)2 
form s a t  low c o n c e n tr a t io n s  rea ch in g  a maximum o f  20% a t  
pH ~ 6 . 5 .  The complex i s  found over  th e  pH range o f  ~ 5 . 0  
t o  8 . 0 .  221 i s  an a n io n ic  complex and i s  found t o  be th e
dominant on e . I t  b e g in s  t o  form a t  pH ~ 5 . 5 ,  r e a c h e s  a 
maximum c o n c e n tr a t io n  o f  70% a t  pH ~ 7 . 5  and th en  d e p le t e s
as th e  pH i s  f u r t h e r  in c r e a s e d .  A t pH ~ 6 . 5  th e  a n io n ic
complex 220 b e g in s  t o  form and re a ch e s  maximum 
c o n c e n t r a t io n  o f  50% a t  pH ~ 8 .5  and then  d e p le t e s  as th e  
pH i s  in c r e a s e d .  The f i n a l  complex 2 2 -1  [Cd2L2OH]~ b e g in s  
t o  form a t  pH ~ 7 . 5  and i t s  c o n c e n tr a t io n  in c r e a s e s  v e r y  
r a p i d l y  w ith  pH r e a c h in g  90% a t  pH ~ 9 . 5  (F ig u re  5 . 3 6 ) .
5 .7 .2 .9  S t a b i l i t y  c o n s ta n ts  and s p e c ie s  d i s t r i b u t i o n  o f
(H^a s p -c v s -v a lT — cadmium(IIT com p lexes
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Model S t a b i l i t y  C o n sta n ts A verage
222 32 .8 2 + 0 .0 8 3 2 .7 4 + 0 .0 8 3 2 .6 6 + 0 .0 6 3 3 .0 4 + 0 .1 2 3 2 . 8 2 + 0 .1 6
221  26 .5 2 + 0 .0 3 2 6 .4 8 + 0 .0 3 2 6 .2 4 + 0 .0 2 2 6 .8 3 + 0 .0 4 2 6 . 5 2 + 0 . 2 4
220  18 .4 8 + 0 .0 4 1 8 .4 1 + 0 .0 3 1 8 .1 7 + 0 .0 3 1 8 .9 4 + 0 .0 6 1 8 .5 0 + 0 .3 2
2 2 - 1  9 • 86+0•04 9 .7 7 + 0 . 0 3 9 .1 8 + 0 .0 3 1 0 .5 9 + 0 .0 5 9 .5 8 + 0 • 5 6
2 2 - 2 Rej • R e j . R e j . R e j .
STATISTICAL ANALYSIS
U
R -f a c
X2
AM
MD
o
MCS
MCK
4 .5 5 4 E -9  
0 .0 0 9 6 0 1  
1 6 7 .7 3  
6 .6 0 9 E -7  
2 .3 3 2 E -6  
3 . 896E -6  
2 .6 0  
1 4 .3 7
0 .0 0 8 3 5 8
7 1 .0 9
6 .4 0 9 E - 7
2 .1 9 6 E - 6
3 .3 8 6 E - 6
2 .1 3
9 .6 3
0 .0 0 7 0 8 9
2 9 4 .3 5
4 .0 5 6 E -7
1 .5 6 6 E -6
2 .8 7 9 E -6
2 .1 4
8 .0 8
0 .0 1 3 7 8 1  
1 5 3 .8 1  
6 .1 0 3 E -7  
3•033E -6  
5 .5 9 3 E -6  
3 .6 2  
2 2 .4 0
4 .5 5 4 E -9
0 .0 0 9 7 0 7
1 7 1 .7 5
5 .7 9 4 E -7
2 .2 8 2 E -6
3 .9 3 8 E - 6
2 .6 3
1 3 .6 2
T a b le 5 . 3 3 . S t a b i l i t y c o n s ta n ts o f  22 com plexes o f
(H3a s p - c y s - v a l )  with' c a d m iu m (II)
pH
F ig u re  5 .3 6 .  % D is tr ib u tio n  a g a in s t  pH o f  22 com p lexes  o f
(H4a s p - c y s -v a l )  w ith  ca d m iu m (II).
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The s t a b i l i t y  c o n s ta n ts  o f  th e  22 H3g l u t a t h i o n e / C d ( I I ) 
system  were found t o  be f o r  th e  222 complex 3 5 . 7 8 ,  f o r  
th e  221 complex 2 9 . 2 3 ,  f o r  th e  220 complex 2 1 .4 4  and f o r  
th e  2 2 - 1  complex 9 .9 5  (T ab le  5 . 3 4 ) .  These s t a b i l i t y  
c o n s ta n ts  a re  h ig h e r  than th o se  o f  th e  H3a s p - c y s -  
v a l /c a d m i u m ( I I ) c om p lexes . The % d is t r ib u t i o n  o f  each  
com plex s p e c i e s  i s  a l s o  q u i t e  d i f f e r e n t .  Complex 222  
forms in  h ig h e r  c o n c e n t r a t i o n s ,  i . e .  40% a t  pH ~ 6 . 2 5 ,  221  
which i s  n ot th e  dominant complex and i t  re a ch e s  a maximum 
c o n c e n tr a t io n  o f  ~ 65% a t  pH ~ 7 . 5 .  The dominant com plex  
i s  2 2 0 .  I t  b e g in s  t o  form a t  pH ~ 6 . 5 ,  re a ch e s  a maximum 
c o n c e n t r a t io n  o f  95% a t  pH ~ 9 . 5 ,  and then  d e p le t e s  s lo w ly  
as th e  2 2 -1  complex b e g in s  t o  form (F ig u re  5 . 3 7 ) .  A good  
"G a u s s ia n "  d i s t r i b u t i o n  i s  in d i c a t e d  f o r  th e  com plexes o f  
b o th  H3 g lu t a t h io n e  and ( H ^ a s p -c y s -v a l ) + .
5 .7 .2 .1 0  S t a b i l i t y  c o n s ta n ts  and % d istrib irfc ion  o f
H jq lu ta th io n e  cadm ium (II) com p lexes
Model S t a b i l i t y  C on stan ts A verage
222 3 5 .9 0 + 0 .0 3 3 5 .7 4 + 0 .0 2 3 5 .6 9 + 0 .0 2 3 5 .7 8 + 0 . 1 1
221 2 9 .4 7 + 0 .0 1 2 9 .1 4 + 0 .0 1 2 9 .0 7 + 0 .0 2 2 9 .2 3 + 0 .2 1
2 2 0 2 1 .9 9 + 0 • 0 2 2 1 .1 7 + 0 .0 1 2 1 .1 6 + 0 .0 2 2 1 .4 4 + 0 . 4 8
2 2 - 1 9 .8 9 + 0 .0 8 9 .8 0 + 0 .0 7 1 0 * 1 7 + 0 .0 8 9 . 9 5 + 0 . 2 0
2 2 - 2 R e j . R e j . Rej
STATISTICAL ANALYSIS
U
R - f a c .
X2
AM
MD
a
MCS
MCK
2 .6 2 9 E -9
0 .0 0 2 9 9 2
1 2 0 .3 3
5 .6 7 7 E -8
1 .0 4 0 E -6
1 .5 0 2 E -6
2 .3 0
1 3 .2 0
0 .0 0 3 1 4 3
1 4 1 .2 7
4 .2 7 0 E -8
1 .0 7 3 E -6
1 .5 3 3 E -6
2 .6 9
1 2 .0 2
0 .0 0 6 2 1 8
1 4 5 .4 2
4 .0 7 8 E -8
1 .6 2 6 E -6
2 .9 7 5 E -6
2 .3 0
1 2 .1 6
2 .6 2 9 E -9  
0 .0 0 4 1 1 8  
1 3 5 .6 7  
4 .6 7 5 E - 8  
1 .2 4 6 E -6  
2 . 003E -6  
2 .4 3  
1 2 .4 6
T a b le  5 .3 4 . S t a b i l i t y  c o n s ta n ts  o f  22 com p lexes  o f
g lu ta th io n e  w ith  ca d m iu m (II) .
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F ig u re  5 . 3 7 .  % D is tr ib u t io n  a g a in s t  pH o f  22 com plexes o f  
g lu t a t h io n e  w ith  c a d m iu m (II) .
5 . 7 . 2 . 1 1  S t a b i l i t y  c o n s ta n ts  o f  B U cvsteine  cadmium(IIT  
com plexes
The s t a b i l i t y  c o n s ta n ts  o f  th e  22 H2c y s t e i n e / C d ( I I ) 
com plexes were found t o  be f o r  th e  222 complex 3 6 . 4 5 ,  f o r
th e  220 complex 2 5 .6 1  (T able  5 .3 5 )  and f o r  th e  221 com plex  
was r e j e c t e d .
Model S t a b i l i t y  C on sta n ts Average
222  36 .5 9 + 0 .0 9 3 6 . 2 6 ± 0 . 10 3 6 .4 9 + 0 .0 6 R e j . 3 6 .4 5 + 0 .1 7
221 R e j . R e j . R e j . R e j .
220  25 .6 9 + 0 .0 3 2 5 .6 6 + 0 .0 2  2 5 .6 1 + 0 .0 4 2 5 • 6 3 + 0 .0 1 2 5 .6 1 + 0 .1 0
STATISTICAL ANALYSIS
U 9 . 4 0 7 E -1 0 9 . 4 0 7 E -1 0
R - f  ac 0 .0 0 4 1 0 0 0 .0 0 2 7 5 2  0 .0 1 3 7 2 8 0 .0 1 4 8 3 1 0 .0 0 8 8 5 2 5
X 8 7 .3 9 5 9 . 2 0  1 3 4 .2 4 3 0 .3 0 8 3 .9 0
AM 4 .6 9 4 E -7 3 .1 1 9 E -7  1 .6 7 2 E -6 6 .2 7 9 E - 8 1 .8 1 8 E -6
MD 1 . 549E -6 1 . 129E -6  5 .0 3 8 E -6 5 . 8 32E -6 4 . 197E -6
a 2 .6 1 1 E -6 1 .7 2 6 E -6  8 .3 4 2 E -6 9 . 100E -7 5 . 006E -6
MCS - 1 . 8 6 1 . 4 8  1 .5 5 - 1 . 0 2 1 .4 9
MCK 6 .0 4 7 4 . 0 9  4 .0 6 5 .7 3 4 .7 8
T a b le  5 .3 5 *  S t a b i l i t y  c o n s ta n ts  o f  22 com p lexes  o f  L-
cy s te in e .H C 1  w ith  ca d m iu m (II).
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From th e  t i t r a t i o n  c u rv es  (F ig u re s  5 .1 7 a - d )  and th e  
% d is t r ib u t i o n  o f  each complex s p e c i e s ,  i t  i s  c l e a r l y  shown 
t h a t  th e  t r i p e p t i d e s  (H3g l y - c y s - g l y ) + , (H3g l y - c y s - a l a ) + , 
(H3g l y - c y s - v a l ) + , (H3v a l - c y s - v a l ) + and (H3l e u - c y s - l e u ) + 
form com plexes having s t a b i l i t y  c o n s ta n ts  which a r e  _ 
n u m e r ic a l ly  v e r y  c l o s e .  G e n e r a l ly ,  as th e  h y d r o p h o b ic ity  
o f  th e  s id e  c h a in  i s  in c r e a s e d ,  e . g  by r e p la c in g  g l y  by  
v a l ,  th e  s t a b i l i t y  c o n s ta n ts  o f  th e  c a t i o n i c ,  n e u t r a l  and 
a n io n ic  com plexes s l i g h t l y  d e cre a se  (T ab le  5 . 3 6 ) .  The 
e x c e p t io n s  are  (H3l e u - c y s - l e u ) + and (H3g l y - c y s - g l y )  +  , 
which b oth  formed s o l i d  com p lexes .
In  c a s e  o f  (H3t h r - c y s - v a l )+ th e  s t a b i l i t y  c o n s ta n t  o f  th e  
c a t i o n i c  complex i s  u n u su a lly  low . The d e c r e a se  in  th e  111  
com plex i s  most l i k e l y  due t o  an e f f e c t  in  which th e  OH 
group o f  th e  th r e o n in e  s id e  ch ain  i n t e r a c t s  w ith  th e  
t h i o l a t e  S red u cin g  i t s  b a s i c i t y .  The 110 s t a b i l i t y  
c o n s ta n t  i s  much h ig h e r  than e x p e c te d . I t  can be due t o  
th e  h yd ro x y l b e in g  p a r t l y  in v o lv e d  in  c o o r d in a t io n ,  o r  no 
lo n g e r  having th e  bonding in f lu e n c e  d e s c r ib e d  above due t o  
changin g c o o r d in a t io n  s i t e s  on th e  l ig a n d  as  a r e s u l t  o f  
d e p r o to n a t io n .  The 1 1 -1  s t a b i l i t y  c o n s ta n t  was a l s o  found  
t o  be h ig h e r  than e x p e c te d .  A 211 com plex made th e  
re f in e m e n t  b e t t e r  by d e c r e a s in g  X , th e  R - f a c t o r  and th e  
o th e r  s t a t i s t i c a l  v a l u e s .  The p l o t  o f  % d i s t r i b u t i o n  
a g a i n s t  pH was found n ot t o  f o l l o w  a "G a u s s ia n "  form and
5 .7 .3  D is c u s s io n  on th e  s t a b i l i t y  c o n s ta n ts  o b ta in e d  f o r
th e  11 system
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( H ^ a s p -c y s -v a l ) + and (H3g l u t )  form com plexes w ith  h ig h  
s t a b i l i t y  c o n s t a n t s .  T h is  i s  most p ro b a b ly  due t o  th e  
f a c t  t h a t  th e  s id e  ch ain  CC^” group may be in v o lv e d  i n  
c o m p lex a tio n  w ith  th e  cadmium( I I ) .  In  th e  c a s e  o f  
g lu t a t h io n e  no 1 1 -1  complex was found t o  e x i s t  in  s o l u t i o n  
which c o n t r a s t s  w ith  th e  r e p o r t  o f  W il l ia m s  e t  
These au th o rs  a l s o  d e s c r ib e  th e  re fin e m e n t  o f  th e  21  
c o m p le x e s . No com plexes o f  t h i s  ty p e  were r e f i n e d  in  t h i s  
c a s e  by "M in iq u a d " .
The two t e t r a p e p t i d e s  were prepared in  o rd e r  t o  i d e n t i f y  
which c o o r d in a t in g  group , th e  amino or  th e  c a r b o x y l ,  i s  
more i n f l u e n t i a l  on c o o r d in a t io n  w ith  c a d m iu m (II) .  The 
backbone o f  th e  p e p tid e  was in c r e a s e d  f i r s t  on th e  amino 
s i d e ,  (H3v a l - v a l - c y s - v a l ) + , and then on th e  c a r b o x y l  s i d e ,  
(H3v a l - c y s - v a l - v a l ) + r e l a t i v e  t o  th e  (H3v a l - c y s - v a l ) + 
t r i p e p t i d e .  In (H3v a l - v a l - c y s - v a l ) + th e  te r m in a l  amino 
group i s  fu r t h e r  away from th e  t h i o l  group and in  th e  
l a t t e r  th e  c a r b o x y l  group . The 111 complex s t a b i l i t y  
c o n s ta n t  should  be a p p roxim ate ly  eq u al f o r  b oth  
t e t r a p e p t i d e s  w ith  p o s s i b l e  sm a ll  changes due t o  s t e r i c
e f f e c t s .  A lthough  (H3v a l - c y s - v a l - v a l ) + has a s l i g h t l y
• • + l a r g e r  s t a b i l i t y  c o n s ta n t  than (H3v a l - v a l - c y s - v a l ) f o r
th e  111 complex i t s  s t a b i l i t y  c o n sta n t  f o r  complex 110 i s
much lo w e r . From t h i s  i t  can be con clu ded  t h a t  th e
c a r b o x y l  group i s  more i n f l u e n t i a l  in  c o o r d in a t in g  w ith
form  and th e  m odel was t h e r e fo r e  r e j e c t e d .
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c a d m iu m (II) than th e  amino group i s .  Between (H3v a l - v a l -  
c y s - v a l ) + and (H3v a l - c y s - v a l )  + th e r e  a re  o n ly  minor  
d i f f e r e n c e s  in  s t a b i l i t y  c o n s t a n t s .  T h is  c o u ld  p o s s i b l y  
i n d i c a t e  t h a t  th e  amino group i s  not d i r e c t l y  in v o lv e d  in  
c o o r d in a t io n  a lth o u g h  i t  can a c t  as a b r id g in g  group t o  
form p o ly m eric  ty p e  com plexes ( 5 . 1 4 ) .
CH, CHo 
\  /
0  0  p n  0
: n n F /
H,N-CH -C-NH-CH-C-NH-CH-C  
1CH O
/ \  P 1*
CH3 CH3 I  Cd
»/ttt ~NH
CHo CHn
\  /o  V  . 0* i ■ CH /
H20(?) I I I v
CH-^-NH-CjH-C-NH-CH-^C
A0 p
CH3 CH3 S  C d ''
5.13
~ n h 2
• 9 1 6 • • ■P re v io u s  work w ith  n o n - c y s t e m y l  d i -  and t e t r a -
p e p t id e s  showed t h a t  th e  m ajor com plexes formed were th e
1 1 1 ,  110 and 1 1 - 1 .  T h e ir  com p lexa tion  c o n s t a n t s  were
much low er than th o s e  r e p o r te d  here f o r  p e p t id e s
c o n t a in in g  a c y s t e i n y l  amino a c id  r e s id u e .
2 7 0
5 . 7 . 4  D is c u s s io n  on th e  s t a b i l i t y  c o n s ta n ts  o b ta in e d  f o r  
th e  22 system
Model 22 f o l lo w s  a s i m i la r  sequence o f  s t a b i l i t y  c o n s t a n t s  
(T a b le  5 .3 7 )  as model 1 1 .  As h y d r o p h o b ic ity  o f  th e  s i d e -  
c h a in  in c r e a s e s  f o r  th e  hydrophobic p e p t i d e s ,  th e  
s t a b i l i t y  c o n s ta n ts  d e c r e a s e ,  w ith  th e  e x c e p t io n  o f  
(H3g l y - c y s - g l y ) + and (H3 l e u - c y s - l e u ) + . (H3v a l - c y s - v a l -  
v a l ) + and (H3v a l - v a l - c y s - v a l ) + have s i m i l a r  s t a b i l i t y  
c o n s t a n t s  f o r  com plexes 222 and 2 2 1 ,  bu t 220 shows th e  
g r e a t e s t  d i f f e r e n c e  due t o  th e  le n g th e n in g  o f  th e  p e p t id e  
b ack bon e.
(H4A s p - c y s - v a l )+ , (H3g l u t )  and H2c y s t e i n e  show a s i m i l a r  
p a t t e r n  o f  s t a b i l i t y  c o n s ta n ts  as t h e i r  11 c o m p le x e s .  
The 221 H2c y s t e i n e  complex was r e j e c t e d  i n d i c a t i n g  t h a t  no 
in te r m e d ia te  com plex i s  formed between 222 and 2 2 0 .
5 . 7 . 5  Chem ical and s t a t i s t i c a l  data  a n a l y s i s  o f  th e  m odels
Both th e  11 and 22 models seem t o  be c h e m ic a l ly  f e a s i b l e .  
One model i s  i n c o r r e c t  a lth ou gh  a good r e f in e m e n t  was 
o b ta in e d  f o r  b o th .  O v e r a l l  th e  11 model seems t o  f i t  a l l  
th e  p e p t i d e s ,  w ith  good c o n s is t e n c y ,  r e f i n i n g  a l l  t h r e e  
com plexes q u i t e  w e l l .  The 22 model r e f i n e s  2 2 2 ,  221 and
220 but en cou n ters  problem s on in tr o d u c in g  th e  2 2 -1  and 
2 2 -2  c o m p lex e s . A l l  th e  s t a t i s t i c a l  p aram eters were  
ta k en  i n t o  c o n s id e r a t io n  t o  come t o  an o v e r a l l  c o n c lu s io n  
as  w e l l  as th e  "G a u s s ia n "  % d is t r ib u t io n s  a g a i n s t  pH and 
th e  c o n s is t e n c y  o f  th e  model r e f i n e d .  The most im p ortan t
2 7 1
f a c t o r  le a d in g  t o  a d e c i s i o n  would be th e  ch em ic a l  
f a v o u r a b i l i t y  s in c e  th e  model chosen has t o  be c h e m ic a l ly  
and s t r u c t u r a l l y  r e a s o n a b le .
I f  th e  s t a t i s t i c a l  param eters are c o n s id e r e d  i t  i s  
ap p arent t h a t  sm a ll  e r r o r s  are  in tr o d u c e d  from th e  
d i s s o c i a t i o n  c o n s t a n t s ,  p r e v io u s ly  r e f i n e d .  The
c o m p lex a tio n  model must not t h e r e f o r e  be e x p e c te d  t o  have  
a b e t t e r  r e fin e m e n t  than t h a t  o f  th e  l ig a n d  d i s s o c i a t i o n  
c o n s t a n t s .  The l ig a n d s  (H3g l y - c y s - g l y )+ , (H3g l y - c y s -  
a l a ) + , (H3g l y - c y s - v a l ) + , (H3- v a l - c y s - v a l ) + and (H3l e u - c y s -  
l e u ) + fa v o u r  th e  22 model on a lm ost a l l  p a ra m e te rs ,  e x c e p t  
on th e  "g o o d n ess  o f  f i t "  f a c t o r ,  X2 , MCS and MCK. The 
d i f f e r e n c e  in  th e  v a lu e s  i s  n ot la r g e  enough t o  r e j e c t  th e  
22 model o u t r i g h t .
A lth ou gh  f o r  (H4 a s p - c y s ~ v a l )+ th e  22 model shows good  
re f in e m e n t  v i a  th e  R - f a c t o r ,  X2 , AM, MCS and MCK a re  
l a r g e r  than th o s e  f o r  th e  11 m odel. (H3g l u t )  shows th e  
same t r e n d .
The t e t r a p e p t i d e s  show a b e t t e r  X v a lu e  f o r  th e  11 m od el,  
a lth o u g h  th e  R - f a c t o r  i s  s m a lle r  f o r  th e  22 m od el. Due t o  
th e  X f a c t o r  b e in g  so  much la r g e r  f o r  th e  22 model th e  11 
model would be th e  f i r s t  c h o ic e  in  t h i s  c a s e .
(H3g l y - c y s - g l y ) + and (H3 l e u - c y s - l e u ) + both  formed c l e a r l y  
v i s i b l e ,  i n s o lu b l e  com plexes which d is tu r b e d  th e  
sm oothness o f  th e  t i t r a t i o n .  A l i t t l e  p r e c i p i t a t i o n  n ot
2 7 2
v i s i b l e  t o  th e  e y e ,  c o u ld  in tr o d u c e  sm a ll  e r r o r s  in  th e  pH 
r e a d in g s  w ith  th e  o th e r  p e p t i d e s .  T h is  would a f f e c t  th e  
pH measurements in  th e  range 6 . 5  t o  8 . 0 ,  p rod u cin g  a 
s l i g h t l y  high  R - f a c t o r .
Most o f  th e  % d is t r ib u t i o n  a g a in s t  pH p l o t s  show a p e r f e c t  
"G a u s s ia n "  c u rv es  f o r  model 1 1 ,  but t a i l  o f f  i n  some c a s e s  
f o r  th e  22 m odel.
The c o n c e n tr a t io n  o f  th e  r e a c t a n ts  were e x tr e m e ly  lo w ,  
(0 .0 0 0 5 M  in  0.1M  NaC104 s o lu t io n )  and t h e r e f o r e  th e  
chances o f  22 p o ly n u c le a r  com plexes form ing a re  low .
On t i t r a t i n g  H2c y s  and cadm ium (II) a g a i n s t  sodium  
h yd roxid e  and in tr o d u c in g  two com plexes i n t o  th e  computer  
model f o r  r e f in e m e n t ,  111 and 1 1 0 , th e  111 com plex was 
r e j e c t e d  and 110 r e f i n e d .  Complex 111 has been p r e v i o u s ly  
i s o l a t e d  and t h e r e f o r e  sh ou ld  e x i s t  in  s o l u t i o n .  Complex 
111 was now in tro d u c e d  t o  "M in iq u ad " a lo n e ,  where a good  
r e f in e m e n t  was o b ta in e d .  I l l  was then  in tr o d u c e d  as  a 
c o n s ta n t  and "M in iq u ad " was asked t o  r e f i n e  1 1 0 .  The 
com plex , 1 1 0 ,  was now r e f i n e d  and th e  s t a t i s t i c a l  d a ta  was 
im proved. I t  can be con clu ded  from t h i s  t h a t  th e  b e s t  
model r e f i n e d  i s  not n e c e s s a r i l y  th e  c o r r e c t  one and a 
com b in ation  o f  ch em ica l and good re fin e m e n t e v id e n c e  must  
be used  t o  produce a f i n a l  d e c i s i o n .
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5 .7 * 6  C o n c lu s io n s
The s t a b i l i t y  c o n s ta n ts  f o r  both  models and a l l  th e  
com plexes are  summarised in  T a b le s  5 .3 6  and 5 . 3 7 .
As th e  h y d r o p h o b ic ity  on th e  s id e -c h a i n  o f  th e  p e p t id e s  i s  
in c r e a s e d  th e  s t a b i l i t y  c o n s ta n ts  in  g e n e r a l  d e c r e a s e  due 
t o  s t e r i c  i n f lu e n c e s  which are  g r e a t e r  than th e  
e l e c t r o s t a t i c  o n e s .
On in t r o d u c t io n  o f  a non c o o r d in a t in g  h y d r o p h i l ic  group on 
th e  s id e  c h a in ,  such as h yd roxyl group , th e  111 o r  222  
complex s t a b i l i t y  c o n s ta n t  i s  reduced due t o  hydrogen  
bonding e f f e c t s .
On i n t r o d u c t io n  o f  a c o o r d in a t in g  h y d r o p h il ic  group on th e  
s id e  c h a in ,  such as a c a r b o x y l  group , th e  111 or  222  
com plex s t a b i l i t y  c o n s ta n t  in c r e a s e s  due t o  th e  c a r b o x y l  
group b e in g  in v o lv e d  in  c o o r d in a t io n .  The o th e r
s t a b i l i t y  c o n s ta n ts  f o r  com plexes 110 and 220 a l s o  
i n c r e a s e .
The most s t a b l e  mononuclear complex and th e  one m ost  
l i k e l y  t o  form a t  p h y s i o l o g i c a l  pH i s  th e  n e u t r a l  1 1 0 ,  
w h ile  f o r  a b in u c le a r  one i t  i s  th e  2 2 0 .
From th e  s t a b i l i t y  c o n s ta n ts  o f  (H3v a l - c y s - v a l - v a l ) + and 
(H3v a l - v a l - c y s - v a l ) + i t  can be conclu ded  t h a t  ( i )  th e  
c a r b o x y l  group i s  more i n f l u e n t i a l  in  c o o r d in a t io n  than  
th e  amino group, ( i i )  th e  su lp h y d ry l  and th e  c a r b o x y l
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grou p s on th e  same p e p t id e  b in d  t o  th e  same ca d m iu m (II).
Peptide Stability Constants
111 110 11-1
giy-cys-gty 14.04(0.06) 7.86(0.01) -1.58(0.02)
g|y-cys-ala 14.61(0.05) 7.87(0.05) -1 .8 6 (a i4 )
giy-cys-va! 14.54(0.54) 7.83(0.05) -1.67(0.10)
val-cys-val 14.32(0.06) 7.53(0.05) -2.29(0.09)
leu-cys-leu 14.42(0.07) 7.86(0.20)
va!-val-cys-val 14.14(0.09) 7.44(0.09) -3.77(0.15)
val-cys-val-val 14.43(0.06) 7.16(0.06) -2.91(0.17)
thr-cys-val 13.43(0.15) 7.57(0.07) -1.61(0.15)
asp-cys-val 14.77(0.07) 7.67(0.15) -1.76(0.18)
glutathione 16.27(0.04) 9.00(0.06) -----------
gluthathione110 17.02(0.02) 10.22(0.25) 0.29(0.63)
cysteine 16,67(0.10) 10.22(0.20) ------------
T a b le  5 . 3 6 .  Log v a lu e s  o f  s t a b i l i t y  c o n s t a n t s  f o r  11 
com plexes o f  v a r io u s  p e p tid e  l ig a n d s  w ith  
c a d m iu m (II) .
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Peptide Stability Constants
gly-cys-gly
gly-cys-ala
gly-cys-val
val-cys-val
thr-cys-val
222 221
32.42(0.10) 25.72(0.20)
32.61(0.11) 26.39(0.04)
32.24(0.27) 26.23(0.04)
31.88(0.12) 25.80(0.05)
leu-cys-leu 32.49(0.29) 26.94(0.04)
val-vai-cys-val 31.63(0.15) 25.40(0.21)
val-cys-val-vat 31.73(0.22) 25.37(0.21)
30.78(1.88) 25.38(0.10)
asp-cys-val 32.82(0.14) 26.52(0.21)
glutathione 35.78(0.09) 29.23(0.17)
cysteine 36.45(0.14) Rej
220
19.30(0.10)
18.97(0.17)
18.80(0.24)
18.22(0.14)
Rej
17.94(0.33)
17.00(0.36)
18.63(0.18)
18.50(0.28)
21.44(0.39)
25.61(0.08)
22-1
Rej.
Rej.
8.47(0.65)
Rej
7.65(0.26)
9.85(0.50)
9.95(0.16)
22-2
Rej
0.29(0.10)
Rej
-0.85(0.20)
7.56(0.40) Rej
Rej
10.09(0.27) Rej
Rej
Rej
T a b le  5 . 3 7 .  Log v a lu e s  o f  s t a b i l i t y  c o n s t a n t s  f o r  22 
com plexes o f  v a r io u s  p e p tid e  l ig a n d s  w ith  
cadm ium (II) •
276
REFERENCES
6 .0  R e fe re n ce s
( l a )  B . J . A y l e t t ,  in  "The Chem istry B io c h e m istr y  and
B io lo g y  o f  Cadmium", M.Webb e d . , 1 - 9 3 ,  E l s e v i e r ,
Amsterdam, 1 9 7 9 .
( l b )  B . J . A y l e t t ,  in  "Comprehensive In o rg a n ic  C h e m is tr y " ,
V o l . 2 .  Pergamon, 1 9 7 1 .  R ep rin ted  as  th e  "C h e m istry  
o f  Z in c ,  Cadmium and M ercu ry ",  Pergamon T e x ts  in  
In o rg a n ic  C h em istry , V o l .  1 8 ,  1 9 7 3 .
(2 )  N . I . S a x ,  in  "Dangerous P r o p e r t ie s  o f  I n d u s t r i a l  
M a t e r i a l s " ,  4 th  e d . ,  New Y ork , Van N ostrand  
R e in h o ld , 1 9 7 5 .
(3 )  E .E .C ,  H ealth  and S a fe t y  D i r e c t o r a t e .  C r i t e r i a  
(d ose  /  e f f e c t  r e l a t i o n s h i p )  f o r  Cadmium. O xford  
Pergamon P r e s s ,  1 9 7 8 .
(4 )  F .F r ie d b e r g ,  Q. Rev. B io p h y s . ,  1 9 7 4 ,  Zr 1 •
(5 )  A .D .M c In ty re  and C . F . M i l l s ,  in  " E c o l o g i c a l  
T o x ic o lo g y  R esearch ; E f f e c t s  o f  Heavy M e ta ls  and 
Organohalogen Compounds". New Y ork , Plenum P r e s s ,  
1 9 7 6 .
(6 )  A .K .K le i n  and H.J.Wichmann, J . A s s o c .  O f f .  A g r i c .  
Chem., 1 9 4 5 , 2 8 ,  2 5 7 .
(7 )  L .F r ib e r g  and E .O d e b la t ,  A c ta  P ath . M i c r o b i o l .  
S c a n d . , 1 9 5 7 ,  41,, 9 6 .
(8 )  J .H .R .K a g i  and B .L .V a l l e e ,  J .  B i o l .  Chem., 1 9 6 0 ,
2 3 5 , 3 4 6 0 .
(9 )  J .H .R .K a g i  and B . L .V a l l e e ,  J .  B i o l .  Chem., 1 9 6 1 ,
2 3 6 , 2 4 3 5 .
(1 0 )  M .P i s c a t o r ,  Nord. Hyg. T i d s k i ,  1 9 6 4 , 4jJ, 7 6 .
(1 1 )  M.Webb, Biochem. P h a rm a c o l.,  1 9 7 2 ,  2JL, 2 7 5 1 .
(1 2 )  G .F .N o rd b e rg , E n viron . P h y s i c o l ,  B io c h em ., 1 9 7 2 ,  2 ,  
7 .
(1 3 )  U .W esen, H.Rupp, F. Donay, F.Linnemann, W .V o e l t e r ,  
W .Voetch and G .Jung, Eur. J .  B io c h e m ., 1 9 7 3 ,  3 9 , 
1 2 7 .
(1 4 )  U .W esen, F.Donay and H.Rupps, FEBS L e t t . ,  1 9 7 3 ,  3 2 ,  
17 1 .
2 7 7
(1 5 )  I .B rem n er, in  "The Chem istry B io c h e m istr y  and
B io lo g y  o f  Cadmium", M.Webb e d . ,  1 7 5 - 1 9 3 ,  E l s e v i e r ,  
Amsterdam, 1 9 7 9 .
(1 6 )  P .P u l i d o ,  J .H .R .K a g i  and B .L .V a l l e e ,  B io c h e m is tr y ,  
1 9 6 6 , 5 ,  1 7 6 8 .
(1 7 )  B .C . S ta r c h e r ,  J .  N u t r . ,  1969 ,' 9 7 ,  3 2 1 .
(1 8 )  W .T .Johnson and G .W .E vans, Biochem. B io p h y s . R e s .  
Commun., 1 9 8 0 ,  5 2 1 .
(1 9 )  G .W .E vans, P .F .M a jo r s  and W .E .C o r n a tz e r ,  Biochem.
B io p h y s . R es . Commun., 1 9 7 0 ,  4 0 ,  1 1 4 2 .
(2 0 )  K .S .  Squibb , R. C o u s in s ,  B. S i l s o n  and S . L ew is ,  
Exp. M ol. P a th o l 1 9 7 6 , 2 5 ,  1 6 3 -1 7 1 .
(2 1 )  T . Taguchi and K. Nakanrura, T o x i c o l .  E n v iro n .
H e a lth ,  1 9 8 2 ,  9 ,  4 0 1 .
(2 2 )  E .S a b b io n i ,  R .M a ra fa n te , L .P i e t r a ,  L .A m a n tin i and 
L . U b e r t a l l i ,  P ro c . Cadmium Sym posium ., 1 9 7 8 ,  Jena  
DDR, 1 -3  A u g u st, 19 7 7 .
(2 3 )  F .O . Brady and M.Webb, J . B i o l .  Chem. , 1 9 8 1 ,  2 5 6 ,
3 9 3 1 .
(2 4 )  I .B rem ner and R .K .M ehra, Chem. S c i . ,  1 9 8 3 ,  2JL, 6 3 1 .
(2 5 )  F .O .B r a d y , Trends Biochem. S c i . ,  1 9 8 2 ,  l_t 1 4 3 .
(2 6 )  A .Z .S h a ik h  and J .C .S m it h ,  A b s t r .  I n t e r n a t .  C o n f . ,  
Heavy M e ta ls  in  th e  Environment, T o r o n t o . ,  1 9 7 5 ,  
2 7 - 3 1 ,  O c to b e r ,  1 3 -1 0 8 .
(2 7 )  A .J .Z e lo z o w s k i ,  J .J .G a r v e y  and J .D .H o e a c h e l le ,
A rch . B io p h y s . ,  1 9 8 4 ,  2 2 9 . 2 4 6 .
(2 8 )  J .K .P io t r o w s k i ,  W.Bolonowska and A .S a p o ta ,  A c ta
Biochem. P o l o n . ,  1 9 7 3 , 20., 2 0 7 - 2 1 5 .
(2 9 )  J .H .R .K a g i  and M .Nordberg, in  " M e t a l l o t h i o n e i n " ,
B irkh au ser  V e r la g  e d . ,  B oston , 1 9 7 9 .
(3 0 )  J .H .R .K a g i ,  M .Vasakh, K .L e rch , D .E .O .  G i l o f ,
P .H u n zik ov , W .R .B ernard and M.Good, E n v iro n . H e a lth  
P e r s p e c . ,  1 9 8 4 ,  5 4 ,  9 3 .
(3 1 )  A .J .Z e lo z o w s k i  and J .D .H o e s c h e l le ,  A rch . Biochem.
B io p h y s . ,  1 9 8 4 ,  2 2 9 ( 1 ) ,  2 4 6 .
2 7 8
M.Kimura, N .O ta k i  and T .K a k efu d a , in
" M e t a l l o t h i o n e i n " ,  J .H .R .K a g i  and M.Nordberg e d . . 
B irkh au ser  V e r la g ,  B o sto n , 19 7 9 .
S .K la u s e r ,  J .H .R .K a g i  and K .J .W i l s o n ,  Biochem. J . ,  
1 9 8 3 ,  2 0 9 ,  7 1 .
M .K a rin , C e l l ,  1 9 8 5 ,  4JL, 9 .
Y .K o jim a , C .B e r g e r ,  B .L .V a l l e e  and J .H .R .K a g i ,
P ro c . N a t .  A cad. S c i . ,  1 9 7 6 ,  7 3 , 3 4 1 3 .
Y .I .H u a n g ,  M.Kimura, H.Tsimou and A .Y o s h id a ,  J .  
B io ch em ., 1 9 8 1 ,  89., 1 8 3 9 .
D .R .W in ge , K .B .N e i l s o n ,  R .D .Z e ik u s  and W .R .G ra y , J .  
B i o l .  Chem., 1 9 8 4 ,  2 5 9 , 1 4 1 9 . •
Y .B o u la n g e r ,  C.M.Goodman, C .P .F o r t e ,  S .W .F e s ik  and 
I . M. A r m ita g e , P ro c . N a t i .  Amer. S c i .  ( U .S . A ) ,  1 9 8 3 ,  
8 0 /  1 5 0 1 .
M .M .K is s l in g  and J .H .R .K a g i ,  FEBS L e t t . ,  1 9 7 7 ,  82., 
2 4 7 .
H.Rupp and U .W esar, FEBS L e t t . ,  1 9 7 4 ,  44., 2 9 3 .
J .H .R .K a g i ,  P ro c . 5 th  I n t .  Congr. B io c h e m ., 1 9 7 0 ,  
1 3 0 .
J .D .O tv o s  and J .M .A r m ita g e , P ro c . N a t .  Acad. S c i .  
( U .S .A ) ,  1 9 8 0 , 7 7 ,  7 0 9 4 .
K .A .M e l i s ,  D .C .C a r t e r ,  D .S to u t  and D .R .W in g s ,  J .  
B i o l .  Chem., 1 9 8 3 ,  2 5 8 , 6 2 5 5 .
W .F .F u r r e y ,  A .H .R o b in s ,  L .L .C la n e y ,  D .R .W in g s ,  
B.C.Wang and C .D .S t o u t ,  S c ie n c e ,  1 9 8 6 ,  2 3 1 , 7 0 4 .
D .G .N e ttr e z h e im , H .R .E n gerseth  and J .D .O t v o s ,
B io c h em ., 1 9 8 5 ,  24./ 6 7 4 4 .
P .B .I s o p o u l o s ,  C. R. Acad. S c i . ,  S e r .  C, 1 9 7 4 ,  
2 7 8 , 2 6 3 .
B .L e n a r c ik  and M.Rzepka, P o l .  J .  Chem., 1 9 8 3 ,  5 7 . 
1 1 4 9 .
G .R . I .G u t z ,  J .  E le c tr o c h e m ., 1 9 8 5 ,  1 8 3 , 1 2 3 .
M .I t o ,  T .S h ib a t a  and Y . S a i t o ,  A c ta  C r y s t . ,  1 9 8 4 ,  
4 0 /  2 0 4 1 .
B .B o s n ic h ,  W.R.Kneen and A .T . P h i l i p ,  In o r g .  Chem., 
1 9 6 9 , 1 8 ,  2 5 6 7 .
J .H .W o r r e l l  and D .H .B usch , In o r g .  Chem., 1 9 6 9 ,  18., 
1 5 6 3 .
J .H .W o r r e l l  and D .H .B usch , In o r g .  Chem., 1 9 6 9 ,  1 8 . 
1 5 7 2 .
J .H .W o r r e l l  and C .R .F o r tu n e ,  J . In o r g .  Chem., 1 9 7 1 ,  
1 3 3 . 3 5 7 1 .
J .H .W o r r e l l ,  In o r g .  Chem., 1975 , JL4, 1 6 9 9 .
R .A .A n d erson  and M .L .T ob e , In o r g . Chem., 1 9 7 2 ,  1 6 , 
2 5 7 6 .
R .A .Goddard and J .H .W o r r e l l ,  In o r g .  Chem., 
1 9 7 7 , 1 1 6 ,  1 2 4 9 .
J .S im a , P .F od ran , J .H l e d i c ,  A .K o to co v a  and
D .V a l ig u r a ,  In o r g .  Chim. A c ta ,  1 9 8 4 ,  8 1 ,  1 4 3 .
N .W .A lc o c k , E .H .C u rzo n , P.Moore and C .P i e r p o i n t ,  J .  
Chem. S o c . ,  D alton  T r a n s . ,  1 9 8 4 ,  6 0 5 .
C .J .P e d e r s e n ,  J .  Chem. S o c . ,  Chem Comm., 1 9 8 6 ,  
1 0 2 0 .
E .Kim ura, Y .L i n ,  R.Machida and H .Zenda, J .  O rg.  
Chem., 1 9 7 1 ,  3 6 ,  2 5 5 .
W .Rosen, J .  Am. Chem. S o c . ,  1 9 6 9 ,  9 1 . 4 6 9 4 .
R .J .Dw yer and F .L i o n s ,  J .  Am. Chem. S o c . ,  1 9 5 0 ,  7 2 ,  
1 5 4 5 .
S .M .I q b a l  and L.M.Owen, J .  Chem. S o c . ,  1 9 6 0 ,  1 0 3 0 .
M .H arington  and J . P i t t - R i v e r s ,  Biochem. J . ,  1 9 4 4 ,  
3 8 ,  4 1 7 .
B .S a n d e l l ,  Ph.D T h e s i s ,  U n iv e r s i t y  o f  S u r r e y ,  1 9 8 3 .
S p e c i a l i s t  P e r io d ic a l  R e p o rts ,  The Chem ical  
S o c i e t y ,  London, 1 9 7 3 -1 9 7 7 ,  V o l .  1 - 5 .
M .N a r d e l l i ,  L .C a v a lc a  and A .B r a i b a n t i ,  G a z e t t a ,  
1 9 5 7 , 8 7 ,  13 7 .
A .D om in ican o , L . T o r e l l i ,  A .V a c ia g o  and
L .Z a m b o n e l l i ,  J .  Chem. S oc . (A ) ,  1 9 6 8 ,  1 3 5 1 .
2 8 0
B .F .H o sk in s  and B .P .K e l l y ,  In o r g .  N u c l .  Chem. 
L e t t . ,  1 9 7 2 ,  8 ,  8 7 5 .
E .F .E p s t e in  and I .B e r n a l ,  J .  Chem. S o c . ( A ) ,  1 9 7 1 ,  
3 6 2 8 .
M.Cannas, G .C a r ta ,  A . C r i s t i n i  and G .M arongiu , J .  
Chem. S o c . ,  D alton  T r a n s . ,  1 9 7 6 , 2 1 0 .
W .D .S c h a e f fe r ,  W .S .D o r se y , D .A .S k in n e r  and
G .C .C h r i s t i a n ,  J .  Am. Chem. S o c . ,  1 9 5 7 ,  7jK 5 8 7 0 .
V .H .P a u lu s ,  Z . A norg. A l l g .  Chem., 1 9 6 9 ,  3 6 9 ,  3 8 .
M .Cannas, G.Marongiu and G .S aba , J .  Chem. S o c .  
D alton  T r a n s . ,  1 9 8 0 ,  2 0 9 0 .
M .Cannas, A c ta  C r y s t . ,  1 9 7 8 , 3 4 ,  5 1 3 9 .
G .D .A n d r e t i ,  L .C a v a lc a ,  M - A .P e l l i n g h e l l i  and 
P .S g a r a b o t to ,  G azz . Chim. I t a l . ,  1 9 7 1 ,  1 0 1 , 4 8 8 .
H .V .A p o sh ia n , S c ie n c e ,  1 9 5 8 , 1 2 8 , 9 3 .
H .Shindo and T .L .B row n , J .  Am. Chem. S o c . ,  1 9 6 5 ,  
8 7 , 1 9 0 4 .
D .D .P e r r in  and I .G .S a y c e ,  J .  Chem. S o c . ,  1 9 6 8 ,  1,  
5 3 .
V .M .K o th a r i  and D .L .B u sc h , In o r g .  Chem., 1 9 6 9 ,  8 ,  
2 2 7 6 .
S .T se tsu m i and T.Kwan, Nippon Kagaku Z a s s h i ,  1 9 6 7 ,  
8 8 /  3 9 5 .
L .J . P o r t e r ,  D .D .P e r r in  and R.W .Hay, J .  Chem. S o c .
A , 1 9 6 9 , 1 1 8 .
J . E . L e t t e r  and B .J o rd a n , J .  Am. Chem. S o c . ,  1 9 7 5 ,  
9 7 ,  2 3 8 1 .
T .T .H uang and G .P .H a ig h t ,  Chem. Comm., 1 9 6 9 ,  9 8 5 .
G .D a v ie s ,  K .K u s t in  and R .F .P a s te r n a c k ,  T r a n s .  
Faraday S o c . ,  1 9 6 8 , 6 4 ,  10 0 6 .
B.Harman and I .S o v a g o ,  In o r g .  Chim. A c t a ,  1 9 8 3 ,  8 0 , 
7 5 .
O .Farooq and A .U .M a l ik ,  J .  E le c t r o a n .
Chem., I n t e r f a c i a l  E le c tr o c h e m ., 1 9 7 0 ,  2 6 ,  4 1 1 .
281
88) V .M .K o th a r i  and D .H .B u sch , In o r g .  Chem., 1 9 6 9 ,  8 ,  
2 2 7 6 .
89) M .D .W alker and D .R .W i l l ia m s ,  J .  Chem. S o c . ,  D a lto n  
T r a n s . ,  1 9 7 4 ,  1 1 8 6 .
90) A .C o l e ,  C .F u r n iv a l ,  Z . -X .H u a n g , D .C .J o n e s ,  P.M .M ay,  
R .L .S m ith ,  J .W h it ta k e r  and D .R .W i l l i a m s , I n o r g .  
Chim. A c t a ,  1 9 8 5 , M r  1 6 5 .
91) G .R .Lenz and A .E .M a r t e l l ,  B ioch em ., 1 9 6 4 ,  3 ,  7 4 5 .
92) Y .S i g i u r a ,  A.Yokoyama and H.Tanaka, Chem. Pharm. 
B u l l . ,  1 9 7 0 ,  1 8 ,  6 9 3 .
93) D .C .J ic h a  and D .H .B usch , In o r g . Chem., 1 9 6 2 ,  JL, 
8 7 2 .
94) A.Nakamura, T .T a k e n is h i  and M .T su b o i, I n t e r n a t i o n a l  
Symposium on M o le c u la r  S tr u c tu r e  and S p e c tr o s c o p y ,  
Tokyo, S e p t .  1 9 6 2 ,  p .  A 108 ; M .T su b o i,  T .T a k e n i s h i ,
A.Nakamura, Kagaku No P y o ik i ,  1 9 6 3 , N o .1 5 .
95) N .C .L i  and R .A .M anning, J .  Am. Chem. S o c . ,  1 9 5 5 ,  
7 7 ,  5 2 2 5 .
96) G .D .Z eg zh d a , V .N .Kabanova and F .M .T u ly u p a , R u ssian  
J . In o r g .  Chem., 1 9 7 5 ,  2 0 ,  1289 .
97) A .J .C a r t y  and N .J .T a y l o r ,  In o r g . Chem., 1 9 7 7 ,  1 6 ,
17 7 .
98) B.P.Bammel and R . F . E v i l i a ,  In o r g . Chim. A c t a ,  1 9 8 4 ,  
8 1 /  L5*
99) I . H . S u f f e t  and W .C .P urdy, J . E l e c t r o a n a l .  Chem.,  
1 9 6 6 ,  1 1 ,  3 0 2 .
100) H .C .Freem an, F.Huq and G .N .S te v e n s ,  J .  Chem. S o c . ,  
Chem. Comm., 1 9 7 6 ,  9 0 .
101) H .C .Freem an, G .N .S te v e n s  and I . F . T a y l o r ,  J .  Chem. 
S o c . ,  Chem. Comm., 1 9 7 4 ,  3 6 6 .
102) P .d e  M eester  and D .J .H od gson , J .  Am. Chem. S o c . ,
1 9 7 7 ,  9 9 ,  6 8 8 4 .
103) M .C laud e, M .P a r is ,  J .P .S c h a r f t ,  M .A p lin c o u r t  and
R .P .H u g e l ,  J .  Chem. R e s e a r c h (S ) ,  1 9 8 1 , 2 2 2 .
104) H .S a k u ra i ,  A.Yokoyama and H.Tanaka, Chem. Pharm. 
B u l l . ,  1 9 7 0 ,  1 8 ,  2 3 7 3 .
282
105
106
107
108
109
110  
111  
112
113
114
115
116
117
118
119
120  
121
122
E .F e l d e r ,  C .R e sc ig n o  and C .R a d ic e ,  G azz . Chim. 
I t a l . , 1 9 5 5 ,  8 5 ,  4 5 3 .
E .C .K n o b lo ck  and W .C .P urdy, R a d ia t io n  R e s . ,  1 9 6 1 ,  
1 5 , 9 4 .
N .d i  G .D e v o to , A .D ia z  and G . P a n t i c e l l i ,  Rend. 
Semin. F ac . S c i .  U ni. C a g l i a r i ,  1 9 7 3 ,  4 3 ,  6 5 .
D .T .C o r w in ,J r . ,  E .S .G r u f  and S .A .K o c h ,  J .  Chem. 
S o c . ,  Chem. Comm., 1 9 8 7 ,  9 6 6 .
D .D .P e r r in  and A .E .W a t t ,  B iochim . B io p h y s .  A c t a ,  
1 9 7 1 ,  2 3 0 ,  9 6 .
A .M .C o r r i e ,  M .D .W alker and D .R .W i l l i a m s , J .  Chem. 
S o c . ,  D alton  T r a n s . ,  1 9 7 6 ,  1 0 1 2 .
B .J .F u h r  and D .L .R a b e n s te in ,  J .  Am. Chem. S o c . ,  
1 9 7 3 ,  9 5 ,  6 9 4 4 .
B .B ir g e n s s o n ,  R .E .C a r t e r  and T .D rak en b erg , J .  Magn. 
R e s o n . ,  1 9 7 7 ,  .28, 2 9 9 .
Y .F u n ae , N .T o sh io k a , I .M i t a ,  T .S u g ih a r a ,  T .O g u ra ,  
Y.Nakamura and S.Kaw aguchi, Chem. Pharm. B u l l . ,  
1 9 7 1 ,  1 9 ,  1 6 1 8 .
Y .S u g iu r a ,  Y .H irayam a, H.Tanaka and H .S a k u r a i ,  J .  
In o r g .  N u c l .  Chem., 1 9 7 5 ,  37., 2 3 6 7 .
C .I .H .A s h b y ,  W .F .P aton  and T .L .B row n , J .  Am. Chem. 
S o c . ,  1 9 8 0 ,  1 0 2 , 2 9 9 0 .
Y .In o m a ta , T .T ak eu ch i and T .M oriw ak i, S p e ctro ch im .  
A c t a ,  1 9 8 4 , 40A, 1 7 9 .
G .K .C a rso n , P .A .W .D ean and M .J .S t i l l m a n ,  I n o r g .  
Chim. A c t a ,  1 9 8 1 ,  5 6 ,  5 9 .
G .K .C a rson  and P .A .W .D ea n , In o r g .  Chim. A c t a ,  1 9 8 2 ,  
6 6 , 1 5 7 .
A .J .C a n t y ,  R .K ish im o to , G .B .D eacon and
G. J . Farquharson, In o r g .  Chim. A c t a ,  1 9 7 6 ,  2 0 ,  1 6 1 .
N .R .K unchur, N atu re , 1 9 6 4 , 2 0 4 , 4 6 8 .
F .F .S a i d  and D .G .T u ck , In o r g .  Chim. A c t a ,  1 9 8 2 ,  59., 
1 .
C .R .L u ca s  and M .E .P each , Can. J .  Chem., 1 9 7 0 ,  4 8 , 
1 8 6 9 .
283
(124
(125
(126
(127
(128
(129
(130
(131
(132
(133
(134
(135
(136
(137
(138
(139
(123
(140
K .S.H agen and R.H.Holm , In o r g . Chem., 1 9 8 3 ,  2 2 ,  
3 1 7 1 .
I .G .D a n c e ,  A.Choy and M .L .S cu d d er , J .  Am. Chem. 
S o c . ,  1 9 8 4 ,  1 0 6 . 6 2 8 5 .
P .A .W .D ean and J . J . V i t t a l ,  J .  Am. Chem. S o c . ,  1 9 8 4 ,  
1 0 6 , 6 4 3 6 .
I .G .D a n c e ,  In o r g .  Chim. A c ta ,  1 9 8 5 ,  1 0 8 , 2 2 7 .
J .L .H e n c h e r ,  M.A.Khan, F .F .S a i d  and D .G .T u ck ,  
P olyh ed ron , 1 9 8 5 ,  4 ,  12 6 3 .
B .P.Kennedy and A .B .P .L e v e r ,  Can. J .  Chem., 1 9 7 2 ,  
M r  3 4 8 8 .
F .T e i x i d o r ,  L .E s c r i c h e ,  J .C a sa d o , E .M o lin s  and
C . M i r a v i t l l e s ,  In o r g .  Chem., 1 9 8 6 , 2 5 ,  4 0 6 0 .
F .T e i x i d o r ,  L .E s c r i c h e ,  I .R o d r iq u e z ,  J .C a s a b o ' ,  
J .R i u s ,  E .M o l in s ,  B .M a rtin ez  and C . M i r a v i t l l e s ,  J .  
Chem. S o c . ,  D alton  T r a n s . ,  1 9 8 9 ,  1 3 8 1 .
L .B u s t o s ,  M.A,Khan and D .G .T uck , Can. J .  Chem.,
1 9 8 3 ,  61,  1 1 4 6 .
J .C .B a y o n , M .C .B ran so , J .L .B r a n s o  and P .G .D u a r te ,  
I n o r g .  Chem., 1 9 7 9 , JL8, 3 4 7 8 .
J .C .B a y o n , P .G -D u arte  and J .V i v e s ,  J .  Chem. S o c . ,  
D alton  T r a n s . ,  1 9 8 4 , 2 6 7 1 .
H .B a r te ra  and F .T e i x i d o r ,  P olyh ed ron , 1 9 8 3 ,  2,
1 1 6 9 .
H .B .B u r g i ,  H .G eh rer , P .S t i c k l e r  and F .K .W in k le r ,  
H e lv . Chim. A c t a ,  1 9 7 6 ,  59., 2 5 5 8 .
R .A.HaHaberkorn, L .Q u e ,J r . ,  W .O .G ilum , R .H .H olm ,
C .S .L i u  and R .C .L o r d ,  In o r g .  Chem., 1 9 7 6 ,  lj5, 2 4 0 8 .
S . L a c e l l e ,  W .C .S te v e n s ,  D .M .K u r tz , J r .  and
J .W .R ic h a r d s o n ,J r . ,  R .A .J a ck b so n , In o r g .  Chem.,
1 9 8 4 ,  2 3 /  9 3 0 .
G .Schow arzenbach, K .G a u tc h i ,  J .P e t e r  and
K .T unaboylu , T ra n s . R. I n s t .  T e c h n o l . ,  S tock holm ,
1 9 7 2 ,  2 7 1 ,  2 9 5 .
P . S t r i c k l e r ,  J .  Chem. S o c . ,  Chem. Commun., 1 9 6 9 ,  
6 5 5 .
H . -B .B u r g i ,  H e lv .  Chim. A c ta ,  1 9 7 4 ,  5 7 ,  5 1 3 .
284
141)
142)
143)
144)
145)
146)
147)
148)
149)
150)
151)
152)
153)
154)
155)
156)
(1 5 7 )
K .S .H a g en , D .W .Stephan and R .H.Holm , I n o r g .  Chem.,
1 9 8 2 ,  2 1 ,  3 9 2 8 .
K .S .H a g en , J .M .B erg  and R.H.Holm , I n o r g .  Chim. 
A c t a ,  1 9 8 0 ,  4 5 ,  L 17 .
I .G .D a n c e ,  J .  Am. Chem. S o c . ,  1 9 7 9 , 1 0 1 , 6 2 6 4 .
J .L .H e n c h e r ,  M.Khan, F .F .S a i d  and D .G .T u ck , I n o r g .  
N u c l.  Chem. L e t t . ,  1 9 8 1 ,  1 7 ,  2 8 7 .
T .C o s t a ,  J .H .D orfm an, K .S .H agen and R .H .H olm ,
In o r g .  Chem., 1 9 8 1 ,  2j0, 2 5 6 8 .
I .G .D a n c e ,  M .L .Scudder and R.Secomb, I n o r g .  Chem.,
1 9 8 3 ,  2 2 ,  1 7 9 4 .
P .B lo n d ea u , C .B e r se  and D .G r a v e l ,  Can. J .  Chem ., 
1 9 6 7 ,  4 5 ,  4 9 .
S .R a tn e r  and H .T .C la r k e s ,  J .  Am. Chem. S o c . ,  1 9 3 7 ,  
5 9 ,  2 0 0 .
R .B .C e r e y  and L .P a u l i n g ,  P roc . R. S o c .  London, 
Ser B . ,  1 9 5 3 ,  1 4 1 . 1 0 .
N.G.Ramachandran and V .S a s is e k h a r a n , Adv. P r o t e in  
Chem., 1 9 6 8 ,  2 3 ,  2 8 3 .
F .K .W in k le r  and J .D .D u n it z ,  J .  M ol. B i o l . ,  1 9 7 1 ,  
5 9 ,  16 9 .
I . L . K a r l e ,  in  "P e p t i d e s :  C h em istry , S tr u c tu r e  and
B i o l o g y " ,  R .W a lt e r ,  J .M e ie n h o fe r  e d . ,  pp . 1 3 1 - 1 3 5 .  
Ann. A rb o r . S c i .  P u b l . ,  Ann. A r b o r . ,  M ich ig a n ,  
1 9 7 9 .
I . L . K a r l e ,  in  "C h em istry  and B io lo g y  o f  P e p t id e s "  
V .M e ie n h o fe r  e d . , pp. 1 1 7 -1 2 2 ,  Ann. A rb o r . S c i .  
P u b l . ,  Ann. A r b o r . ,  M ich igan , 1 9 7 9 .
S .S c h e in e r  and C .W .K ern , J .  Am. Chem. S o c . ,  1 9 7 7 ,  
9 9 ,  7 0 4 2 .
B .Pullm an and A .P u llm an , Adv. P r o te in  Chem., 1 9 7 4 ,  
2 8 ,  5 0 5 .
R .W a lt e r ,  I .B e r n a l  and L .F .J o h n so n , in  "C h em istry  
and B io lo g y  o f  P e p t id e s "  J .M e ie n h o fe r ,  e d . ,  p p .  
1 3 1 - 1 3 5 .  Ann. A r b o r .  S c i .  P u b l . ,  Ann. A r b o r . ,  
M ich igan , 1 9 7 9 .
R . L . H i l l ,  Adv. P r o te in  Chem., 1 9 6 5 , 2_0, 3 7 .
285
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
K .H .S h in ,  S .S a k a k ib a ra  and G .P .H e s s ,  B iochim .
B io p h y s . R es . Commun., 1 9 6 2 , 8 ,  2 8 8 .
S .S a k ib a r a ,  K .H .S h in  and P .G .H e s s ,  J .  Am. Chem 
S o c . ,  1 9 6 2 , 8 4 ,  4 9 2 1 .
J .L en ard  and G .P .H e s s ,  J .  B i o l .  Chem., 1 9 6 4 ,  2 3 9 ,  
3 2 7 5 .
H .B orsook , Adv. P r o te in  Chem., 1 9 5 3 ,  8 , 1 2 7 .
H .W e issb a ch , in  "M o le c u la r  Mechanisms o f  P r o te in  
B i o s y n t h e s i s " ,  S .P e s t k a ,  ed . Academic P r e s s ,  New 
Y ork , 1 9 7 1 .
P .N .S a t c h e l l ,  Chem. In d . (London), 1 9 7 4 ,  6 8 3 .
M .L .B en d er , Chem. R e v . ,  1 9 6 0 , 6j), 5 3 .
R .Schw yzer, M .F eu rer , B . I s e l i n  and H .K a g i ,  H e lv .  
Chim. A c t a ,  1 9 5 5 , J38, 6 9 .
F .M u za lew sk i,  in  "P e p t id e s  1 9 7 1 "  H .N esvabda, e d . ,  
pp. 3 9 - 4 4 ,  North H olland  P u b l . ,  Amsterdam, 1 9 7 3 .
R .G e ig e r  and W .K on ig , Chem. B e r . ,  1 9 7 3 ,  1 0 6 . 3 6 2 6 .
J .L .B a d a ,  J .  Am. Chem. S o c . ,  1 9 7 2 , 9 4 ,  1 3 7 1 .
J .L .B a d a ,  Nature (London), 1 9 7 4 , 2 5 2 . 3 7 9 .
M .W .W illia m s and G .T .Y ou n g, J .  Chem. S o c . ,  1 9 6 4 ,  
3 7 0 1 .
R .B .M e r r i f i e l d  and A .M .M a r g lin ,  in  "P e p t id e s  1 9 6 6 "
H. C . Bey erman, A . van de L in d e , W. Maas sen van de  
B rin k , e d . ,  pp . 8 5 - 9 0 .  North H ollan d  P u b l . ,  
Amsterdam, 1 9 6 7 .
R .B .M e r r i f i e l d ,  J .  Am. Chem. S o c . ,  1 9 6 3 ,  8 5 ,  2 1 4 9 .
R . B .M e r r i f i e l d ,  Adv. E n zym ol.,  1 9 6 9 ,  3 2 ,  2 2 1 .
R .C .S h ep p a rd , E .A th e r to n  and C .J .L o g a n , J .  Chem. 
S o c . ,  P erkin  T r a n s . ,  19 8 1 ,  JL, 5 3 8 .
R .C .S h ep p ard , Chem. B r . ,  1 9 8 3 ,  JL£, 4 0 2 .
A .D ry la n d  and R .C .S h ep p ard , J .  Chem. S o c . ,  P erk in  
T r a n s . ,  1 9 8 6 ,  1,  1 1 5 1 .
R .K i r s t g e n ,  R .C .Sheppard  and W .S t e g l i c h ,  J .  Chem. 
S o c . ,  Chem. Commun., 1 9 8 7 ,  1 8 7 0 .
286
178
179
180  
181  
182
183
184
185
186
187
188
189
190
191
192
193
194
R .C .S h ep p ard , Chem. B r . ,  19 8 8 , 2 4 ,  5 5 7 .
E .A th e r to n ,  H .F ox, D .H a rk iss  and R .C .S h e p p a rd , J .  
Chem. S o c . ,  Chem. Commun., 1 9 7 8 ,  4 5 8 .
A .R . M i t c h e l l ,  S .B .H .K e n t ,  M .Engelhard and
R .B .M e r r i f i e l d ,  J .  Org. Chem., 1 9 7 8 ,  4 3 ,  2 8 4 5 .
C .B i r r ,  W .L o c h in g e r , G .Stahnke and P .L an g , J u stu s  
L i e b ig s  Ann. Chem., 1 9 7 2 , 7 6 3 , 1 6 2 .
B .E .S an d b erg  and U .R agnarsson , I n t .  J .  P e p tid e  
P r o te in  R e s . ,  1 9 7 5 , 1_, 5 0 3 .
G .R .M atsueda and J .M .S tew ard , in  " P e p t i d e s :
C h em istry , S tr u c tu r e  and B i o l o g y " ,  p p . 3 3 3 - 3 3 9 ,  
R .B .W a lt e r ,  J .M e ie n h o fe r ,  e d . ,  Ann. A r b o r .  S c i .  
P u b l . ,  Ann. A r b o r .  M itc h ig a n , 1 9 7 5 .
C .D.Chang and J .M e ie n h o fe r ,  I n t .  J .  P e p tid e  P r o te in  
R e s . ,  1 9 7 8 ,  1 1 ,  2 4 6 - 2 4 9 .
G.Barany and R .B .M e r r i f i e l d ,  in  "The P e p t i d e s " ,
2 ,  pp . 1 - 2 8 4 .  E .G r o s s ,  J .M e ie n h o fe r  e d . ,  Academic  
P r e s s ,  New York , 1 9 8 0 .
S .B .H .K e n t ,  A .R .M i t c h e l l ,  M .Engelhard  and
R .B .M e r r i f i e l d ,  P roc . N a t l .  Acad. S c i . ,  1 9 7 9 ,  7 6 ,
2 1 8 0 .
J .T .L u c a s ,  B .M .P rystow sky and B .W .E r ic k s o n ,  P r o c .  
N a t l .  A cad . S c i . ,  1 9 8 1 ,  7 8 ,  2 7 9 1 .
K .C .H o o p er , H.N.Rydon, K .A .S c h o f i e ld  and
G .S .H e a to n ,  J .  B i o l .  Chem., 1 9 5 6 ,  3 1 4 8 .
A . L o f f e t  and J .C l o s e ,  in  " P e p t i d e s " ,  E .B r i c a s  e d . ,  
N orth H o lla n d , Amsterdam, pp 1 8 5 - 1 8 9 ,  1 9 6 8 .
Y .F u n ae , Y.Nakamura and S.Kaw aguchi, Chem. Pharm. 
B u l l .  (J p n ) ,  1 9 7 1 ,  1 9 ,  1 6 1 8 .
A .M .C o r r i e ,  G .K ,R .M akar, M .L .D .T ouche and
R .D .W i l l ia m s ,  J .  Chem. S o c . ,  D alton  T r a n s . ,  1 9 7 5 ,  
1 0 5 .
A .A v d e e f  and J .A .B row n , In o r g .  Chim. A c t a ,  1 9 8 4 ,  
91,  6 7 .
M .J .A .R a in e r  and B .M .R ode, In o r g . Chim. A c t a ,  1 9 8 2 ,  
5 2 /  5 9 .
D .R eedy, B .Sethuram  and T .N av a n eeth ra o , In d . J .  
Chem., 1 9 8 1 ,  2 0 ,  1 5 0 .
2 8 7
(1 9 5 )  G .S .M a l ik ,  S .P .S in g h  and J .P .T a n d o n , In d . J .  Chem.,  
19 8 0 , 1 9 ,  9 2 2 .
(1 9 6 )  G .S .M a l ik ,  S .P .S i n g h ,  J .P .Tandon and J .F .P r a k t .  
C h em ie .,  1 9 7 8 , 5 ,  3 2 4 .
(1 9 7 )  J .D .J o s h i ,  J .  In d . Chem. S o c . ,  1 9 8 4 ,  6 1 ,  2 5 7 .
(1 9 8 )  K .S .B a i ,  P olyhed ron , 1 9 8 3 ,  2 ,  5 1 3 .
(1 9 9 )  I .S o v a g o ,  Symp. In o r g .  Biochem. M o lec . B io p h y s .  
1 9 8 6 ,  6 3 .
(2 0 0 )  I .S o v a g o ,  A .G e r g e ly ,  B.Harman and T. K i s s ,  Magy. 
Kem. F o l y . , 1 9 7 9 ,  8 5 , 81 .
(2 0 1 )  H .M atsu i and H .O h ta k i ,  Polyhedron, 1 9 8 3 ,  2 ,  6 3 1 .
(2 0 2 )  S .Takeshim a and H .S a k u ra i ,  In o r g .  Chim. A c t a ,  1 9 8 2 ,  
6 2 ,  1 1 9 .
(2 0 3 )  D .C .J o n e s ,  G .L .S m ith ,  P.M.May and D .R .W i l l ia m s ,
In o r g .  Chim. A c t a ,  1 9 8 4 ,  93., 9 3 .
(2 0 4 )  P .G o n z a le z -D u a r te  and J .V i v e s ,  In o r g .  Chem., 1 9 8 9 ,  
2 8 ,  2 5 .
(2 0 5 )  D .L .R a b e n s te in ,  R.Guevremont and C .A .E v a n s ,  M et.  
I o n s .  B i o l .  S ystem s, 1 9 7 9 ,  9., 11 9 .
(2 0 6 )  M . I s r a e l i  and L . D . P e t t i t ,  J .  In o r g .  N u c l .  Chem., 
1 9 7 5 , 3 7 ,  9 9 9 .
(2 0 7 )  G .A ren a , R . C a l l ,  V .C u c in o tta  and S .M usum eci,
E . R i z z a v a l l i ,  J .  Chem. S o c . ,  D alton  T r a n s . ,  1 9 8 4 ,
1 6 5 1 .
(2 0 8 )  R .S .S a n d h i l l  and R.Kumar, Thermochimica A c t a ,  1 9 8 1 ,  
4 3 ,  1 0 3 .
(2 0 9 )  H . S i g e l ,  K .H .S c h e l le r  and R .M .M ilb u rn , I n o r g .  
Chem., 1 9 8 4 ,  2 3 ,  1 9 3 3 .
(2 1 0 )  H .M a tsu i,  J .  In o r g .  N u c l .  Chem., 1 9 8 1 ,  4 3 ,  2 1 8 7 .
(2 1 1 )  A .D em aret, T .M h ir i ,  M .F o u r a ti ,  L .A b e l l o  and
G .L a p lu y e , J .  Chem. R e s e a r c h (S ) ,  1 9 7 9 ,  3 2 8 .
(2 1 2 )  I .S o v a g o ,  K .Varnagy and A .B e n y e i ,  Magy. Kem. F o l y . ,  
1 9 8 6 , 9 2 ,  1 1 4 .
(2 1 3 )  G .B .G a v i o l i ,  M .B o r s a r i ,  .C .P e l la c a n i  and L.Menabue,  
M .S o la ,  In o r g .  Chem., 1 9 8 8 , 2 7 ,  1 5 8 7 .
288
(215
(216
(217
(218
(219
(220
(221
(222
(223
(224
(225
(226
(227
(228
(229
(230
(231
(232
(214
(233
L .L om ozik , A .Woclechowska and M .J a s k o ls k i ,
M o n a tsh efte  Fur Chemie, 1 9 8 3 , 1 1 4 , 1 1 8 5 .
A .P .B r u n e t t i ,  E .J -B u r k e ,  M .C.Lim and G .H .N a n c o l la s ,  
J . S o lu t io n  Chem., 1 9 7 2 , 1,  1 5 3 .
G .A .R en a , Ann. C h im ., 1 9 8 4 ,  74., 3 9 9 .
R .S .Sandhu and R.Kumar, J .  In d . Chem. S o c . ,  1 9 8 1 ,  
M ,  6 5 9 .
N .F .E w e is s ,  M .S .E l -E z a b y  and J .M .A l -H a s s a n ,  J .
U n iv . Kuwait ( S c i . ) ,  1 9 8 4 , 1 1 , 7 5 .
R .S .S a x e n a ,  A .G u p ta , K .C .G upta and T .K a u r , A c ta  
Chim. H un garica , 1 9 8 3 ,  1 1 3 . 139 .
R .S .S a x e n a  and A .G u p ta , Chemica S c r i p t a ,  1 9 8 3 ,  2 2 , 
6 9 .
R .S .S a x e n a  and P .S in g h ,  In d . J . Chem., 1 9 7 0 ,  J8, 7 6 .
N .G u p ta , C .P .S .C h a n d e l ,  P .C .G u p ta  and C .M .G u p ta ,  
B u l l .  Chem. S o c . J p n . ,  1 9 8 3 ,  5 6 ,  3 1 3 8 .
S .N .P ra b h u , S .S .K e lk a r  and B .A.Nem ade, J .
E lecrochem . S o c .  I n d i a . ,  1 9 8 0 ,  29., 1 7 8 .
M .M .P alrech a  and J .N .G a u r , J . E le c tro c h e m . S o c .
I n d i a . ,  1 9 7 9 ,  2 8 ,  2 3 3 .
D .G .D h uley  and V .G .D o n g re , In d . J .  Chem., 1 9 8 1 ,  
2 0 ,  2 0 8 .
K.Nag and P .B a n e r je e ,  J .  In o r g .  N u c l .  Chem., 1 9 7 4 ,  
3 6 ,  2 1 4 9 .
A .R .A g g a r w a l,  K .B .Pandeya and R .P .S in g h ,  Ann.
C h im ., 1 9 8 1 ,  7 1 ,  3 8 7 .
V .G .D o g r e ,  In o r g .  Chim. A c ta ,  1 9 8 3 , 7 3 ,  2 8 1 .
A .R .A g g a r w a l,  H .K .A r o r a ,  K .B .Pandeya and R .P .S in g h ,  
J . In o r g .  N u c l .  Chem., 1 9 8 1 ,  4 3 ,  6 0 1 .
G.L.Cumming, J . S . R o l l e t  and J . C . R o s s o t t i ,  J .  Chem. 
S o c . ,  D alton  T r a n s . ,  1 9 5 2 , 2 6 5 2 .
R .R o b b rec h t , H .S te y a e r t  and H .P .Thun, B u l l .  S o c .  
Chim. B e l g . ,  1 9 7 3 ,  5 0 5 .
L . G . S i l l e n ,  A c ta  Chem. S c a n d . , 1 9 6 2 ,  JL6., 1 5 9 .  
L . G . S i l l e n ,  A cta  Chem. S c a n d . ,  1 9 6 4 ,  JL8, 1 0 8 5 .
289
(234 )
(2 3 5 )
(2 3 6 )  
(237a )  
(237b )  
(2 3 7 c )
(2 3 8 )
(2 3 9 )
(2 4 0 )
(2 4 1 )
(2 4 2 )
(2 4 3 )
(2 4 4 )
(2 4 5 )
(2 4 6 )
(2 4 7 )
(2 4 8 )
(2 4 9 )
(2 5 0 )
(2 5 1 )
D .D .P e r r in  and I .G .S a y c e ,  J .  Chem. S o c . ( A ) ,  1 9 6 7 ,  
8 2 .
R .S .T o b ia s  and M .Yasuda, In o r g .  Chem., 1 9 6 3 ,  1 2 , 
1 3 0 7 .
I .G .S a y c e ,  T a la n ta ,  1 9 6 8 ,  JL5, 1 3 9 7 .
I .G .S a y c e ,  T a la n ta ,  1 9 7 1 , 18., 6 5 3 ,
I .G .S a y c e ,  T a la n ta ,  1 9 7 2 , 19., 8 3 1 .
W .A .E .M cB ryde, T a la n ta ,  19 7 2 , JL£, I 4 8 6 .
A .S a b a t i n i  and A .V a c c a ,  J . Chem. S o c . ,  D a lto n  
T r a n s . ,  1 9 7 2 ,  16 9 3 .
P.Gans and A .V a c c a ,  T a la n ta ,  19 7 4 , 21 ,  4 5 .
A .S a b a t i n i ,  A .V a cca  and P .G ans, T a la n t a ,  1 9 7 4 ,  2 1 , 
5 3 .
P .G an s, A .S a b a t i n i  and A .V a c c a , I n o r g .  Chim. A c t a ,  
1 9 7 6 ,  1 8 /  2 3 7 .
A .S a b a t i n i  and A .V a c c a ,  J .  Chem. S o c . ,  D a lto n  
T r a n s . ,  1 9 8 5 ,  1 1 9 5 .
P .J .J o c e l y n ,  in  "B io c h e m istr y  o f  th e  T h io l  G r o u p ",  
Academic P r e s s ,  London and New York , 1 9 7 2 .
A .G e r g e ly ,  M et. Ion s B i o l .  System s, 1 9 7 9 ,  9 ,  7 7 .
N .W .P i r i e  and K .G .P in h e y , J . B i o l .  Chem., 1 9 2 9 ,  8 4 ,  
3 2 1 .
D .L .R a b e n s te in ,  J .  Am. Chem. S o c . ,  1 9 7 3 ,  £ 5 ,  2 7 9 7 .
R .B .M a r tin  and J . T . E d s a l l ,  B u l l .  S o c .  Chim. B i o l . ,  
1 9 5 8 ,  4 0 /  1 7 6 3 .
N .C . L i ,  O.Gawron and G .B a seu a s , J .  Am. Chem. S o c . ,  
1 9 5 4 ,  7 6 ,  2 2 5 .
A .G e r g e ly  and I .S o v a g o ,  Met. I o n s .  B i o l .  S y stem s,  
19 7 9 , 9 ,  1 0 3 -1 4 1 .
R .E .B e n e sc h , J .  Am. Chem. S o c . ,  1 9 5 5 , 77., 5 8 7 7 .
D.M.E.Reuben and T .C .B r u ic e ,  J . Am. Chem. S o c . ,  
1 9 7 6 , 9 8 /  H 4 .
290
(2 5 2 )  A .A l b e r t  and E .P .S e r j e a n t ,  in  "The D eterm in a tio n  o f  
I o n i s a t i o n  C o n s t a n t s " ,  pp. 1 - 4 3 ,  Chapman and H a l l  
L td ,  London, 1 9 7 1 .
(2 5 3 )  A .J .B a r d ,  in  "C hem ical E q u i l ib r iu m " ,  p p . 1 - 4 5 ,  
Harper and Row, New York , E ranston and London, 
1 9 6 6 .
(2 5 4 )  M .T .B ec k , in  "C h em istry  o f  Complex E q u i l i b r i a " ,  pp.  
1 3 - 8 8 ,  Van N ostrand R einh old  Company, London, 1 9 7 0 .
291
